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Abstract 
A high and increasing proportion of people in the United Kingdom are living with a 
long-term condition (DH, 2005a).  The National Health Service is facing the 
challenge of increased pressure on its service provision.  Government Policy has 
placed emphasis on supporting individuals to self-care (Department of Health, 
2005a, c).  However, there are specific challenges associated with living with a long-
term condition, and in particular the psychosocial aspects of illness when set 
alongside a clinical approach to care (Gabe et al, 2004, Bury et al, 2005)  It has been 
argued that disclosure of illness may in itself be a self-care strategy (Munir et al, 
2005).  However, to date individuals‟ experiences of disclosure of long-term 
conditions are neither clearly defined nor its role in managing a long-term condition 
fully understood.  The aims of the study were to explore the role of disclosure in the 
management of a long-term health condition.  The study drew on constructivist 
grounded theory (Charmaz, 2006) undertaking thirty-five in-depth qualitative 
interviews (fifteen people living with epilepsy, and twenty people living with type 1 
diabetes) recruited from patient support groups and clinical nurse specialist‟s clinics.   
This study identified that strategies of disclosure are not necessarily fixed but may be 
subject to change over time.  “Learning about disclosure” is an integral part of living 
with a long-term condition.  Three key disclosure roles were identified: (1) access to 
self-care and social support, (2) non-disclosure (concealment) of the condition to 
protect one‟s identity from stigma. (3) redressing myths about the condition in 
advance: to avoid perceived stigma. 
The findings provide important insights that could enable health care professionals to 
develop more of an emphasis on including disclosure as an issue when talking to 
15 
patients about managing type 1 diabetes and epilepsy and this is also relevant to a 
broad spectrum of long-term conditions.  
16 
1.0 CHAPTER ONE: INTRODUCTION 
1.1 Introduction 
Disclosure, the act of telling others about one‟s health condition may at first appear 
to be a simple process, yet “who” to tell, “when” to tell and “how” to tell are 
complex decisions for those people who are living with long-term conditions.  The 
current role which disclosure plays in the lives of those living with a long-term 
condition is poorly understood and this thesis addresses this gap in understanding.   
The introductory chapter presents an overview of the rationale for the study, the 
research objectives, and the structure of the thesis. 
1.2 The Rationale for the Study  
1.3 Long-term Conditions 
There are a large number of people in the UK living with a long-term health 
condition.  It was recently reported that as many as seventeen and a half million 
people in the United Kingdom are living with long-term health conditions such as 
diabetes and epilepsy (Department of Health, 2005a).  As a consequence of these 
high numbers, it has been argued that the National Health Service  is facing a new 
challenge as to how its services will cope to meet the: “needs and expectations of 
increasing numbers of people with long-term medical conditions” (Department of 
Health, 2005b, p7).  Recent Government Policy has placed increasing emphasis on 
self-care approaches to manage long-term conditions (Department of Health, 2005a, 
c).  Indeed as many as 70-80% of those living with a long-term condition are 
arguably able to self-care (Department of Health, 2005a).  It has been proposed that a 
feature of self-care may include gaining appropriate social support (Clark et al 1991, 
Gallant, 2003, Munir et al, 2005).   
17 
Living with a long-term condition can be particularly challenging for individuals 
because they are unlikely to be “cured.” As a consequence, daily management of 
long-term conditions may be required (LTCA, 2005; Gabe et al, 2004, Holman and 
Lorig 2000). As Holman and Lorig (2000) note: “with chronic disease, the patient‟s 
life is irreversibly changed” (p.527).   
1.4 Disclosure of Long-term Conditions Research 
Despite the relatively high number of people living with a long-term condition and 
the resulting challenges which they face, there is little understanding of disclosure of 
long-term conditions.  The means by which individuals decide to disclose their 
condition and how they cope with the responses to such disclosure, particularly for 
those with conditions which may not be immediately obvious to others, is not 
evident (Joachim and Acorn, 2000).  For example, a gap has been left in terms of: 
“the decision and experience of disclosing one‟s illness to…friends, family or work 
colleagues” (Williams and Healy, 2001 p109).  As a consequence, the nature and 
role of disclosure remain unclear.   
1.5 The Research Gap 
Choosing whether to disclose one‟s illness to another is an important decision to take 
for those with long-term conditions (Joachim and Acorn, 2000).  However, many of 
the studies on disclosure have adopted a quantitative approach to determine factors 
which may influence decisions to disclose (Beatty, 2004, Munir et al, 2005,).  As a 
consequence, the decisions and rationale for disclosure remain unclear.  
Furthermore, previous studies on disclosure of illness are often set within specific 
contexts such as the workplace (Fesko, 2001, Beatty, 2004, Munir et al, 2005), yet it 
is important to explore the role of disclosure across different settings.  There have 
18 
been a number of studies of disclosure in the field of psychology (Jourard, 1971, 
Pennebaker et al, 1986, 1988, 1990, 1999, Derlerga et al, 1993).  However 
psychological research has focused upon the area disclosure in relation to revealing 
personal information about the “self” rather than disclosure of illness.  Psychological 
studies have also predominantly adopted objective measurement approaches such as 
questionnaires to study disclosure, leading to a gap in subjective understanding 
(Jourard, 1971, Derlerga, 1979, Pennebaker et al, 1988, 1990, 1999).  There is 
therefore a need for additional research on individuals‟ experiences of disclosure of 
illness.  Several studies have called for additional research on disclosure within the 
field of health care research (Joachim and Acorn, 2000, Williams and Healy, 2001).  
The aim of this study is to contribute towards filling this gap in research.   
As managing long-term conditions are now considered to be a key challenge for the 
National Health Service, understanding how individuals cope with this and the role 
which disclosure plays in assisting in this process may lead to an improvement in 
patient care.  In the context of current policy which stresses the importance of self-
care and the provision of “patient-centred” care, clarification and theoretical 
development of the role of disclosure would be particularly timely.   
1.6 Research Objectives  
This study has been designed to address and explore the following research question: 
What is the role of disclosure in managing a long-term condition?   
1.7 Structure of the Thesis  
The remaining thesis chapters have been organised as follows:  
Chapter Two presents the literature review.  It begins with a review of government 
policy on long-term conditions, then presents existing evidence on disclosure, and 
19 
identifies gaps in the research.  The chapter concludes by arguing that exploratory 
research is required into the role of disclosure in managing a long-term condition 
using an inductive, qualitative approach. 
Chapter Three presents a consideration of the most appropriate research 
methodology to address the aims of the study.  Previous studies on disclosure have 
focused upon objective measurement, rather than subjective understanding; in other 
words using questionnaires rather than qualitative interviews (Munir et al 2005, 
Beatty, 2004).  Here it is argued that an exploratory, qualitative research 
methodology is best suited to the study because it will provide insight into the role 
of disclosure of illness from the individual‟s perspective.  Grounded theory is 
identified as an appropriate approach to adopt in the current study.  An overview of 
the debates within grounded theory is presented.  Following this it is concluded that 
constructivist grounded theory is the most appropriate methodological framework 
for the current study (Charmaz, 2006). 
Chapter Four presents the methods.  The methods employed in this study are open- 
ended, qualitative interviews conducted with participants living with either type 1 
diabetes (insulin dependent) or epilepsy.  Interviews with twenty members of patient 
support groups, and fifteen attendees at clinical nurse specialist clinics were 
undertaken. The process of conducting the interviews is discussed and the 
implications for fieldwork issues are considered.  
Chapter Five presents the findings of the study concerning the role of disclosure as 
follows.  The study findings provide valuable insights into the nature of disclosure, 
the process by which disclosure occurs and the role of disclosure in the lives of those 
living with type 1 diabetes or epilepsy.  Section one presents the nature and the 
20 
process of disclosure across both conditions illustrating that it is deemed to be a 
highly personal matter, the process of disclosure illustrating that disclosure may 
occur in a broad range of ways.  Section two presents mediating issues around 
disclosure which influence decisions to disclose or not.  Section three presents an 
overview of the challenge of disclosure: “who needs to know?” identifying the role 
of disclosure as facilitating access to self-care and social support.  The role of 
disclosure in the workplace is set out.  Section four presents findings which identify 
a process of “learning about disclosure”: disclosure is a dynamic process subject to 
change over time.  Firstly patient support group findings are set out illustrating the 
role of strategic disclosure and redressing myths about the condition in advance.  
Secondly, nurse specialist findings are set identifying the role of non-disclosure in 
order to avoid perceived stigma.  Finally, Section five set outs views on information 
needs, sources of information and the role of patient support groups and nurse 
specialist clinics in the provision of information on disclosure.  
In summary, three roles for disclosure are identified: (1) access to self-care and 
social support, (2) redressing myths about the condition in advance: “preventive 
telling” to avoid perceived stigma and (3) non-disclosure (concealment) of the 
condition to protect one‟s identity from stigma.  The generic findings are further 
explored in the discussion chapter.  
Chapter Six presents the discussion and study conclusions as follows: there are two 
parts to this chapter.  Part one of this chapter sets out a discussion of the findings, 
within the context of current evidence and health care agenda.  A conceptual 
framework of disclosure is presented.   
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The conceptual framework of disclosure has six elements: 1. Nature: the essence of 
disclosure, (what?). 2. Process: the manner in which disclosure occurs, (how?), 3. 
Context: in which disclosure occurs, (where?), 4. Mediators which are taken into 
account when considering disclosure, 5. The Role of disclosure, (why?) its purpose 
and role, 6. Living with a long-term condition: the overarching challenges of living 
with a long-term condition including: the enduring nature of the condition, managing 
the medical, managing the social elements of the condition, and managing 
disclosure: namely the process of “learning about disclosure” over time. 
Part two of this chapter sets out the credibility of the current study, the lessons 
learned from the study and reflects upon the process of adopting constructivist 
grounded theory as the methodological framework for this study.  The specific 
implications of the study findings for health care practice, policy, education and 
future research are presented.  Finally the study conclusions are set out noting that 
living with a long-term condition is an increasingly common feature in individuals‟ 
lives and a crucial element of managing a long-term condition includes the process 
of “learning about disclosure”.  
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2.0 CHAPTER TWO: LITERATURE REVIEW 
2.1 Introduction  
This chapter argues that to date disclosure of long-term conditions is neither clearly 
defined as a concept nor fully understood and so its role in relation to living with and 
managing a long-term condition requires additional exploration. In this chapter I 
review the literature on disclosure of long-term conditions and in particular illustrate 
the need for further research of the role which disclosure plays in the field of health 
care research.   
Firstly, this chapter sets the scene for the study noting that a high proportion of 
people in the United Kingdom (UK) are living with a long-term condition 
(Department of Health, 2005a).  The Government‟s policy response to long-term 
conditions is set out including the rationale for individuals to increase levels of self-
care.  Secondly, there are particular challenges associated with living with a long-
term condition and so key features of enduring conditions are discussed, and in 
particular the relevance of understanding the psychosocial aspects of illness set 
alongside a clinical approach to care (Gabe et al, 2004, Bury et al, 2005a).  It has 
been argued that disclosure of illness may in itself be a self-management strategy 
(Munir et al, 2005).  Whilst there has been considerable sociological research on 
living with long-term conditions, the role of disclosure has been arguably neglected. 
Thirdly, the limitations of existing studies of disclosure of illness with respect to the 
measurement and definitions are also discussed.   Finally the argument is presented 
for the need for further research on the role of disclosure within the lives of those 
living with epilepsy or type 1 diabetes.  
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2.2 Sources of Literature 
The role of the literature review in this study is to set out the broad parameters of the 
study and in order to: “critique earlier studies and theories and to make 
comparisons” (Charmaz, 2006, p164.).  This includes a review of studies across 
disciplines.  
The following electronic databases were searched: EMBASE, MEDLINE, 
PSYCHINFO, CINAHL, BRITISH NURSING INDEX, AMED, INDEX TO 
THESES and DISSERTATION ABSTRACTS.  This is set out in further detail in the 
appendix (Appendix 1).  The term disclosure is used to identify studies but 
additional terms were also used and referred to as MESH terms and free text terms.  
For example: Self-Disclosure, Concealment, Truth-Disclosure, Secrets.   
The bibliographies of all the articles/books were reviewed to identify relevant 
material.  The keywords used in relevant journal articles were noted to assist 
accessing relevant information in the future.  Hand searches of relevant journals 
were undertaken (Journal of Advanced Nursing, Social Science and Medicine, 
British Medical Journal).  Relevant websites were also searched; MIND UK, 
Disability UK,  Diabetes UK, Epilepsy Action, and the Department of Work and 
Pensions in order to identify information on workplace legislation for those living 
with long-term conditions.  
2.3 Setting the Scene: The Context for Further Research on Long-term 
Conditions 
2.4 The Rise in the Number of People Living with a Long-term Condition 
It has been recently reported that as many as seventeen and a half million people in 
the UK are living with a long-term condition (Department of Health, 2005a).  Long-
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term conditions are on the rise not only within the United Kingdom and are among 
the leading reported causes of illness and deaths globally (Horton, 2005).  The World 
Health Organisation suggests that such conditions will be the leading cause of 
disability by the year 2020 (Department of Health, 2004). There may be several 
reasons for this increase.  The UK population is ageing and at the same time fertility 
rates are decreasing leading to significant demographic changes (Department of 
Health, 2008, Gabe et al, 2004).  Older people are more likely to have a long-term 
condition: as many as 75% of those aged over seventy-five years old.  Furthermore, 
45% of those aged over seventy-five years old are likely to have co-morbidities: 
more than one long-term condition (Department of Health, 2005a, 2004).  As a 
consequence of people living longer, long-term conditions associated with the 
elderly such as arthritis, stroke, dementia, Parkinson‟s disease, heart disease and 
cancer have increased (Gabe et al, 2004, Department of Health, 2001a,b).  Estimates 
suggest that the proportion of people aged sixty-five years and over living with a 
long-term condition will double by the year 2030 (Department of Health, 2004).  
However, long-term conditions are not confined solely to older people.  Younger 
people are affected by long-term conditions.  For example, Multiple Sclerosis affects 
around 85,000 people each year and is most likely to be diagnosed in individuals 
between the ages of twenty and forty-years old (Multiple Sclerosis Society, 2008,  
Department of Health, 2001a).  Furthermore, 1.5 million children are living with 
asthma and around 14,500 children living with arthritis (Department of Health, 
2001b).  People of all ages and backgrounds are affected by a range of conditions 
(LTCA Website, 2005). The Long-term Conditions Alliance (LTCA) a charity 
whose remit is to represent the needs of those with such conditions, and advise 
policy makers has over one hundred member organisations representing diverse 
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conditions including: Acquired Immune Deficiency Syndrome (AIDS), cancer, 
stroke and diabetes (LTCA Website, 2005).   
The increase in those living with long-term conditions has had an impact upon health 
services and therefore treatment costs, as they are higher users of both primary and 
secondary care (Department of Health, 2005a, 2008) and this also applies to both 
social and community care services, such as community nurse services (Department 
of Health, 2008).  These trends are likely to increase in line with the rise in the 
number of older people in the population (Department of Health, 2008).  Indeed, 
around 80% of visits to General Practitioners and eight of the top eleven causes of 
hospital admissions concern people living with long-term conditions (Department of 
Health, 2004, 2005a).  A significant proportion of health care resources are therefore 
spent upon those living with long-term conditions: around 69% of the health and 
social care budget in England (Department of Health, 2008).  The high costs of 
caring for large numbers of people with such conditions has led to a number of 
policy initiatives being developed to manage the financial implications of this rise on 
the health care budget.  
2.5 The Challenges of Living with a Long-term Condition  
Long-term conditions can be particularly challenging because they are unlikely to be 
“cured” and therefore likely to remain a “long term” and enduring feature of the 
individual‟s life (Gabe et al, 2004, LTCA Website, 2005, Bury et al, 2005a).  Long-
term conditions are defined by the government as: “those conditions that cannot, at 
present, be cured, but can be controlled by medication and other therapies” 
(Department of Health, 2008, p10).  As Holman and Lorig (2000) note: “With 
chronic disease, the patient‟s life is irreversibly changed” (p.527).  The focus shifts 
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therefore from curing the condition to learning how to manage it.  Daily management 
of long-term conditions may be required such as taking medication and lifestyle 
adjustments.  
2.6 The Policy Response to the Rise in Long-term Conditions  
The rise in the numbers of people experiencing long-term conditions has become an 
area of concern for policy makers and it has been argued that the National Health 
Service is facing a test as to how its services will cope: “The NHS faces the 
challenge of responding to the needs and expectations of increasing numbers of 
people with long-term medical conditions” (Department of Health, 2005d p7.).  In 
order to meet the challenge of long-term conditions there have been numerous 
legislative documents published on this subject (Department of Health, 2001b, 2004, 
2005a,d,e,f, 2008). The following policy documents relate to legislation in England 
and Wales.  The publication of the policy documents, Saving Lives; Our Healthier 
Nation (Department of Health, 1999) and, The NHS Plan (Department of Health, 
2000) were key documents which set out the Government‟s agenda for a National 
Health Service and argued that health services should be: “designed around the 
patient” (Department of Health, 1999, 2000, 2005b).  The White Paper, Our health, 
our care, our say: a new direction for community services (Department of Health, 
2006) sets out to give people greater participation by involving their views in the 
provision of services and the NHS Plan and White Paper legislative documents are 
relevant to long-term conditions because they underpin the need to provide care to 
this group. In the context of legislation which places increased emphasis upon 
addressing the needs of service users, research which can further explore the means 
by which they manage such conditions may be particularly timely.  In the next 
section I go on to discuss the introduction of policy supporting the self-care of long-
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term conditions.  
2.7 The Rationale for Self-Care 
A key element of The NHS Plan (Department of Health, 2000) included the 
promotion of self-care to aid the development of patient-centred services.  The 
National Service Framework for long-term conditions (2005) and The NHS 
Improvement Plan (Department of Health, 2004) further set out an agenda to 
improve self-care of long-term conditions (Department of Health, 2005d).  Self-care 
is defined in policy documents as related to daily living: “It is the care taken by 
individuals towards their own health and well being, and includes the care extended 
to their children, family, friends and others in neighbourhoods and local 
communities” (Department of Health, 2005f p.1).  Government policy also defines 
self-care to include eating healthily, exercising regularly, limiting alcohol 
consumption and refraining from, or giving up smoking (Department of Health, 
2005f).  However, the extent to which these goals are achievable is questionable 
given that the symptoms of many long-term conditions may limit their ability to 
undertake these actions.  For example conditions such as chronic pain may 
sometimes prevent individual‟s from participating in exercise (Diamond and 
Coniam, 1997).   
Self-care is presented in government policy in terms of “enabling” those living with 
long-term conditions: “Promoting independence, empowering patients and allowing 
them to take control of their lives, and prolonging and extending the quality of life” 
(Department of Health, 2005a, p.7).  The underlying message of this definition of 
self-care is that those living with long-term conditions have a role to play in 
improving their quality of life. Through learning skills to assist them to manage their 
28 
condition, they have the potential to improve and extend their quality of life with the 
possibility of minimising the deterioration of the condition (Department of Health, 
2001a).  However this generic approach may not be applicable to the diverse range 
of conditions and individuals‟ experiences of living with long term conditions. 
Despite the renewed focus of policy makers the concept of self-care is not new but 
rather has existed for many years in the lives of those living with long-term 
conditions (Bury et al, 2005a).  The increasing number of people living with long-
term conditions has also led to a call for greater recognition of the key role which the 
patient plays in the management of their health care.  As Holman and Lorig (2000) 
note:“health care can be delivered more effectively and efficiently if patients are full 
partners in the process” (p526).  The Government‟s policy on self-care appears to be 
resource driven and emanating from financial concerns over the increase in the use 
of health services rather than as a consideration from the patients perspective.  The 
Government has set targets to reduce the number of contacts people living with long-
term conditions have with services; visits to general practitioner by 24% to 69% and 
hospital admissions by 50% (Department of Health, 2008).  However, the diverse 
range and symptoms of long-term conditions have not been fully taken into account 
in such policy documents which have a generic approach yet strongly argue the 
relevance of “self-care” in the daily lives of individuals (Department of Health, 
2005a, e).  
Different interventions are thought to be appropriate for those living with long-term 
conditions and a three-tiered model was developed and outlined in the Department of 
Health (2005a) policy document: Supporting People with Long-term conditions, An 
NHS and Social Care Model (Figure 1).   
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Figure 1 The NHS and Social Care Long-term Conditions Model (Department 
of Health, 2005a) 
 
“Level 3: Case management - requires the identification of the very high intensity 
user of unplanned secondary care. Care for these patients is to be managed using a 
community matron or other professional using a case management approach, to 
anticipate, co-ordinate and join up health and social care.  
Level 2: Disease-specific care management - This involves providing people who 
have a complex single need or multiple conditions with responsive, specialist 
services using multi-disciplinary teams and disease-specific protocols and pathways, 
such as the National Service Frameworks and Quality and Outcomes Framework. 
Level 1: Supported self-care - collaboratively helping individuals and their carers 
to develop the knowledge, skills and experience to care for themselves and their 
condition effectively”. 
(Figure reproduced from: Supporting People with Long-term conditions, An 
NHS and Social Care Model, Department of Health, 2005a, p10).
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A new nursing role has been specifically developed implying that long-term 
conditions are an area of concern for the government.  The new post of „community 
matron‟ was set out in the NHS Improvement Plan (Department of Health, 2004) and 
created to explicitly address the management of long-term conditions.  The role is to 
provide advanced clinical nursing skills and a case management approach for those 
with long-term conditions at risk of hospitalisation, co-ordinating both health and 
social services care (Department of Health, 2005d, University of the West of 
England, 2007).   
The intention is that community matrons will be in regular contact with those 
individuals who are considered to be high users of health care and their role is to 
enable patients to be treated at home rather than in hospital (Department of Health, 
2007a).  An evaluation of the delivery of the national pilot education programme to 
prepare nurses to take up the role of community matrons has been conducted 
(University of the West of England, 2007).  The evaluation found that patients 
reported to nurses that the community matrons‟ role had improved their quality of 
life.  However the community matrons stated that they faced organisational 
challenges when seeking to co-ordinate both health and social care services 
(University of West of England, 2007).  
Policy documents have placed an increasing focus on supporting the majority of 
those living with long-term conditions to self-care: 70-80% of the population 
(Department of Health, 2005a).  Given that there are many different kinds of long-
term conditions it is questionable the extent to which such a large group might be 
able to self-care or be informed as to what self-care constitutes.   
Against the backdrop of proliferation of policy on self-care, public attitudes to self-
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care, and what it means to individuals, remains poorly understood (Ellins and 
Coulter, 2005).  Indeed, there is a lack of consensus regarding what the terms self-
management or self-care constitute (McGowan, 2005, Coulter and Ellins, 2006).  
These terms are frequently employed interchangeably yet they are not the same 
(Coulter and Ellins, 2006).  As McGowan (2005) notes: “to date there is no “gold 
standard” universally accepted definition of self-management…several terms are 
used (and) include: self-management preparation/training: patient empowerment; 
and self-care…the terms imply varying specification regarding attributes, roles and 
responsibilities of both people with chronic health conditions and health care 
providers (p1). 
Studies suggest that self-care of a condition may not be a straightforward process 
because it involves understanding and reacting to symptoms as well as adopting 
medication regimes (Clark et al 1991, Gallant, 2003).  Large scale quantitative 
surveys of public attitudes to self-care suggest that whilst some groups want to self-
care, certain groups may need additional assistance in this area (Department of 
Health, 2005c, Ellins and Coulter, 2005).  These may be groups such as the elderly, 
ethnic minorities and those of low socio-economic status who may be in poor health 
(Department of Health, 2005c).  Overall, Ellins and Coulter, (2005) note: “relatively 
little is known about the capacity of patients and the public to be successful 
managers on their health and healthcare” (p31).  A telephone survey to explore 
public attitudes to self-care was conducted although it had a low response rate (19%) 
and so the results may not be generalisable (Ellins and Coulter, 2005).  Furthermore 
the format of the questions was pre-fixed and so the breadth of individuals‟ 
subjective experiences of self-care may not have been fully captured (Ellins and 
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Coulter, 2005).  However it is one of the few studies which has examined public 
attitudes to self-care. 
There does appear to be a gap between the policy agenda and the everyday 
experiences of living with a long-term condition.  For example, the policy documents 
have presented a generic approach to the management of all long-term conditions 
and does not acknowledge their diversity such as complex medication regimes, 
diverse range of symptoms, ages and access to services (Department of Health, 
2005a,e).  It may be important to do so however, given that the self-care needs of an 
individual with diabetes may differ substantially to those of an individual living with 
epilepsy. The complex and evolving symptoms of managing certain long-term 
conditions do not appear to have been taken into account yet they may limit an 
individual‟s ability to self-care. 
2.8 Self-management Training Programme 
The policy document The Expert Patient: a New Approach to Chronic Disease 
Management for the 21st Century recommended the introduction of a self-
management training programme the Expert Patient to the NHS (Department of 
Health, 2005b).   
The Expert Patient Programme is a six week course teaching self-care skills and is 
an adapted version of the Chronic Disease Self-management Programme developed 
by Kate Lorig and colleagues at Stanford University, California, (Lorig et al 1999).  
It is a lay-led rather than health professional-led programme that follows a scripted 
course and is open to anyone with a long-term condition: it is not condition specific.  
It sets out to provide “confidence, skills and knowledge” in order to assist the patient 
to manage their condition (Expert Patient Website, 2005).  One of the areas which it 
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covers is “communication” with family, friends, and health professionals.  However 
the intention of the communication training is unclear, for example if it is to garner 
social support or whether it covers areas such as how to disclose one‟s condition to 
others.   
The self-management training is underpinned by Bandura‟s (1997) psychological 
concept, “self-efficacy” the intention of which is to build confidence and help 
individuals to set goals and achieve tasks (Bandura, 1997).  However the group 
settings in the Expert Patient Programme may not be appropriate for all those living 
with long-term conditions.  Also, setting psychological goals may bear little relation 
to the practical challenges they face in living with the condition on a daily basis. 
Overall, the evaluation of the self-management courses has been conducted primarily 
in the United States in the form of large randomised controlled trials (Lorig et al 
1999).  Limited work was undertaken within the United Kingdom health care context 
prior to their introduction.  Studies which have evaluated the effectiveness of such 
courses have focused only upon the short term, rather than the long-term outcomes 
(Bury et al, 2005a).  Therefore there is limited evidence to support the introduction 
of such courses to England.  Furthermore those who join the groups are not 
necessarily typical of those living with a long-term condition because they are “self-
selecting” and so evaluations may not capture the diverse range of views of what it 
means to live with a long-term condition. 
Since the introduction of the courses the report of the evaluation of the Expert 
Patients Programme in England has been published, highlighting a number of 
limitations to the courses (Rogers et al, 2006).  The qualitative research element of 
the evaluation found that attendees felt that the course did not assist them in the 
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development of new self-care approaches but rather re-affirmed their current self-
care strategies.  Participants also criticised the generic approach of the course, 
arguing that a condition specific approach would have been more helpful. 
The findings from the randomised controlled trial element of the evaluation found no 
significant reduction in the use of primary or secondary care services amongst course 
attendees (Rogers et al, 2006).  Overall, the evaluation notes the narrow nature of the 
course and the fact that it: “does not currently acknowledge the broader social issues 
and needs relevant to living with a long-term condition” (Rogers et al, 2006, p5).   
The introduction of the courses does however suggest that policy makers accept that 
individuals need to be supported in managing their condition.  Whilst the courses 
may prove beneficial to some, they may also exclude large sections of those living 
with long-term conditions.  For example, those who are unable to travel as a result of 
their condition, and those undergoing intensive treatment.  Furthermore, some people 
living with a long-term condition may not wish to attend a group meeting.  Also it is 
unclear the extent to which disclosing to others about long term conditions is 
covered and since the course is scripted there may be little opportunity to diverge 
from key topics. 
In summary, overall, policy documents suggest that a range of tools and strategies 
are required to manage one‟s health.  These involve making decisions, planning 
ahead, managing symptoms, making use of support, and being a “partner” with one‟s 
clinician, such as discussing and making joint decisions.  However, the policy 
documents tend to represent a generic approach to the management of all long-term 
conditions and as such do not take into account that individuals living with such 
conditions may require different approaches.   
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The sociological literature on long-term conditions (in contrast to the work cited in 
policy documents) is primarily qualitative and does acknowledge the psychosocial 
impact of living with such conditions and takes broader contextual issues into 
account. As Bury et al (2005a) note, “awareness of the varied social processes 
underpinning everyday life warn against…normative statements about what patients 
should do” (p20).  Therefore such “normative statements” set out in policy work 
adopt a prescriptive approach to individuals‟ health behaviours, yet the broader 
contextual issues question this approach to changing individuals behaviour.  In the 
next section I will argue that it is also important to consider the psychosocial aspects 
of living with such conditions.  
2.9 The Psychosocial Impact of Living with a Long-term Condition  
A number of studies concerning the psychosocial aspects of living with long-term 
conditions have been conducted within the social sciences.  Indeed, some have 
argued that it is precisely because of the non-curable and therefore enduring nature 
of long-term conditions that it is a serious topic of study for medical sociologists 
(Gabe et al, 2004).  As Strauss (1975) noted some time ago: “Chronic illness… is 
here to stay.  It will not vanish” (p.7).  Psychosocial studies suggest that aside from 
the medical difficulties, the social impact of living with a long-term condition is 
equally important to take into account (Strauss, 1975).  Studies have illustrated that 
the symptoms of long-term conditions can have a serious impact on the individual‟s 
ability to participate in daily activities which in turn may have a negative impact on 
their identity (Radley, 1989, Bury, 1982, 1991, Charmaz, 1991).  Indeed, Radley 
(1989) has argued, the unpredictable symptoms of long-term conditions may limit 
the everyday activities of individuals and so influence psychosocial aspects of their 
lives: “the unpredictable yet pressing demands of the body which dictate the terms in 
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which that day shall be lived and personal relationships engaged in” (p.232).  
Furthermore, having a long term condition can affect others around them for 
example partners, family or work colleagues.  The symptoms of the condition can 
also lead to being misunderstood by others, which in turn can result in social 
isolation (LTCA Website, 2005).  
2.10 Identity 
Charmaz (1983) has described the limitations which long-term conditions may place 
on an individual to constitute “loss of self” because the condition changes how they 
view themselves.  She argues that living with pain and the subsequent limiting effect 
it has on an individual‟s ability to participate in everyday life constitute a form of 
“suffering” and individuals fear “becoming a burden” to others around them 
(Charmaz 1983).  In one key sociological study, Bury (1982) has argued that the 
impact of living with a long-term condition is so significant it completely changes 
individuals‟ lives, not only clinically but the entire context of their lives.  Bury 
(1982) describes the impact of living with a long-term condition to constitute: 
“biographical disruption.”  In other words the condition completely disrupts what 
individuals previously considered to be their “normal identity.”  This concept has 
been widely adopted in studies and reviews of long-term conditions within the 
sociological field (Williams, 2000).  Bury (1982) conducted qualitative interviews 
with individuals recently diagnosed with rheumatoid arthritis to explore how people 
deal with and acknowledge the condition.  Specifically Bury (1982) argues that 
being diagnosed with a long-term condition had three key impacts on the individual:  
an awareness of symptoms, which led to seeking clinical intervention, the condition 
changed how people viewed themselves because they were now “sick”; and 
“disruption” which indicated the new limitation the condition had placed on the 
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individual‟s everyday, “taken for granted life” spanning all areas including 
relationships (Bury, 1982).  More recently, however, the term “biographical 
disruption” has been critiqued by Williams (2000) who questions the relevance of 
the term for the diverse group of people living with a long-term condition.   Williams 
(2000) cited three potential limitations which need to be taken into account:  
 the model focuses upon the disruption experienced only by those who are in 
adulthood and thus excludes younger people and those born with a condition 
who may not consider it to be a disruption 
 the model excludes a consideration of class, age, gender and ethnic minority 
views on disruption 
 it does not take into account that issues of timing and context, norms and 
expectations may affect how individuals perceive long-term conditions. 
In summary, the symptoms of a long-term condition may limit individuals‟ ability to 
participate fully in everyday activities.  Furthermore, such conditions are unlikely to 
be cured and so individuals must adapt to living with them throughout their lives. 
Sociological studies have set out to further explore the psychosocial impacts of 
living with long-term conditions and highlighted that it may have a major impact on 
an individual‟s identity.  This suggests that not only is it difficult to live with a long-
term condition but individuals may employ strategies to manage it.  Psychosocial 
studies highlight how individuals‟ perceive that the broader social aspects of their 
lives must be taken into account as well as the medical aspects of the condition.  For 
example, several studies have argued that having access to social support is 
beneficial to one‟s health (Davison et al, 2000, Wang et al, 2005, Magliano et al, 
2006).  Whilst there has been considerable research on the sociological aspects of 
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living with long-term conditions what is arguably neglected however is the role of 
disclosure. The link between self-care, social support, and disclosure as they relate to 
health is now discussed. 
2.11 Self-Care, Social Support and Disclosure  
It has been argued that a feature of self-care may include gaining appropriate social 
support (Clark et al 1991, Gallant, 2003, Munir et al 2005).  For example, a recent 
study of disclosure of illness in the workplace states:“disclosing an illness may elicit 
social support from colleagues and line managers by increasing their understanding 
of the effects of the illness” (Munir et al 2005, p.1398). 
Studies which have investigated the link between social support and long-term 
conditions, suggest it is beneficial to have people with whom you can converse 
(Davison et al, 2000, Wang et al, 2005, Magliano et al, 2006).  Social support may 
play a positive role in physical and emotional health (Wang et al, 2005). Yet, access 
to social support may not be straightforward as factors such as gender, level of 
education, earnings and employment may influence access to social networks 
(Magliano et al, 2006).  However, individuals with a similar condition may be able 
to offer social support.  For example, the support group “Alcoholics Anonymous”, 
recommended that an important route to recovery is through the shared experiences 
of others with the same condition (Davison et al, 2000).   
A relatively new source of social support for those with long-term conditions is the 
Internet.  Online forums offer the opportunity to discuss symptoms and other issues 
with those who have similar conditions.  A major advantage of these forums is that, 
in contrast to group settings, they are accessible at all times (White and Dorman, 
2001).  They may also offer one of the few opportunities for those living with a rare 
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condition to discuss issues with others in a similar situation (White and Dorman, 
2001). 
Whether on the Internet or through a self-help group, talking about the condition is 
clearly important.  Williams and Healy‟s (2001) study of those with mental 
conditions also suggests that it is beneficial: “talking to friends, family members or 
seeking professional help avoided some of the problems of burden” (p111).  Davison 
et al (2000) argue that individuals make sense of their condition through talking to 
others such as friends and family or clinicians.  This may offer a key source of 
support.  Yet this feature of self-care, such as accessing social support or talking to 
others about one‟s health, has not been explicitly outlined in the definition of 
governmental self-care policy documents or community self-management 
programmes.   
2.12 Stigma and Disclosure Research  
A key factor which may preclude disclosure of condition and access to social support 
is the stigma associated with certain long-term conditions such as mental health or 
Human Immunodeficiency Virus (HIV), (Williams and Healy, 2001, Fesko, 2001).  
A number of studies of long-term conditions have identified fear of stigma to be a 
reason for not disclosing their condition to others (Williams and Healy, 2001, Fesko, 
2001, Joachim and Acorn, 2003, Chapple et al, 2004).  Stigma has been associated 
with long-term conditions because one of the difficulties of living with them is the 
negative impact they have on an individual‟s identity:  being “discredited” or 
perceived as “different” to others around you (Goffman, 1963, Charmaz, 1983, 
Scambler, 1989, Rogers et al, 1999, Mason et al, 2001, Gabe, et al, 2004).  The 
origins of research on stigma lie with the sociologist Erving Goffman who conducted 
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a seminal study of patients in a psychiatric hospital in the 1960s (Goffman, 1963). 
Goffman, (1963) has defined stigma as: “an attribute that is deeply discrediting 
within a particular social interaction”(p3).  The original meaning of stigma stems 
from the Greeks and referred to those with physical marks on their body such as 
brandings.  Such marks were seen as a token of shame or disgrace and thus denoted 
people to be avoided in public (Goffman, 1963).  He argues that the majority, “the 
normal” group, perceives groups who are labelled with stigma as “inferior:” “by 
definition, of course, we believe the person with a stigma is not quite human” 
(Goffman, 1963, p.15).  In contrast “the normals” are those people who fit societies‟ 
expectations of a “normal identity.” 
Goffman (1963) refers to: “the discredited and the discreditable.”  In his view the 
people with stigma are “the discredited” and everyone knows about their limitation.  
In contrast, the “discreditable” controls who knows about his limitation which is not 
directly obvious to others.  Goffman (1963) argues that there is a decision to be made 
concerning disclosure of information to others:“To display or not to display; to tell 
or not to tell; to let on or not to let on; to lie or not to lie; and in each case, to whom, 
how, when, and where”(p.57).  
He refers to the process of hiding something discreditable as “passing” the intention 
of which is to remain part of the “normal” group.  He refers to “covering” as a 
process of not concealing the condition completely, but attempting to minimise its 
importance (Goffman, 1963).   
To relate this to the current topic of disclosure of long-term conditions, those living 
with such conditions may therefore face a dilemma, to risk disclosing or not.  Several 
studies have described the decision to disclose to others to be a “double-edged 
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sword” (Williams and Healy 2001, Fesko, 2001).  On the one hand, it may lead to 
not only a diagnosis but better social support, yet on the other hand it comes at the 
cost of disclosure which may result in one being stigmatised.  Decisions as to whom 
to interact with are, he argues, a key issue for those with long-term conditions 
associated with stigma in order to: “minimize the obtrusiveness of their stigma” 
(Goffman, 1963, p127).  In other words, the “normals” are those who do not have a 
long-term condition and so fit into societies‟ expectations of a normal “identity.”   
However, Goffman‟s (1963) work on stigma is relatively dated now and it is 
important to consider whether perceptions of stigma have evolved over time, in 
terms of others reactions to disclosure.  Furthermore it is questionable as to whether 
his terms can be applied universally, given that those living with long-term 
conditions are not a homogenous group.  
A study of mental health service users highlighted such dilemmas for those 
considering disclosure of illness to others: “seeking help may result in a 
diagnosis…at the cost of disclosure and potential labelling and stigma” (Williams 
and Healy, 2001, p.115).  Others have argued that in order to cope with the stigma 
associated with a long-term condition, strategic decisions must be made concerning 
disclosure of illness to whom and how much to tell others (Joachim and Acorn, 
2000).  A study of the rare disease scleroderma suggested that disclosure of illness 
was strategic because individuals selected whom to tell about their illness based on 
the assumption of positive responses: “most participants strategically decided when 
to tell and when not to tell about the illness” (Joachim and Acorn, 2003, p602).   
Perceptions of the means by which the person contracted the long-term condition 
may influence others‟ reactions to the disclosure.  Chapple et al‟s (2004) qualitative 
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study explored how participants living with lung cancer perceived and experienced 
stigma.  They found that others‟ views of the manner in which they had contracted 
lung cancer, for example through smoking, caused them to be stigmatised.  This was 
particularly distressing for respondents, as some had contracted the disease through 
passive smoking, and not by actively smoking.  Their study also found that such 
stigma may influence decisions to disclose to others and have far reaching effects 
that may lead to not seeking appropriate clinical support: “…fear of disclosure 
may… prevent them from seeking support” (Chapple et al, 2004, p4).  However, the 
topic of disclosure emerged as an unanticipated area of concern rather than the main 
focus of the study. Therefore whilst the issue of disclosure was raised, it was not 
discussed in-depth in the paper and further exploration of perceptions of disclosure 
may prove beneficial in the context of clinical support.   
A study of mental health service users similarly argues that the stigma attached to 
such conditions may prevent individuals disclosing that they have the condition 
because they fear others‟ reactions (Williams and Healy, 2001).  They argue that 
there is a need to explore the influence of social responses to a condition and its 
impact on people seeking clinical assistance for their conditions (Williams and 
Healy, 2001).  
2.13 Difficulties of Disclosing Illness to Others  
Despite the relatively high number of people living with a long-term condition and 
challenges which they face, studies suggest that disclosure to others may be a 
difficult, and complex decision (Joachim and Acorn, 2000, Fesko, 2001, Dyck and 
Jongbloed, 2000).  A number of studies of illness in the workplace suggest that 
decisions to disclose were mediated by several concerns: the impact of the disclosure 
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on identity, stigma, fear of discrimination and the fear that others may see them as a 
poor worker.  Individuals also expressed fears that disclosing their illness to others 
may have significant financial implications such as losing their job, impact on their 
social security entitlements, and reduce their employment prospects (Fesko, 2001, 
Dyck and Jongbloed, 2000, Beatty, 2004). These studies highlight that there are a 
number of additional factors to take into account when disclosing, aside from stigma, 
thus highlighting it is arguably not a simple process.  However, several of the studies 
of disclosure of condition are set within the workplace in the United States or 
Canada and so the findings may not be generalisable to the UK setting which has 
different employment laws regarding discrimination (Fesko, 2001, Dyck and 
Jongbloed, 2001, Beatty, 2004, Disability Discrimination Act, 1995).   
2.14 Visible and Invisible Conditions  
The issue of disclosure is further complicated as some long-term conditions have 
been referred to as “visible” or “invisible” (Joachim and Acorn, 2000).  Those with 
“visible” conditions arguably have no control over whether or not to disclose their 
condition because others can see the existence of the long-term condition (Joachim 
and Acorn, 2000).  This has been described by Goffman (1963) as: “the special 
indignity of knowing that they wear their situation on their sleeve” (p.152).  
In contrast, conditions which do not have visible symptoms are therefore described 
as “invisible” because there are no obvious signs of illness.  A study of the rare 
condition scleroderma found that those with “invisible” symptoms had a choice as to 
whether to disclose or not because they appear “normal” to others (Joachim and 
Acorn, 2003).  Decisions to disclose may be problematic because it may result in 
additional stigma and an alternative strategy would be to try to hide the condition 
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and be perceived as “normal” (Joachim and Acorn, 2000).  Some have argued that 
when the condition is “medically controlled” it is invisible to others.  For example 
Trosters‟s (1997) study of “information management” in people living with epilepsy 
states: “As long as their seizures are under control, they can choose to conceal their 
epilepsy or disclose it (p1227).  However, there is a need to explore whether other 
issues aside from medical control are taken into account when deciding to disclose 
their condition or not.  
Overall, studies have indicated that fear of stigma is a reason not to disclose a 
condition which in turn may have far reaching effects on the individual‟s ability to 
cope with it.  It is also notable that an individual “becomes stigmatised” as a 
consequence of the disclosure and specifically as a result of the reaction of others to 
them.  Therefore further research should take into account the link between 
disclosure of a long-term condition and the consequences of social interaction.  
2.15 Non-Disclosure 
Despite the risks involved in disclosing, the decision to conceal illness from others 
may have a negative impact on one‟s health.  A study exploring disclosure of the 
long-term condition HIV found that non-disclosure to family or partners led to 
negative outcomes including depression, lack of support, isolation, and anxiety 
(Fesko, 2001).  He argues that those who chose not to disclose their condition did so 
due to:“concern for their own safety and protection” (Fesko, 2001, p239).  They 
feared others‟ responses to the knowledge of their condition.  Yet a consequence of 
not telling others was that they lacked support and felt socially isolated.  For 
example, individuals felt unable to give an account for why they were having an 
unproductive day at work.  Some stated they: “wished they could be more frank” 
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(Fesko, 2001, p.239).  A study of disclosure of epilepsy in the workplace found that 
some chose to conceal their condition perceiving it to be a “private” and “personal” 
issue (Beatty, 2004). Those living with potentially “transferable” long-term 
conditions who do not disclose may affect the health of others.  A study of disclosure 
of HIV infection to sexual partners found that 51% had not disclosed their status to 
one or more partners (Marks et al, 1991).  This study suggests that depending on the 
type of condition, there may be both a legal and a social responsibility to disclose the 
condition. 
2.16 The Limitations of Studies of Disclosure of Illness  
It is difficult to ascertain the role of disclosure in long-term conditions due to the 
limited number of subjective studies on experiences of disclosure within the field of 
health care research.  Previous studies have sought to measure disclosure using 
questionnaires; but these do not facilitate an exploration of what the role or 
components of disclosure are.  The limited conceptual or theoretical development of 
disclosure of long-term conditions is discussed in the following section.  
2.17 The Measurement of Disclosure  
There is a need for more exploratory subjective accounts of the rationale for 
disclosure because the concept requires further clarification.  Many of the studies on 
disclosure have adopted a quantitative approach to determine factors which may 
influence decisions to disclose or not (Munir et al, 2005, Beatty, 2004, Marks et al, 
1991).  The underlying reasons for non-disclosure of HIV infection to sexual 
partners were unclear due to the limitations of using a questionnaire as the 
participants were responding to closed questions (Marks et al, 1991).  
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A further limitation regarding the measurement of disclosure is that studies have 
primarily used conditions specifically associated with stigma for example HIV and 
Acquired Immune Deficiency Syndrome (AIDS), mental health and epilepsy 
(Beatty, 2004, Williams and Healy, 2001, Fesko, 2001, Marks et al, 1991).  
Although stigma appears to be a significant mediator in decisions to disclose this 
focus on particular “stigmatised” groups has limited the generalisability of the 
findings. The relevance of disclosure to long-term conditions not traditionally 
considered to be stigmatised as yet remains unclear. The review has also highlighted 
limitations in terms of the generalisability of samples adopted to conduct studies 
upon disclosure of long-term conditions.  For example many studies of HIV/AIDS 
focus upon perceptions of disclosure among predominantly gay men within an 
American context (Edward Rutledge, 2007, Marks et al, 1991, Sheon and Crosby, 
2004, Green and Sobo, 2000).  Whilst other studies of disclosure have considered a 
broader range of long-term conditions such studies have predominantly included 
women (Dyck and Jongbloed, 2000, Beatty, 2004, Joachim and Acorn 2003).  
However long-term conditions also affect men.  
Overall the majority of studies examining disclosure have been conducted in the 
United States of America (Jourard, 1971, Pennebaker et al, 1988, 1990, Beatty, 
2004, Fesko, 2001).  There may be cultural differences in terms of what one may 
disclose.  Primarily studies of disclosure are set within the context of the workplace 
(Beatty, 2004, Munir et al 2005, Dyck and Jongbloed, 2000, Fesko, 2001).  Some of 
these studies of disclosure have included in their sample those who were no longer 
employed and so the relevance of these findings may be limited (Dyck and 
Jongbloed, 2000, Fesko, 2001).  Thus the picture of disclosure is not complete. 
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Munir et al‟s (2005) quantitative study of disclosure of condition in the workplace 
argues that disclosure may be a self-management strategy: “We implicate a strategy 
employed by chronically ill employees, in that such employees control the level of 
information disclosed, according to their self-management needs” (p.1405).  
However such views on disclosure were gauged from respondents by asking them to 
indicate whether or not they had disclosed by ticking “yes” or “no.”  In using this 
quantitative measurement approach the barriers to disclosure remain unclear. As 
previously stated the quantification of disclosure does not provide insight to the 
rationale for disclosure and how it may link to the self-management of the condition.   
2.18 Measurement Issues: Psychological Studies of Disclosure 
There have been a number of studies of disclosure in the field of psychology 
(Jourard, 1971, Pennebaker et al, 1986, 1988, 1990, 1999, Derlerga et al, 1993). 
However much of the research and its links to health have focused upon objective 
measurement rather than subjective understanding (Jourard, 1971, Derlerga, 1979, 
Pennebaker et al, 1988, 1990, 1999).   
The roots of research on self-disclosure can be traced to the work of the 
psychotherapist Sidney Jourard (1926-1974) in the field of humanistic psychology 
(Jourard, 1971, Archer, 1979).  He conducted a number of studies on self-disclosure, 
which are regarded to be influential within the field of psychology (Jourard, 1971).  
He developed the “Real Self Questionnaire” which set out to explore which topics 
individuals had disclosed to those whom he describes to be: “target-persons” such as 
partner, mother, father or close friends.  He conducted studies on college students 
and work colleagues to examine whether self-disclosing has a causal effect on 
others to disclose and whether “liking” someone, influences how much they 
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disclose.  This is referred to as the “dyadic effect: the reciprocal nature of self-
disclosure.”  He argues that the degree to which one tells another information 
relates to factors which include: “closeness” of the relationship, and of the affection, 
love, or trust that prevails between the two people” (Jourard, 1971 p.13).  He sought 
to capture their views on disclosure using pre-fixed questions as set out in 
questionnaires and so this methodological approach does not facilitate an 
exploration of their rationale for disclosure or non-disclosure.  From a measurement 
perspective the study has a relatively low sample of twenty-five people and was 
completed by college students.   
The samples in such studies were relatively small and included largely high school 
or college students (Pennebaker et al, 1986, 1988, 1990, 1999, Jourard, 1971). 
Therefore, the generalisability of their findings on disclosure to the broader 
population and in particular those with long-term conditions may be limited.  The 
limitations of measurement approaches within psychological literature have been 
acknowledged as Baxter and Sahlstein (2000) note: “Traditionally, research on self-
disclosure and privacy has been dominated by experimental designs and self-report 
questionnaires” (p.299).   
Some psychological studies have taken a sample group of students who responded to 
hypothetical questions about disclosure of long-term conditions.  For example, 
Greene (2000) conducted a quantitative study to examine individuals‟ disclosure of 
cancer or AIDS to members of their family. They found that people living with these 
conditions were most likely to disclose to their partner or friend and least likely to 
disclose to their brother or father.  However as stated earlier, the study was 
hypothetical so recorded potential attitudes towards disclosure.  Therefore, their 
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responses may not reflect the views of those living with the condition and the real 
life choices they have to make.   
I now go on to review key studies of disclosure of long-term conditions within the 
field of health care research and argue for the need to conduct further exploratory 
research in this area.   
2.19 Definitions of Disclosure  
The literature review highlighted that the term disclosure has been applied across 
many disciplines displaying a range of different associated meanings and 
interpretations.  Table 1 presents a multi-disciplinary comparison of definitions of 
disclosure.  These include studies in the field of psychology, philosophy, social 
sciences and organisational studies as well as health-care.  The range of these 
definitions are now presented 
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Table 1 Multi-disciplinary Comparison of Definitions of Disclosure 
Discipline Author Definitions of Disclosure 
Sociology Charmaz (1991) 
Disclosure is ongoing: “Telling does not end.” (p109). 
Protective Disclosing: “Designed to control how, what, when, and who 
people tell about their illness.  They intend to protect others and 
themselves from shock, anger, and fear about their illness and its future 
implications…protective disclosure typically necessitates planning” 
(p119). 
Spontaneous Disclosing: “Full expression of raw feelings, open exposure 
of self, and minimal or no control over how, when, where, what, and 
whom to tell.  People spontaneously disclose when they receive startlingly 
bad news or perceive dramatic changes” (p119). 
Social 
Sciences 
Schneider and 
Conrad, 1980 
Preventive Disclosure: “Intended to influence other‟s actions/ and ideas 
toward self and towards epileptics in general…when actors think it 
probable that others, particularly others with whom they share some 
routine  will witness their seizures…others then know “what it is” and 
“won't be scared” (p40). 
Organisational 
Studies Beatty (2004) 
Instrumental Disclosure: “Intended to influence other‟s actions and 
ideas toward the person with illness” (p134). 
Psychology Troster (1997) 
Preventive Telling: “The persons with epilepsy strive to counteract 
stigmatisation not only through nondisclosure and active concealment but 
also by purposeful mention of the disease” (p1229). 
Organisational 
Studies 
Munir et al 
(2005) 
Partial Self-disclosure: “Employees informing line managers about the 
presence of a chronic illness” (p1397). 
Full Self-disclosure: “Employees informing line managers how that 
chronic illness affected them at work” (p1397). 
Social Work Dyck & Jongbloed (2000) 
Disclosure: “Making a diagnosis known” (p344). 
Nursing Joachim & Acorn (2003) 
Strategic disclosure:“[Deciding] When to tell and when not to tell about 
the illness…telling was perceived as letting others in”(p602). 
Mental Health Williams and Healy (2001) 
Disclosure: “The process of revealing one‟s illness to others” (p108). 
Informal expression: “For people with minor mental health problems 
typical symptomatology is likely to manifest itself as informal expression 
e.g. social withdrawal, apathy, irritability and generally behaving in a 
depressed mood” (p111). 
Formal expression: “Acts directed towards some aim such as seeking 
help or understanding” (p111). 
Psychology Jourard (1971) 
Self-disclosure: “The act of revealing personal information to others” 
(p2). 
Psychology Derlerga & Grzelak (1979) 
Self disclosure: “Objectively defined as any verbal message that formally 
begins with the word “I” (for instance, “I think”, “I feel” or any other 
verbal message about the self)” (p152). 
Psychology Rosenfield (2000) 
Disclosure: “The process that grants access to private things and 
secrets” (p6). 
Philosophy Burnard & Morrison (1992) 
Self-disclosure: “As we communicate with others we reveal ourselves to 
others in various ways and to varying degrees” (p60). 
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Disclosure is defined by the Oxford English Dictionary (2001) as: “to make secret or 
new information known.”  However definitions of disclosure within health care 
research are less clear since the review of disclosure has identified few exploratory 
qualitative studies.  A qualitative study of individuals living with long-term 
conditions entitled, “Good days, Bad days” (to indicate the variable nature of living 
with long-term condition) identified two types of disclosure (Charmaz, 1991).  
Firstly, “protective disclosing” a strategy adopted to manage the disclosure in terms 
of both the information provided and the selection of to whom it is told. The purpose 
of this disclosure is to protect the disclosee and to allow others to adjust their 
expectations of them.   
Secondly, “spontaneous disclosing” denotes a form of disclosure, which is not pre-
planned or managed.  This can occur on receipt of particularly negative news or 
information such as the perception that there has been a significant downturn in the 
prognosis of their condition.  However, whilst long-term conditions was the focus of 
the study, disclosure of condition was not, but rather emerged as an area of concern 
(Charmaz, 1990).   
Disclosure has been defined as:“the process of revealing one‟s illness to others” 
(Williams and Healy, 2001, p.108).  It is one of the few studies conducted within 
health care research which defines disclosure.  Although it is not clear whether this 
definition has been devised by the researchers rather than grounded in participants‟ 
data.  Also there is a lack of clarity as to the dimensions of the term disclosure and 
its context.   
Aside from “verbal” disclosure, studies have indicated that a condition may be 
disclosed through behaviour.  One study found that “coughing” may constitute a 
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form of disclosure of cystic fibrosis (Lowton, 2004), and others have argued that 
“acting differently” may reveal mental conditions (Williams and Healy, 2001).   
Schneider and Conrad‟s (1980) classic sociological study of epilepsy focused upon 
exploring how those living with epilepsy: “manage information to control the stigma 
potential of epilepsy” (p32). Their study based on eighty in-depth qualitative 
interviews; illustrated the variable nature of disclosure and refers to it as a: 
“revolving door.”  This study whilst useful would benefit from a more recent 
exploration of views on disclosure as disclosure took place nearly thirty years ago. 
Lowton‟s (2004) qualitative study of thirty-one adults aged eighteen to forty-years 
old set out to explore how adults living with cystic fibrosis make decisions around 
disclosure.  The rationale for the study stemmed from cystic fibrosis no longer being 
a fatal childhood condition.  Since people with this condition are living longer, this 
has led to a gap in research on adults living with cystic fibrosis and their experiences 
of disclosure in the workplace or within intimate relationships (Lowton, 2004).  She 
identified three settings for disclosure and argued that they were strongly related to 
risk: “low risk situations,” a short period of social contact with individuals; “medium 
risk”,  a higher level of contact leading to greater concern over how others may react 
to the disclosure, and “high risk” which referred to disclosure to employers or 
potential partners where negative reactions carry greater consequences (Lowton, 
2004).  However this study has limitations because the data have been drawn from a 
larger study focussing upon issues of infertility and potentially reduced life span as 
they relate to cystic fibrosis and this is the underlying rationale for this categorisation 
of risk rather than being grounded in participants‟ data. 
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2.20 Models of Disclosure 
Two models of disclosure have been developed and their relevance are now 
discussed. 
Figure 2 Model of Types of Expression and Subsequent Disclosure Problems 
(Williams and Healy, 2001). 
 
 
(Figure reproduced with kind permission from: “Disclosure of Minor Mental 
Health Problems: An Exploratory Study”, Williams and Healy, 2001) 
Informal expression 
(Behaving in a depressed 
manner.  This may include 
apathy, Social withdrawal, 
irritability etc). 
Formal expression 
(Directly informing 
others of the depression) 
Mediating factors 
Form of expression 
Context of expression 
Social expectancies 
(age, sex, culture) 
Reactive Problems 
(Response and behaviour 
of others towards the 
person) 
Burden Problems 
(Impact on others of 
informal expression) 
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Williams and Healy (2001) conducted a qualitative exploratory study of disclosure 
of minor mental conditions.  They developed a model of the relationship between 
types of expression and subsequent disclosure problems (figure 2).  Their study 
examined disclosure from the approach of the person “to whom” one discloses rather 
than from the perspective of the “disclosee.”  Two types of disclosure were 
identified: “informal expression” and “formal expression.”  Informal expression 
refers to acting or stating how one feels such as: “social withdrawal, apathy, 
irritability and generally behaving in a depressed mood.”  This form of disclosure 
was perceived to “burden others” (Williams and Healy, 2001, p111).  Formal 
expression involved directly disclosing to others and was deemed to be more 
beneficial.  Qualitative interviews were conducted with forty-seven users and non-
users of community mental health services.  Perceptions of “burden” and “reactive 
problems” were identified as two areas of difficulties which emerged from the 
disclosure in terms of the response of others. Almost half of the study sample 
constituted those who were not current users of the community mental health 
service. Thus, in these instances participants were responding to hypothetical 
questions around their views on disclosure.  This may account for the study‟s focus 
on the difficulties associated with disclosure and does not illuminate any of the 
potential benefits.  Since the study‟s focus is upon disclosure of minor mental 
conditions which are strongly associated with stigma, the relevance of findings to 
other long-term conditions may be limited.  I now go on to discuss the model 
developed by Joachim and Acorn (2000). 
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Figure 3 The Elements of Stigma with the Factors that Influence Disclosure and 
Non-disclosure in Chronic Illness (Joachim and Acorn, 2000). 
 
(Figure reproduced with kind permission from: Stigma of Visible and Invisible 
Chronic Conditions, Joachim and Acorn, 2000). 
Joachim and Acorn (2000) conducted a meta-study (1980-1996) of qualitative 
research on the “lived experience” of chronic illness and conditions as well as a 
review of quantitative studies on “coping” with long-term conditions. They 
developed a model of stigma and factors that influence disclosure or non-disclosure 
in chronic illness.  However from a methodological perspective there are limitations 
to this study because it is unclear how many key studies on disclosure were 
identified and which studies in particular were drawn upon for the model.  Their 
review of quantitative studies on “coping” also precludes an understanding of the 
individual‟s decision-making process regarding disclosure.  The model also suggests 
a clear dichotomy between invisible and visible conditions as they relate to 
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disclosure.  However this does not take into account the role that context may play in 
the decision making process: disclosure may be more complex than the model 
suggests.  Arguably their study presents a review of the key concepts identified in 
disclosure research to date, but the components and role of disclosure require 
additional exploration.  
Studies of disclosure of long-term conditions within the workplace have identified a 
range of definitions (Munir et al, 2005, Beatty, 2004).  Munir et al‟s (2005) study 
identified two types of disclosure: “partial self-disclosure” denotes telling a line 
manager that one has a long-term condition whereas, “full self-disclosure” denotes 
telling a line manager how the condition affects the disclosee in the workplace.  It is 
not clear why two separate definitions have been identified and does not address the 
point that in certain situations, “partial disclosure” may lead on to “full disclosure.”  
Furthermore, the study did not consider the issue of stigma yet this has been 
identified as an important predictor of disclosure and so the relevance of the findings 
may be limited.  The study tested relationships between variables and did not provide 
insight regarding what the reasons for “partial” or “full” disclosure were.   
Studies on disclosure within the healthcare setting have drawn on definitions from 
the field of Psychology and these are examined in the next section (Munir et al 
2005).  
2.21 Psychological Definitions of Disclosure 
Jourard (1971) defines self-disclosure as: “to describe the act of revealing personal 
information to others” (p.2).  His research interest in disclosure stemmed from his 
work as a psychotherapist working with clients encouraging them to disclose, to 
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clarify what he describes as the parameters of “secretivenss and openness” (Jourard, 
1971, p2).   
However within the discipline of Psychology the role of self-disclosure has a 
different focus to studies in health care research.  For example, common to 
psychological definitions is a sense of disclosing something personal about oneself 
to a trained professional which does not necessarily relate to simply one‟s health 
status.  Derlerga and Grzelak (1979) have described disclosure as a “verbal message 
about the self” (p152).  More recently Rosenfield (2000) has defined it as: “the 
process that grants access to private things and secrets” (p6).  This suggests that 
disclosure is not a decision to be taken lightly because what is being disclosed may 
be a “secret” and as such only disclosed under specific circumstances.  In contrast to 
studies in the field of health care research, within psychological literature self-
disclosure is clearly defined in terms of what disclosure is, and what it represents for 
the person disclosing.  The term self-disclosure describes the process of the client‟s 
disclosure within the counselling context (Burnard and Morrison, 1992).  In “person-
centred” therapy the self-disclosure of the client is fundamental to the process.  They 
go on to argue that disclosure is essentially about communication to others around us 
and note that we generally disclose to a range of people from friends to colleagues at 
work (Burnard and Morrison, 1992).  Although this disclosure may not necessarily 
relate to the same issues brought up in a counselling context.  As Burnard and 
Morrison (1992) argue: “we do not live as isolated beings.  We are dependent upon 
others to tell us about ourselves” (p32). This perspective is helpful because it 
indicates that it is through others that we may learn about ourselves: the extent to 
which this is relevant to disclosure of long-term conditions in health care research 
requires additional exploration. 
58 
2.22 The Rationale for further Research on the Role of Disclosure  
Overall, the literature review of studies, which examined disclosure of illness, 
highlighted that primarily disclosure emerges as an unanticipated area of importance 
to research participants rather than being the main focus of the research study design 
(Charmaz, 1991, 2000, Williams and Healy‟s 2001, Chapple et al 2004, Lowton, 
2004).  
Furthermore the topic of disclosure emerges as a significant issue within the context 
of debates around issues of stigma associated with long-term conditions rather than 
being the key focus of the study itself (Williams and Healy, 2001, Chapple et al, 
2004).  For example studies which appear to be discussing issues of disclosure refer 
to the process of “information management” about one‟s condition (Schneider and 
Conrad, 1980, Troster, 1997, Green and Sobo, 2000, Joachim and Acorn, 2000, 
Munir et al, 2005).  This term emanates from Goffman‟s (1963) study of stigma who 
refers to the process of “managing potentially discrediting information” which may 
lead to stigmatisation.  Goffman‟s (1963) study whilst important is relatively dated 
now.  Thus it may be timely to review how those living with long-term conditions 
perceive disclosure and whether disclosure does constitute “information 
management” particularly as studies have frequently drawn upon the term without 
clarifying that it has emanated from Goffman‟s (1963) work on stigma rather than an 
issue of current concern to participants in studies (Troster, 1997, Green and Sobo, 
2000, Joachim and Acorn, 2000, Munir et al, 2005).  
In terms of context, research on disclosure has been conducted in a variety of 
settings such as clients disclosing to psychologists or psychotherapists (Jourard, 
1971, Pennebaker, 1999).  The term disclosure also appears frequently in studies of 
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sexuality in terms of the process of disclosing one‟s sexual orientation to others 
particularly within the context of “coming out” (McLean, 2007).  In addition the 
research on disclosure focuses on the dilemmas of disclosing conditions associated 
with sexuality such as the process of disclosing HIV/AIDS to current or potential 
sexual partners (Edward Rutledge, 2007, Marks et al, 1991, Sheon and Crosby, 2004, 
Green and Sobo, 2000).  Therefore the role of disclosure in this context appears to 
relate most directly to issues of risk of transmission of a potentially transferable 
condition.  However, not all long-term conditions are transferrable (Department of 
Health, 2005). Disclosure within the biomedical literature predominantly refers to 
the process of doctor patient communication (May 1993, Kirk et al 2004).  
In summary, there is no single definition of the process of disclosure. It is a poorly 
understood concept and lacks theoretical development. The components of 
disclosure remain unclear since there have been few primary or exploratory studies 
of disclosure of long-term conditions within the field of health care research.  
Variations in definitions of disclosure make it difficult to assess what is really being 
examined.  Clearly, the conceptualisation of disclosure differs between and across 
different disciplines.  
Several studies have called for additional research on disclosure of long-term 
conditions within the field of health care research (Joachim and Acorn, 2000, 
Williams and Healy, 2001). It is regarded to be of relevance since choosing to 
disclose one‟s condition to another (particularly if it is not visible to others) is likely 
to be a difficult decision not least due to possible negative reactions by others 
(Joachim and Acorn, 2000).  Furthermore, nurses are key providers of care for those 
with long-term conditions (Department of Health, 2005d).  Therefore the role of 
disclosure and in particular how patients perceive disclosure has particular relevance 
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for clinical practice and the delivery of quality patient care.  Furthermore patients 
may ask for specific guidance on the advisability of disclosing a condition.  Policy 
changes have resulted in the development of specific nursing roles for those living 
with long-term conditions such as epilepsy (SIGN Epilepsy guideline, 2003). Nurses 
also play a significant role in the provision of services to those living with diabetes 
(Department of Health, 2007c). 
As Joachim and Acorn (2000) note, many of the key studies on stigma and 
disclosure such as Goffman (1963) and Schneider and Conrad (1983) are now over 
twenty years old.  Yet this literature review has identified that subsequent studies 
have continued to draw upon their work and so a more recent exploration of the role 
of disclosure would be timely in order to explore possible changes in personal and 
public perceptions. 
The research question for this study is set out below: 
2.23 Research Question 
 What is the role of disclosure to others in managing a long-term condition? 
Having set out the argument for the need for additional exploration of the role of 
disclosure in the lives of those living with a long-term condition, those living with 
epilepsy or type 1 diabetes were selected as appropriate participants for this study. I 
now set out the medical and social implications for those living with epilepsy and 
type 1 diabetes (both long-term conditions).   
2.24 Living with Epilepsy and Disclosure 
Epilepsy is the most common serious neurological condition in the UK (NHS Direct 
Website, 2006).  The condition affects 382,000 people in England, one in every 131 
people has epilepsy.  For example from a medical perspective, epilepsy is a 
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neurological condition which is typically caused by sudden changes in the brains 
electrical activity between cells which may cause individuals to have a seizure 
(Epilepsy Action, 2006, National Society for Epilepsy, 2007).   
Self-care of epilepsy involves a process of taking medication.  This is not a 
straightforward process as it often involves a period of trying a range of medications 
and dosages to determine the most appropriate treatment.  There are also a number of 
side effects associated with taking such medication which can be difficult to cope 
with as they may affect the central nervous system (Epilepsy Action, 2006).  Others 
elements of self-care include seeking to control the frequency of seizures by making 
lifestyle changes (Shaw et al, 2007).  Dilorio et al‟s (2003) study suggests there may 
be a link between stigma and self-management.  They found that those with higher 
levels of perceived stigma had low levels of self-efficacy regarding their ability to 
manage epilepsy.  
Studies suggest that those living with the condition not only have to cope with a 
biomedical diagnosis, but the “social” judgements of others to the condition.  From a 
sociological perspective stigma is strongly associated with epilepsy (Scambler, 1989, 
Prinjha et al, 2005). For example powerful misconceptions concerning epilepsy 
related the condition to religious perceptions of being “possessed” by demons: 
“seizures are dramatic, public and frightening…The forced cry, the loss of 
consciousness, the fall, the twitching and the foaming at the mouth suggest 
possession by a spirit” (Eisenberg, 1998, p42).  Historically people living with 
epilepsy were regarded to be “mad”, and treated as “criminals” who should be 
locked away from society (Eisenberg, 1998).   
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Schneider and Conrad (1981) have argued that people living with epilepsy should 
not be judged by the type of seizures and the medical terms which define it, but 
rather by the strategies of managing the condition apart from the medical diagnosis. 
A classic study on epilepsy describes two types of stigma: “felt” and “enacted” 
(Scambler 1989).  “Enacted” stigma is defined as those instances when individuals 
have been penalised or treated differently because of having the condition.  “Felt” 
stigma refers to anxiety associated with enacted stigma as well as a sense of 
embarrassment related to living with epilepsy.   
This review identified few studies specifically examining the role of disclosure as it 
relates to the everyday lives of those living with epilepsy.  Instead the question of 
disclosure emerges predominantly within the context of discussion of stigma 
management (Schneider and Conrad, 1980, Troster, 1997).  Schneider and Conrad‟s 
(1980) seminal study of epilepsy refers to the process of “preventive telling” which 
they defined as follows: “Intended to influence others‟ actions/ and ideas toward self 
and towards epileptics in general…others then know “what it is” and “won't be 
scared”(p40). However subsequent studies have borrowed their term “preventive 
telling”, sometimes referring to it instead as “instrumental telling” (Troster, 1997, 
Beatty, 2004).  The current relevance of the strategy of “preventive telling” from the 
perspective of those living with epilepsy would be particularly timely.  
2.25 Living with Type 1 Diabetes and Disclosure 
A long-term condition which is particularly prevalent among younger people is type 
1 diabetes (Commission for Healthcare Audit and Inspection, 2007).  The rates of 
people being diagnosed with type 1 diabetes are increasing and the condition is 
estimated to affect around 25,000 people aged under 25 in the UK (Department of 
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Health 2007b).  From a medical perspective type 1 diabetes occurs when the body‟s 
immune system destroys the cells which produce insulin.  This may occur suddenly.  
When there is insufficient insulin in the body this leads to higher levels of glucose in 
the blood which can cause potentially serious medical problems such as a coma 
(hypoglaecaema) (NICE, 2004).  Several policy documents have been published by 
the Government setting out the integral role of self-care and diabetes.  For example 
The National Service Framework for Diabetes (Department of Health, 2001c) states 
that self-care is fundamental for those living with diabetes.  A recent report by 
Diabetes UK (2006) also notes the key role of self-care in managing diabetes: “Self-
care is the cornerstone of diabetes care as 95 percent of managing the condition is 
self-care” (p12).  However, living with diabetes is not only a medical diagnosis but 
has broader social implications such as employment, life expectancy, lifestyle and 
health since it: “impacts upon every aspect of life” (Department of Health, 2001c, 
p6).  Self-care is required on a daily basis for those living with type 1 diabetes. They 
must manage their diet carefully.  They must also learn how to check their blood 
glucose levels and require daily injections of insulin in order to live (Department of 
Health, 2001c).  Adopting a strategy of taking insulin is vital, the aim being to 
achieve:”best glucose control with the fewest problem…that suits you best” (NICE, 
2004, p20).  
However, relatively little is known on how those living with type 1 diabetes perceive 
disclosure and how this may impact on the self-care of the condition.  The review 
identified surprisingly few studies examining disclosure of type 1 diabetes.  Studies 
do refer to stigma and the process of injecting insulin but they do not specifically 
examine the role of disclosure in this process.  For example, a qualitative study of 
type 1 diabetes did identify fears around social stigma as a barrier to self- 
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management (Tak-Ying Shiu et al, 2003).  However this study sample was perhaps 
atypical of those living with type 1 diabetes as they recruited those with high anxiety 
levels around having a hypoglaecaemic episode.  Furthermore, the management of 
diabetes among younger people differs to that of adults (Department of Health, 
2007b).  These differences in perceptions of stigma and its management need to be 
explored further, particularly in relation to the area of self-care and the role of 
disclosure.   
2.26 Summary and Conclusion 
In summary, additional exploratory research on the views of those living with long-
term conditions such as epilepsy and type 1 diabetes regarding their experiences of 
disclosure would be timely.  As stated earlier, limitations in measurement issues 
have led to difficulty in ascertaining the role of disclosure.  This study therefore sets 
out to fill the research gap by exploring the role of the social process of disclosure 
for those living with a long-term condition.  Research which has been conducted on 
the topic of stigma in particular suggests that the reaction of others to disclosure has 
a vital role to play in stigmatisation of a condition.  In light of this review, an 
exploratory qualitative research methodology which can provide valuable insights 
into the role of disclosure to others would be beneficial.  The selection of an 
appropriate research methodology is set out in the following chapter (Chapter three). 
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3.0 Chapter Three: Philosophical and Methodological Framework 
3.1 Introduction 
Chapter two reviewed the literature on disclosure, illustrating that the majority of 
research on disclosure has been conducted using survey techniques within the 
positivist paradigm.  The extent to which the individual perspectives of those living 
with long-term conditions have been included remains unclear and so the concept is 
relatively poorly defined.  A qualitative methodology has been adopted to clarify the 
role of disclosure.  This is based on Blumer‟s (1969) assumption that disclosure of a 
long-term condition is a subjective individual experience made sense of through 
others‟ reactions.  
It is also based upon the assumption that disclosure is a social process.  
In this chapter I set out the rationale for adopting constructivist grounded theory as 
the philosophical and methodological framework (Charmaz, 2006).  This decision 
has been based upon two key issues: the methodological limitations of existing work 
within the field of research on disclosure of illness, and the researcher‟s 
constructivist philosophical stance.  Since its development, grounded theory has been 
subject to considerable debate and has evolved both philosophically and 
methodologically.  The underlying reasons for the selection of this particular 
approach is placed within an historical overview of grounded theory and the debates 
surrounding it.  
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3.2 Consideration of Research Paradigm 
3.3 Methodological Limitations within Existing Research on Disclosure of 
Illness  
In considering the most appropriate paradigm to select I took into account the aim of 
the study and the type of knowledge required.  As Weaver and Olson (2006) 
state:“…the purpose of the inquiry, in conjunction with the state of knowledge 
development in the substantive area” (p466).  Thus firstly I consider the relevance of 
the positivist paradigm to the current study, reflecting upon the existing knowledge 
of disclosure of long-term conditions and the research gaps identified in the literature 
review.  
3.4 Consideration of the Positivist Paradigm 
The term positivism was developed by the French philosopher Auguste Comte 
(1798-1857) (Schwandt, 2001). The philosophical and epistemological 
underpinnings of the positivist paradigm perceives “knowledge” as identifiable, 
objective and therefore measurable predominantly using questionnaires: “there is a 
reality out there to be studied, captured and understood” (Denzin and Lincoln, 
2000, p9).   
I considered the existing knowledge of disclosure of long-term conditions and the 
research gaps identified in the literature review in terms of the type of knowledge 
required to gain insight into individuals personal experiences of disclosure.  The 
review of the literature (chapter two) illustrated that the majority of studies 
concerning disclosure have used questionnaires to identify individuals‟ views on 
disclosure (Jourard, 1971, Troster, 1997, Marks et al, 2001, Greene, 2000, Munir et 
al 2005, Beatty, 2004, Pennebaker, 1999).  The predominant focus of using 
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questionnaires to measure disclosure has arguably led to a research gap in terms of 
capturing the individuals subjective experiences of disclosure.  As Denzin and 
Lincoln (2000) suggest: “quantitative studies emphasize the measurement and 
analysis of causal relationships between variables, not processes…within a value-
free framework” (p8). Such quantitative studies are designed to test relationships 
between variables rather than seeking to describe and understand social processes 
(Denzin and Lincoln, 2003).  This has resulted in methodological limitations within 
existing research on individuals‟ personal experiences of disclosure of illness. It is 
my contention that disclosure is a social process and my philosophical stance does 
not operate within a: “value-free framework” as I go on to discuss later in this 
chapter.  Research located within the positivist paradigm therefore focuses upon an 
objective understanding of disclosure of illness.  There is a need to explore and 
clarify subjective knowledge of disclosure as perceived by the individual living with 
the condition, in order to identify, explore and build concepts for further research.  
This study has therefore been designed with this purpose in mind by drawing upon 
and exploring individuals‟ views and accounts of disclosure.   
Applying the positivist approach to this study would not facilitate access to the 
potentially dynamic nature of disclosure as a social process for the individual, since 
it focuses on the quantification rather than the exploration of the role of disclosure.  
Within the positivist theoretical perspective disclosure of illness would be positioned 
as an observable “fact”, which is fixed and quantifiably measurable.   
3.5 Consideration of the Constructivist Paradigm  
In this chapter I argue that the constructivist paradigm is best suited to the study,  
noting that it is appropriate for developing areas of inquiry where further exploratory 
68 
research is required.  The key principles of qualitative research within the 
constructivist paradigm are:  
 to shed light upon the: “phenomena in terms of the meanings people bring to 
them”(Denzin and Lincoln, 2003, p.13) 
 to tap into the subjective personal accounts of individuals (Schwandt, 2004) 
 the inclusion of the researcher‟s knowledge and experience of the research 
area  
 co-construction of the data:“Both the research and the participant together 
generate meaning for example, I ask and interpret together I need their 
account to understand” (Denzin and Lincoln, 2003, p.35) 
 there are many different views of “reality” in terms of what constitutes 
“knowledge” (Denzin and Lincoln, 2003) 
In order to access the participant‟s perspective of the role of disclosure of illness I 
judged an exploratory approach located within the constructivist paradigm was 
appropriate: “Constructivism assumes the relativism of multiple social realities, 
recognises the mutual creation of knowledge by the viewer and the viewed and aims 
toward interpretive understanding of subjects meanings (Charmaz, 2000a, p510).  
The constructivist perspective also fits with my philosophical stance and 
epistemological beliefs as I now go on to outline.  
3.6 Why Constructivist Grounded Theory? Philosophical Stance 
The researchers‟ perception of what constitutes “knowledge” (epistemology) 
influences the theoretical perspective, methodology and methods applied to a study 
(Schwandt, 2001, Crotty, 2003).  My view of the world and the nature of being 
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(ontology) and the ways in which this may be understood through means of enquiry 
(epistemology) have influenced the study alongwith my decision to use a qualitative 
approach specifically within this constructivist grounded theory (Charmaz, 2006).  
Ontologically, I perceive meaning in the social world to be socially constructed, that 
is to say, there are multiple realities as opposed to a single “truth” (Crotty, 2003).  It 
is my contention that the data gathered in the current study will not constitute 
“reality” because true knowledge does not exist independently to be “discovered” 
but rather is socially constructed.  As part of this approach it is proposed that the 
researcher‟s views and experiences be taken into account (Schwandt, 2001).  Indeed 
as I go on to argue one of the reasons why Charmaz‟s (2006) version of grounded 
theory has been selected is because philosophically it is explicitly located within the 
constructivist paradigm in contrast to other approaches within grounded theory such 
as Strauss and Corbin‟s (1990,1998) approach whose philosophical stance has been 
subject to much interpretation (Macdonald and Schreiber, 2001, Annells, 1997a)  
Philosophical clarification is important since it influences the methods adopted in 
grounded theory studies as well as the researchers‟ stance to the data (Charmaz, 
2006).  The constructivist version of grounded theory therefore takes into account 
that I, the researcher, am not “neutral” in my approach to this study (Charmaz, 
2006).  That is to say, I have selected the topic of disclosure, and brought my interest 
in long-term conditions to this area of inquiry.  Social processes such as disclosure of 
illness are likely to involve a range of subjective experiences including personal 
emotions and interactions with others.  As a health care researcher, trained in the 
Social Sciences, I believe that access to personal subjective accounts is vital when 
exploring the diverse issues surrounding an illness which may in certain cases last 
for many years or throughout ones‟ lifetime. 
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My main experiences of long-term conditions in both my personal and professional 
life are as result of observing others.  As a qualified social scientist and academic 
researcher in the field of health services research for the past thirteen years, I have 
interviewed many people living with both acute and long-term conditions.  At that 
time the focus of the interviews concerned individual‟s experiences of seeking 
treatment and care from health care professionals.  As patients were largely recruited 
from hospital waiting lists or outpatient appointments, the nature of their condition 
had already been identified and so there was no necessity to disclose it.  However, on 
occasions during interviews some disclosed information on conditions additional to 
the illness which had led to the hospital appointment.  I have also experienced 
“spontaneous” disclosure whilst attending a large international conference on self-
management of long-term conditions.  On explaining the focus of my PhD topic 
several individuals were moved to disclose that they or their relatives had a long-
term condition.  There were no visual cues that those present had a long-term 
condition and I felt privileged that they had confided in me.  Within my personal life, 
one person revealed to me on our first meeting that she had a long-term condition 
and requested that I kept it a secret.  This disclosure elicited a change in behaviour 
towards her as I sought to offer her empathy and support whilst taking particular care 
not to tell others within the same social group.  On reflection it may be that 
identifying myself as a researcher on patient‟s experiences may have facilitated such 
disclosures.  Within my personal life several relatives and close friends are living 
with long-term conditions.  One friend has frequently disclosed to me her symptoms 
and difficulties in managing her long-term condition.  The purpose of this disclosure 
was I felt in order to garner social support. In contrast, a relative seldom discusses 
his long-term condition, despite having to follow a new and intensive daily treatment 
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regime.  Disclosure has also impacted on me personally as I became unwell during 
the process of conducting this thesis and I was led to make personal decisions 
regarding to whom, how and when I should disclose. This will be explored further in 
the discussion and conclusions chapter (Chapter six).   
3.7 Summary 
Having reflected upon my personal and professional experiences of disclosure of 
illness, I perceive that individuals adapt to long-term conditions in different ways, 
and furthermore, are likely to produce diverse strategies regarding their management.  
In considering the appropriate methodological framework to adopt I also explored 
the applicability of adopting either phenomenology or ethnography which are both 
qualitative, inductive approaches (Cresswell, 1994).  I now go on to discuss these 
approaches and their limitations with regard to the current study in the following 
section.  
3.8 Consideration of Possible Qualitative Methodologies  
3.9 Phenomenology  
The central focus of phenomenology is to explore individual experiences of 
everyday phenomena: “human experiences are examined through the detailed 
descriptions of the people being studied” (Cresswell, 1994, p12).  The intention of 
this approach is to access the “essences” of the lived experience: “a description of 
„things‟ (the essential structures of consciousness) as one experiences them” 
(Schwandt, 2001, p191).  There are two predominant strands of phenomenology, 
“descriptive phenomenology” developed by Edmund Husserl (1838-1959) and 
“hermeneutic phenomenology” as developed by his former pupil Martin Heidegger 
(1889-1959) (Maggs-Rapport, 2001).  Hermeneutic phenomenology was considered 
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to be particularly relevant to the current study since it is also located in the 
constructivist paradigm and also acknowledges the researcher‟s perspective (Omery, 
1983).  That is to say the researcher‟s worldview should not be excluded from the 
analysis of the phenomenon but be taken into account.  In contrast, the “descriptive” 
phenomenological approach excludes the researchers “taken for granted” 
understanding of phenomena, a process termed “bracketing.”  The intention of 
bracketing is to exclude the researchers understanding of the phenomena so that we 
can go “back to the things themselves” in order to access new understandings or 
confirm previously held meanings of phenomena (Crotty, 2003, Schwandt, 2001).  
Phenomenology shares several procedural steps with grounded theory, it uses open, 
in-depth qualitative interviews to gather data but there are key differences.  For 
example, phenomenological studies typically interview a smaller number of 
participants compared to grounded theory (Cresswell, 1994). These participants are 
described as “key informants” who give an individual account of their experience of 
the phenomenon disclosure of illness.   
To summarise I have reflected that a hermeneutic phenomenological approach would 
not fit the broader remit of the research question: what the role of disclosure is in 
managing a long-term health condition?  A descriptive phenomenological approach 
would set out a rich description of disclosure of illness but not explore or capture the 
meaning of social interactions or social processes.  The phenomenological focus on 
experiences offers insights into the lived experiences of disclosure of illness but does 
not provide an explanation of the role of disclosure, nor assist in its theoretical 
development.  Since I have judged disclosure to be a social process my selection of a 
theoretical framework is based upon the need to take the role of others in making 
sense of disclosure into account (Blumer, 1969).  This is viewed to be particularly 
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important in order to move understanding forward from not simply experiences, 
which a phenomenological approach would offer, but towards the development of an 
inductive theory thus contributing a body of knowledge to the field.  I now go on to 
discuss ethnography in relation to the current study.  
3.10 Ethnography 
Ethnographic studies observe, question and listen to participants of interest to 
uncover a sense of “what is going on?” (Hammersley and Atkinson, 1983).  The 
stance of the researcher is that of a stranger seeking to understand taken for granted 
meanings for members of the culture of interest in order to acquire: “inside 
knowledge of it” (Hammersley and Atkinson, 1983, p8).  The foundations of 
ethnographic research lie in the field of anthropology, notably the early work of 
anthropologists such as Malinowski who conducted observational studies of non-
western societies (Fitzgerald, 1997).  Participant observation is a key method 
adopted in ethnography drawn from the perception that in order to fully understand a 
particular group of people, it is necessary to observe and participate in everyday 
activities over a period of time.  Other methods include conducting in-depth 
interviews and the use of field-work diaries (Hammersley and Atkinson, 1983).  The 
researcher‟s personal views and experiences about the area of research are deemed to 
be relevant and may become part of the data.   
3.11 Summary 
Having noted these key features I have elected not to adopt an ethnographic 
approach for the following reasons.  Its focus is upon explaining participants “shared 
values” and “taken for granted” meanings that participants within it hold 
(Hammersley and Atkinson, 1983). Whilst a cultural understanding of disclosure 
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may prove to be of interest, this is not the focus of my research question which seeks 
to define and provide a broader insight into the role of disclosure across the 
individual‟s life (as set out in the literature review).  
Disclosure of illness may occur in a group sense such as within the setting of a 
patient support group or “expert patient” group.  Participant observation is a key 
method adopted in ethnographic research.  However, since disclosure can be 
spontaneous and occur in diverse settings this approach would be unlikely to capture 
all types of disclosure and perceived reactions to disclosure would prove difficult to 
observe.  Using this approach would also fail to capture individual personal 
experiences of disclosure.  For these reasons an ethnographic approach with its slant 
on cultural meaning does not address the research question and its focus upon social 
processes.   
In the following section I reflect upon my reasons for selecting grounded theory as 
the methodological framework for the study.  I set out the broad parameters of the 
methodology followed by the debates surrounding grounded theory and the rationale 
for adopting constructivist grounded theory.   
3.12 Why Grounded Theory?  
Grounded theory is a particularly appropriate methodology to adopt in my study with 
its focus upon social processes (Glaser and Strauss, 1967, Strauss and Corbin, 1990).  
Also it fits the nature of the research question: “Grounded theory questions…tend to 
be oriented toward action and process” (Strauss and Corbin, 1990, p38).  This study 
of disclosure is “action” orientated because it seeks to explore subjective 
understanding by taking into account the role which interaction with “others” plays 
in developing “meaning” (Blumer, 1969, Schwandt, 2001).  A fuller explanation can 
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be found later in this chapter where I set out the philosophical roots of grounded 
theory. Disclosure of illness is a social process and elements of it are likely to 
involve social interaction.  Grounded theory‟s inductive approach facilitates greater 
understanding of the phenomenon of interest as Strauss and Corbin (1990) note“one 
does not begin with a theory, then prove it. Rather, one begins with an area of study 
and what is relevant to that area is allowed to emerge” (p.23).  As discussed in the 
literature review disclosure is poorly defined, and grounded theory presents 
particular utility to the current study through the clarification of concepts relevant to 
disclosure.   
3.13 The Key Tenets of Grounded Theory 
Grounded theory has a number of distinguishing procedural features compared to 
other qualitative approaches (Charmaz, 2006).  It is considered to be a rigorous 
approach because it outlines a series of steps concerning how to gather, collect and 
analyse the data (Glaser and Strauss, 1967).  Its intention is to develop a theory 
which might be recognisable to those involved with the phenomena and in which 
they can identify a degree of “fit” with their experience (Glaser and Strauss, 1967).  
A distinguishing feature of grounded theory is the constant comparative technique of 
analysis: examples of the phenomena identified by participants are coded then 
compared and contrasted throughout the data collection phase of the study (Glaser 
and Strauss, 1967).   Key issues raised by the participants are followed up in 
subsequent research interviews (Glaser and Strauss, 1967).  Unstructured, open 
interviews are used to gather the data, to ensure that the participant‟s subjective 
views are allowed to emerge.  The resulting theory is therefore said to be grounded 
in the data and discovered, not preconceived by the researcher (Glaser and Strauss, 
1967, Charmaz, 2006).  The subsequent debates concerning this process referred to 
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as the emerging versus forcing are set out in further detail later in this chapter.   The 
theory must be developed prior to conducting an in-depth literature review (Glaser 
and Strauss, 1967). An essential element of the theory is the development of a core 
category which explains the phenomenon under consideration and is intended to be a 
central product of the participant‟s accounts (Glaser and Strauss, 1967, Annells 
1997a).   
3.14 Summary  
The choice of approach was based on the following considerations.  Firstly, the need 
for an exploratory methodology which can develop understanding of the 
phenomenon of disclosure of illness.  Secondly, an inductive qualitative 
methodology to allow data to emerge from the participants rather than testing a 
hypothesis.  Thirdly, an approach explicitly setting out the author‟s philosophical 
stance, acknowledging the researcher‟s role in the analysis and thus the construction 
of the theory which emerges (Charmaz, 2006).  Constructivist grounded theory has 
been selected for this study because the approach fits all these criteria (Charmaz, 
2006).  In the next section I set out the rationale for adopting constructivist grounded 
theory within the context of an historical overview of grounded theory.  
3.15 Why Constructivist Grounded Theory? Historical Overview  
Charmaz (2006) developed her own strand of grounded theory, entitled 
“Constructivist Grounded Theory”, setting out a new approach for the future: “…we 
look back into the history of grounded theory in the twentieth century and look 
forward into its yet unrealised potential for the twenty-first century” (p1).  I 
therefore contextualise the decision to adopt constructivist grounded theory in this 
study by setting out an overview of the origins and the philosophical underpinning of 
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grounded theory.  I also set out the key debates about grounded theory which were 
taken into account in my decision to adopt constructivist grounded theory (Charmaz, 
2006).  
3.16 The Origins of Grounded Theory 
In this section the origins and philosophical underpinning of grounded theory are set 
out.  Table 3 sets out a chronology of key relevant methodological texts on grounded 
theory, beginning with the original textbook on grounded theory (Glaser and Strauss, 
1967).   
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Table 3 Chronology of Key Methodological Texts on Grounded Theory by 
Glaser and Strauss, Glaser, Strauss and Corbin and Charmaz  
 1967 Glaser and Strauss The Discovery of Grounded Theory 
 Strategies for Qualitative Research 
 1978 Glaser Advances in the Methodology of Grounded Theory,  
 Theoretical Sensitivity  
 1987 Strauss Qualitative Analysis for Social Scientists 
 1990 Strauss and Corbin Basics of Qualitative Research Grounded 
 Theory Procedures and Techniques  
 1992 Glaser Emerging Versus Forcing Basics of Grounded Theory  
 analysis 
 2000 Charmaz Objectivist Versus Constructivist Grounded Theory 
 2002  Glaser Constructivist Grounded Theory? 
 2006 Charmaz Constructing Grounded Theory: A Practical Guide 
 Through Qualitative Analysis 
 
Grounded theory was developed in reaction to the predominant positivist approaches 
at the time (Glaser and Strauss, 1967).  Both Glaser and Strauss each went on to 
modify the approach (Glaser, 1978, Strauss and Corbin, 1990).  Glaser‟s (1992) book 
entitled: “Emerging versus Forcing” was written in response to, and strongly 
challenged Strauss and Corbin‟s (1990) modifications.  Glaser (2002) also critiqued 
Charmaz‟s (2000) constructivist grounded theory, arguing that this approach again 
“forces the data”.  
The origins of grounded theory lie in Sociology, particularly the Sociology of Health 
and Illness (Glaser and Strauss, 1967).  It was the American sociologists Glaser and 
Strauss who developed the research approach grounded theory in the seminal book, 
Discovery of Grounded Theory: Strategies for Qualitative Research (Glaser and 
Strauss, 1967).  When Glaser was employed by Strauss to work on a study of “dying 
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in hospital" (Glaser and Strauss, 1965) the need to formulate an explicit, methodical 
system to code the data was identified (Glaser, 1992, Strauss, 1990).  The 
methodology as presented in Discovery of Grounded Theory was a reaction to the 
challenge of the dominance of the quantitative approaches which posited that 
qualitative research was less rigorous (Glaser and Strauss, 1967).  As a reaction to 
this, Glaser and Strauss (1967) developed a technique within the context of social 
research with the purpose of “discovery of theory from the data.”  Their intention 
was to close what they described as:”the embarrassing gap between theory and 
empirical research” (p7).  That is to say they set out to legitimise the generation of 
theory within the qualitative paradigm by outlining methods to develop theory.  
During the 1960s when grounded theory was developed, the dominant view was that 
knowledge was regarded to be “true” or “false” only if it had been “tested” and 
deemed a verifiable “fact.”  The intention was to offer an alternative approach to the 
prevailing consensus that sociologists could only conduct research in the vein of 
“verification.”  Verification is defined as: “the activity of determining whether a 
statement is true or accurate” (Schwandt, 2001, p270). The prevailing positivist 
paradigm emphasised the gathering of verifiable “facts.”  One difficulty with this 
view of knowledge was that such research limited the creative approach necessary to 
discover the theory (Glaser and Strauss, 1967).  In contrast, Glaser and Strauss 
(1967) argued that a theory might be “discovered” and so in order to do this 
researchers should enter the field devoid of preconceptions with regards to what 
categories or hypotheses are likely to be of importance (Glaser and Strauss, 1967).  
In their view, grounded theory may be used to develop two types of theory: 
“substantive” and “formal.”  Substantive theory sets out to explore a broad area of 
sociological interest such as patients‟ treatment for long-term conditions.  Whereas, 
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formal theory explores areas of sociological interest such as “stigma” or “deviance” 
and so has a narrower focus (Glaser and Strauss, 1967).  The nature of the theory 
which emerges is not necessarily generalisable to other contexts or settings.   
I now go on to present an overview of the philosophical roots of grounded theory: 
pragmatism, symbolic interactionism and the Chicago School of Sociology noting 
their influences on Charmaz leading to the development of constructivist grounded 
theory (Charmaz, 2006).  
3.17 Philosophical Roots of Grounded Theory 
3.18 Pragmatism 
George Herbert Mead (1863-1931) a professor of philosophy at the University of 
Chicago was a key founder of pragmatism (Hammersley, 1989, Benzies, 2001).  
Pragmatism was particularly influential in the development of grounded theory.  
Pragmatists argue that: “we cannot know anything beyond our 
experience…experience (is)…a world of interrelated phenomena that we take for 
granted in everyday life” (Hammersley, 1989, p45).  This viewpoint is reflected in 
its two defining features: anti-foundationalism, the view that knowledge may not be 
known completely in an objective positivist way and the fallibilistic view, that our 
knowledge of the world is limited and so cannot be fully known (Schwandt, 2001).  
Therefore pragmatism influenced Charmaz‟s perspective that knowledge is socially 
constructed and we cannot know things completely, only partially (Charmaz, 2006).   
Mead was interested in the role of symbolic language and the role which interaction 
with others plays in defining oneself.  He discussed the differences between the self, 
I and me.  In his view, “I” represents the inner voice of the individual and the notion 
of “me” is constructed through the responses of others to us.  It is through the 
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process of interacting with others that the self is developed (Benzies, 2001).  This 
construction of meaning appears relevant to the current study, as research suggests 
that it is interaction with others that leads to stigma (Goffman, 1963).  Thus the role 
of others in making sense of things is important to take into account. 
3.19 Summary 
Pragmatism offered new ways to examine interaction between individuals within the 
social world.  It established the socio-philosophical foundation which led to the 
development of the theoretical perspective Symbolic interactionism, and 
subsequently the Chicago School of Sociology and grounded theory (Blumer, 1969, 
Hammersley, 1989, Crotty, 2003, Rice 1999, Benzies, 2001, Schwandt, 2001).  In 
the following section I discuss symbolic interactionism.  
3.20 Symbolic Interactionism  
Symbolic interactionism was developed by Herbert Blumer (1969).  Blumer was a 
postgraduate student at the University of Chicago, and Mead‟s research assistant.  In 
Blumer‟s (1969) book Symbolic Interactionism Perspective and Method, he notes 
that Mead outlined two types of social interaction: “the conversation of gestures” and 
“the use of significant symbols.”  The “conversation of gestures” is the description of 
the process of interaction as in what may cause things to “act” and whether it is 
individuals themselves who have caused others to act:“when our gestural meanings 
take on identical meanings to ourselves and to others, then we have the “significant 
symbol” (Hammersley, 1989, x111).  Blumer (1969) renames them: “non-symbolic 
interaction” and “symbolic interaction.” Symbolic interactionism sees individuals as 
“actors” who must “act” as a consequence of being in a particular situation which 
warrants “action.”  “Meanings” he suggests play their part in action through self-
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interaction, in other words through a process of communication with oneself.  
Objects are also regarded as playing an important role.  These are defined as: 
“anything that can be indicated or referred to. The crucial point however is that it is 
through others that the meaning of the object is conferred (Blumer, 1969, p5).  
Blumer (1969) states there are three key tenets to symbolic interactionism:  
 “The first premise is: human beings act toward things on the basis of the 
meanings that the things have for them 
 The second premise is: the meaning of such things is derived from, or arises 
out of, the social interaction that one has with one‟s fellows 
 The third premise is: these meanings are handled in, and modified through, 
an interpretative process used by the person in dealing with the things he 
encounters” (p.2). 
3.21 Summary 
In summary grounded theory is underpinned by symbolic interactionism and as 
noted earlier was heavily influenced by pragmatism (Strauss and Corbin, 1990, 
Benzies, 2001, Charmaz, 2000, 2006).  One of the co-founders of grounded theory, 
Strauss was particularly influenced by Blumer whom he described as: “my 
intellectual hero” (Baszanger, 1998).  The interactive and dynamic nature of 
symbolic interactionism are of relevance to the current study.  Disclosure of illness 
inherently involves others and thus represents a form of interaction as well as 
conveying the notion that disclosure is a dynamic process (Charmaz, 2006).  As 
Charmaz (2006) notes, the symbolic interactionist‟s perspective assumes that: 
“interaction is inherently dynamic and interpretive and addresses how people 
create, enact and change meanings and actions” (p7).  
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The meaning of disclosure from a symbolic interactionist perspective posits that the 
responses and reactions of the person to whom the individual has disclosed play an 
important role in the development of meaning.  Therefore it is through a social 
process of interaction with others that meaning may be created.  The meaning 
attributed to interactions with others is the focus of my study.  Disclosure of illness 
inherently involves others and it is through telling others that meaning is generated.  
Symbolic interaction perceives the individual to self-interact with themselves in 
processing the meaning generated through others responses (Blumer, 1969).  
Symbolic interaction also fits with my study because it suggests that individuals do 
not live in isolation.  Charmaz (2006) argues that her version of grounded theory 
seeks to build upon the pragmatist Chicago School roots of grounded theory and so 
an overview of this is now presented. 
3.22 The Chicago School of Sociology 
The University of Chicago‟s Department of Sociology built up a significant 
reputation for conducting qualitative research (Hammersley, 1989).  It became 
known as the “Chicago School of Sociology” emphasising the importance of seeking 
understanding of social interaction and social processes: “at the centre of their 
attention” (Strauss, 1987, p.6).  They conducted ethnographic fieldwork in Chicago 
seeking to identify: “a slice of life” (Denzin and Lincoln, 2000, p13).  The “Chicago 
School” strongly influenced Strauss with its interest in the dynamic nature of human 
experiences (Strauss and Corbin, 1990). Its preferred method was to use interviews 
and observations to gather data, rather than survey techniques.  As Strauss and 
Corbin, (1990) note: such influences fed into the development of grounded theory in 
several ways, by highlighting the importance of:  
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 The necessity of conducting research in the natural setting of the people 
being investigated 
 The significance of theory, based on real life, and its ability to advance an 
area of academic thought 
 The view that knowledge is subject to continual change  
 That individuals are engaged in and can influence “the world”  
 The focus on the dynamic and temporal nature of the social world  
 The relationship between meaning and action  
Charmaz (2006) argues that she has realigned the focus of grounded theory returning 
it to the philosophical roots of pragmatism and the Chicago School of Sociology by:  
 “examining processes  
 making the study of action central 
 creating abstract interpretive understandings of the data” (p9). 
In the next section I set out an overview of the debates on grounded theory 
considering which approach is most relevant to the current study and the rationale 
for adopting constructivist grounded theory (Charmaz, 2006).  
3.23 Debates on Grounded Theory 
Over time there have been several modifications to the grounded theory approach 
and extensive debate as to: “who‟s got the real grounded theory?” (Charmaz, 2000, 
p513).  Firstly, I present a consideration of Glaser‟s (1978, 1992) version of 
grounded theory with reference to the current study.  Secondly, I present a 
consideration of Strauss and Corbin‟s version of grounded theory with reference to 
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the current study setting out why I have elected not to adopt these approaches.  
Thirdly, I set out an overview of the key “emerging versus forcing” debate between 
Glaser (1992) and Strauss and Corbin‟s (1990) versions of grounded theory.  Finally 
I set out the rationale for adopting Charmaz‟s (2006) constructivist grounded theory 
as the methodological framework for this study taking the debates into account.  
3.24 Consideration of Glaserian (1978, 1992) Grounded Theory in this Study 
The table below sets out the key tenets of Glaserian (1978) grounded theory.  
Table 4 Key Tenets of Glaserian (1978) Grounded Theory  
 Theoretical Sensitivity – remain open: “as few predetermined ideas as 
possible” (p3). 
 Theoretical Sampling 
 Theoretical Saturation of Categories 
 Substantive (open) Coding 
 Theoretical (selective) Coding 
 Constant Comparative Data Analysis 
 Writing of Theoretical Memos 
 Inductive and Deductive Process of Coding: “derive or induce logic 
from data then apply it to data after ideas emerge” (p11). 
 Identify a Basic Social Process (BSP) which: “explains a considerable 
portion of the action in an area (and) integrative of all the categories 
needed in a theory” (p5).  
 
Glaser (1978) argues that one should not enter the field with a preconceived notion 
or deductive hypotheses of what the important concepts or phenomena might be: 
“the problem emerges, and questions regarding the problem emerge by which to 
guide the theoretical sampling” (p25).  Glaser (1978) advocates allowing the 
phenomenon to emerge from the data, thus ensuring “theoretical sensitivity” (Glaser, 
1978).  Applying a Glaserian perspective to the current study would not initially 
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identify disclosure as a phenomenon of importance; instead one would wait to see 
what emerges in the data once fieldwork has commenced.  The first step is open 
coding which Glaser (1978) describes as: “coding the data in every possible way” 
(p56).  The researcher codes different occurrences into categories which may “fit” 
until theoretical saturation occurs.  The key aim is to allow the data to emerge and 
not force it into predefined categories.  Open coding also plays a role in decisions 
regarding theoretical sampling. A range of questions inform the process of open 
coding: “what is this data a study of?” (Glaser, 1978).  This highlights the fact that 
unexpected data may be discovered in the study.  The researcher then embarks on a 
process of “constant comparison” of categories, posing the question: “what category 
or property of a category, of what part of the emerging theory, does this incident 
indicate?” (Glaser, 1978, p.57).  He suggests that it is important to ask these 
questions in order that the codes:“earn the right” to be part of the theory and so are 
grounded in the data (Glaser, 1978).  Theoretical selective coding is used to identify 
the core variable, that is the “basic social process.”  This process involves coding the 
data to identify key variables which appear to bear particular significance and so 
may form part of the emergent theory.  Theoretical selective coding sets out to link 
substantive codes and examine the relationships as they relate to one another in the 
form of hypotheses which may then become part of the theory. Two types of code 
emerge, substantive and theoretical, which are defined as follows:“substantive codes 
conceptualize the empirical substance of the area of research.  Theoretical codes 
conceptualize how the substantive codes may relate to each other as hypotheses to 
be integrated into a theory” (Glaser, 1978, p55).  Finally, the “basic social process” 
which explains the key constituents of the theory is identified.  The emergent theory 
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should “fit” and “work” providing a relevant account of the area of interest (Glaser, 
1978).   
3.25 Summary  
Having outlined Glaser‟s (1978) procedures and considered their relevance to the 
current study I have elected not to adopt his approach.  This decision is based on 
both philosophical and procedural decisions.  Philosophically, Glaser‟s (1978, 1992) 
approach is arguably positivist in its underpinnings: the researcher adopts a neutral 
stance using a set of procedures to render the data into identifiable knowledge 
(Charmaz 2000a).  Procedurally, whilst Glaser (1978) presents insights into the 
methods of grounded theory, due to their complexity these are arguably not easily 
implemented: “the abstract terms and dense writing Glaser employed rendered the 
book inaccessible to many readers” (Charmaz, 2000a, p512).   
I now go on to present a consideration of Strauss and Corbin‟s (1990) version of 
grounded theory with reference to the current study. 
3.26 Consideration of Strauss and Corbin’s (1990) Grounded Theory in this 
Study  
In time Strauss (1990, 1998) developed his own guide to conducting grounded 
theory: “Basics of Qualitative Research, Grounded Theory Procedures and 
Techniques.” His book was co-authored by Juliet Corbin, an American nurse and 
colleague of Strauss (Strauss and Corbin, 1990).  The key additional procedural 
techniques suggested by Strauss and Corbin (1990, 1998) are presented below (table 
5) and later compared and contrasted with Glaser (1978) (table 7). 
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Table 5 Key Additional Procedures Strauss and Corbin (1990, 1998) Grounded 
Theory 
 Open coding 
 Axial coding 
 Selective coding 
 Theoretical sensitivity permits literature 
 Constant comparative techniques: Waving the red flag, Flip-flop 
technique 
 Use of matrices: Paradigm model, Conditional matrix 
 
As the title of the book suggests, it outlines a series of additional procedural steps 
and techniques which are intended to enhance “theoretical sensitivity.” The 
additional procedures and techniques stemmed from discussions with students 
requesting clearer guidance on methods of translating data into “theory.” (Strauss, 
1998)  They recommend additional “constant comparative” techniques and the use of 
matrices in analysis, in order to improve the quality of grounded theory studies 
(Strauss, 1987).  As Strauss and Corbin (1990) note: “we need theoretical sensitivity, 
the ability to “see” with analytic depth what is there” (p76).  These 
recommendations mark a divergence from both the original version of Glaser and 
Strauss‟s (1967) grounded theory and Glaser‟s (1978) subsequent modifications.  
New additions include the proposition of three levels of coding: open coding, axial 
coding and selective coding (not necessarily sequential).  Open coding sets out to 
identify from the data concepts, their properties and dimensions (Strauss and Corbin, 
1998).  Axial coding examines the relationship between categories of the 
phenomenon in the data according to: “who, when, where, why, how, and with what 
consequences?” (Strauss and Corbin, 1998, p.127).  The results of such questions 
serve to illuminate how and why the phenomenon occurs (Strauss and Corbin, 1998).  
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Selective coding is an important stage, the purpose of which is to identify the “core 
category: “the central phenomenon around which all other categories are 
integrated” (Strauss and Corbin, 1990, p116).  Theoretical memos are used 
throughout the process to track the ongoing analysis and offer guides for areas which 
may require additional sampling. Strauss and Corbin (1990) also permit the use of 
literature to inform the research process and enhance theoretical sensitivity. In 
particular, they set out to enhance a creative approach to analyzing the data including 
the researcher‟s perspective who interacts with the data to explore: “what is going 
on?” (p145).  The findings of this process influences subsequent sampling as 
examples are compared and contrasted with existing data.  This is crucial they argue, 
in order to gain fresh understanding of phenomena.  Strauss and Corbin‟s (1990) 
approach focuses upon social process. Its focus is on process and meaning as defined 
through interaction with others: “meaning is defined and redefined through 
interaction”(p9).  They define process to mean: “sequences of action/interaction 
pertaining to a phenomenon as they evolve over time” (Strauss and Corbin, 1998, 
p.123).  Process is regarded to be dynamic and fluid changing as individuals move in 
and out of interaction in different situations and context.  Indeed, Strauss and Corbin 
(1990) describe process to be similar to music because it changes in terms of tempo 
and style.   
3.27 Summary 
Having outlined Strauss and Corbin‟s (1990) procedures and considered their 
relevance to the current study I have elected not to adopt their approach, the reason 
being that Strauss and Corbin‟s (1990) epistemological position is not explicitly set 
out in their text and so has been subject to much interpretation (Glaser 1992, 
Annells, 1997a,b, Charmaz 2000a, Macdonald and Schreiber, 2001).  Annells 
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(1997a) states that their stance is relativistic because the theory which they develop 
reflects: “a local and constructed reality” (p202).  Although Annells (1990) had 
earlier described it as “neo-positivist” because the researcher must adopt a prescribed 
number of steps in order to analyse and judge the utility of the findings.  As Strauss 
and Corbin (1998) state, there is an element of construction of the data: “Although 
we do not create data, we create theory out of data…enabling (participants) to speak 
in voices that are clearly understood” (p56).  There is a mix of subjective and 
objective approaches to the data as they argue it is difficult to suspend prior views of 
the data (Strauss and Corbin, 1990). The range of perceptions of their philosophical 
stance seem to support Macdonald and Schreibers (2001) assertion that it open to 
interpretation: “people can find support in it for any ontology they wish” (p45).   
I now go on to set out an overview of the “emerging versus forcing” debates 
concerning Glaser‟s (1992) critique of Strauss and Corbin (1990) grounded theory.  
3.28 The “Emerging versus Forcing” Debate: Glaser’s (1992) critique of 
Strauss and Corbin (1990)  
As noted earlier, since its inception in 1967 there have been several modifications to 
grounded theory and extensive debate often referred to as the “Emerging versus 
forcing” debate (Glaser, 1992, Strauss and Corbin 1990, Charmaz, 2000).  Charmaz 
(2000) notes: “grounded theory methods have come under attack both within and 
without…What grounded theory is and should be is contested” (p510).  The key 
differences between the procedures used by Strauss and Corbin (1990) and Glaser 
(1978, 1992) to develop a grounded theory are set out in this section with reference 
to the emerging versus forcing debate.  I go on to clarify the contribution of Charmaz 
(2000, 2006, 2007) to this debate in the following section.   
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The differences between Strauss and Corbin (1990) and Glaser‟s (1978, 1992) 
versions of grounded theory can be summarized into three points (see table 7).  
Firstly, procedural differences Strauss and Corbin (1990) advocate the use of 
additional procedures such as, “waving the red flag”, “the flip flop”, technique and 
the use of “matrices” to maximise theoretical sensitivity and ensure the development 
of a grounded theory which is dense and precise (Strauss and Corbin, 1990).  Glaser 
(1992) challenges these additional procedural techniques arguing that constant 
comparative methods are sufficient in themselves to develop a grounded theory: 
“and that is all there is to it” (p43).  Thus arguing that they are “forcing” the data 
rather than allowing what is important to emerge.   
Secondly, the researcher‟s stance to the data.  Strauss and Corbin‟s (1990) approach 
permits the inclusion of the researcher‟s views and experiences, since coding the 
data is essentially a creative process and argues that previous experience or reading 
of an area is beneficial to the development of the theory.  In contrast, Glaser (1992) 
argues that one should not approach the data with preconceived ideas, and the use of 
literature should be delayed until the theory has been developed.  This he states 
facilitates the emergence of what is likely to be important in the study. 
Thirdly, philosophical differences exist between the authors.  The divergent 
procedural techniques may be traced to philosophical perspectives (Annells, 1996, 
Charmaz, 2000).  The philosophical differences between Glaser and Strauss may 
stem from their earlier training and intellectual influences: Glaser‟s quantitative and 
Strauss‟s qualitative influences.  Glaser studied at Columbia University, New York 
United States of America and was influenced by the work of Paul Lazarsfeld who 
was renowned for developing quantitative survey methods (Strauss, 1990, Charmaz, 
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2006).  Glaser‟s (1992) philosophical stance has been described as “critical realist” 
whose perspective posits that: “the social and natural worlds have differing realities, 
but that both forms of reality are probabilistically apprehensible, albeit imperfectly 
(Annells, 1996, p385).  By contrast, Strauss trained at the University of Chicago, 
whose Department of Sociology had built up a significant reputation for conducting 
qualitative research.  
Having set out an overview of the key debates and consideration of approaches 
within grounded theory in the next section I go on to discuss the role of 
constructivist grounded theory as applied to the current study. 
3.29 The Role of Constructivist Grounded Theory in this Study  
3.30 Constructivist Grounded Theory as an Emergent Technique 
In essence I have elected to adopt constructivist grounded theory for the following 
reasons.  Firstly, its philosophical approach fits my constructivist philosophical 
assumptions as set out earlier in this chapter.  Secondly, the flexible approach to the 
methods and thirdly, the central role of the researcher in the analysis process and 
theory which facilitates an emergent approach to the data.  The key tenets of 
constructivist grounded theory are set out below in table 6.   
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Table 6 The Key Tenets of Constructivist Grounded Theory Charmaz (2000, 
2006) 
 Constructivist Epistemological Assumptions (include the 
researcher‟s perspective) 
 Theoretical Sensitivity: Emergence is Accessed via the Researcher 
who is not a “distant observer” (p178).  
 Methods are Flexible and thus “Emergent” to access the 
Unanticipated and Facilitate the Creative Process of Coding 
 Initial Coding: “remain open to exploring whatever theoretical 
possibilities we can discern in the data” (p47). 
 Theoretical Coding: “Clarify and sharpen your analysis but avoid 
imposing a forced framework on it with them” (p66). 
 The End Product of Constructivist Grounded Theory is not Pre-
ordained: “the finished work is a construction –yours.” (Charmaz, 
2006, px1). 
 
Charmaz (2000) published a key paper entitled objectivist versus constructivist 
grounded theory in which she sets out her constructivist approach which: reclaim 
these tools from their positivist underpinnings to form a revised, more open-ended 
practice of grounded theory that stresses its emergent, constructivist elements 
(p510).  Glaser (2002) responded to Charmaz‟s (2000) paper by arguing that: the 
researcher‟s interactive impact on the data (is) more important than the 
participants. Constructionism is used to legitimate forcing (p4).  That is to say, 
including the researcher‟s perspective is intrusive and unnecessary since the process 
of conducting constant comparative methods are: “all that is required” (Glaser, 
2002).  However I have elected to adopt the constructivist grounded theory because I 
disagree with Glaser‟s (2002) point and believe that: “more is required”.  For 
example, Charmaz‟s constructivist grounded theory (2000,2006, 2007) is an 
“emergent” technique which will allow further exploration and so facilitate fresh 
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insight into the area of disclosure  of illness on which there is limited research to 
date.  I now go on to set out its relevance to this study in detail.  
Charmaz (2006) presents grounded theory as an emergent, approach whose methods 
can be adopted flexibly: a set of principles and practices, not …prescriptions or 
packages (p9).  Procedurally, Charmaz (2007) states that the methods should be seen 
as “flexible” rather than “prescriptive” in order to facilitate the emergence of 
unanticipated data.  Indeed Charmaz (2006) argues that one can adopt the procedures 
of grounded theory set out by Glaser and Strauss (1967) and later modified by Glaser 
(1978) because the procedures are essentially neutral (Glaser and Strauss, 1967, 
Glaser, 1978).  As Charmaz (2006) states: We may think our codes capture the 
empirical reality.  Yet it is our view: we choose the words that constitute our codes 
(p47).  In this study the participants‟ views will not be “forced” into pre-defined 
categories but rather their data will emerge and I, the researcher, will be highlighting 
the data and constructing the codes.  Therefore, this approach fits my study well 
since emphasis is placed upon the significance of the role which I play in terms of 
the theory which “emerges” from the data.  Charmaz (2007) argues that the 
constructivist version of grounded theory draws its emergent nature from the 
researcher in terms of the questions they pose and means employed to analyse the 
data as well as the choice of topic itself.  I have also selected constructivist grounded 
theory because this approach puts participants‟ views to the fore by arguing that 
there is no “pre-ordained” end product of grounded theory.  Whereas Glaser‟s (1978, 
1992) approach is actively seeking to identify the endpoint of:“basic social 
processes” as a means by which to illustrate the emergent nature of the data 
(Charmaz, 2007).  
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Philosophically, Charmaz‟s (2006) approach is constructivist because she argues that 
the researchers‟ perspective is integral to the process of collecting data and 
influences the theory which emerges because it stems from both the participants 
accounts and the researcher: “neither data nor theories are discovered. Rather, we 
are part of the world we study and the data we collect.  We construct our theories 
from our past and present involvements and interactions with people, perspectives 
and research practices” (p10).  In contrast Glaser and Strauss‟s (1967) classic 
version of grounded theory sets out to “discover” the theory entirely independent of 
the researchers‟ stance.  Charmaz (2000) argues that Glaser‟s (1978, 1992) approach 
is positivist since his intention is that the researchers perspective must be excluded, 
and a set of procedures are recommended to render the data into identifiable 
knowledge.  She argues that Strauss and Corbin‟s (1990) approaches are also 
inherently positivist: “Both…assume an external reality that researchers can 
discover and record.  Glaser through discovering data, coding it and using 
comparative methods step by step; Strauss and Corbin through their analytic 
questions, hypotheses and methodological applications” (Charmaz, 2000, p513).  
However, Charmaz (2000) goes on to argue that Strauss and Corbin‟s (1998) second 
edition of Basics suggests a “post-positivist” philosophical stance. 
3.31 Chronicity 
Charmaz‟s (2006) grounded theory is further relevant to my study aims to explore 
ongoing, long-term conditions which may evolve over time because it regards 
interaction to be dynamic and subject to change.  Indeed, as an approach it is well 
suited to exploring long-term conditions and disclosure in particular because the 
theory “emerges” and is not “generated” (Charmaz, 2000, 2006).  Furthermore, 
according to Charmaz (2006) it is important to code for “actions” rather than 
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“themes” to identify potential temporal sequences in the data.  Grounded theory has 
been useful in aiding theoretical understanding of long-term conditions.  It has also 
provided insight into the meanings that individuals attach to such conditions: 
“Grounded theory can illuminate how people learn the difference between having a 
diagnosis and an illness.  By studying how people learn about chronicity, we also 
gain ideas about what having the illness means to them” (Charmaz, 2006, p152).  
Charmaz has conducted much qualitative work on living with long-term conditions 
(Charmaz, 1983, 1991, 2000).  Her book “Good Days, Bad Days: The self in chronic 
illness and time” was notable because it sets out the changing nature of living with a 
long-term condition and the difficulties participants faced.  She has also written on 
the topic of disclosure of long-term conditions noting that issues around disclosure 
emerged unexpectedly in participants qualitative accounts and so she explored it 
further: “Ill people attached such significance to these issues, which, in turn, caused 
me to look at them more systematically and to raise new questions about them” 
(Charmaz, 1990, p1169).    
3.32 Summary and Conclusion 
In this chapter I have set out my rationale for adopting constructivist grounded 
theory as the methodological framework for my study. In summary the selection of 
an inductive, qualitative research approach located within the constructivist 
paradigm has been guided by the specific aims of the current research study.  Firstly, 
philosophically, Charmaz‟ s (2006) approach is particularly relevant to the current 
study because she provides explicit clarification on her constructivist stance, in 
contrast to Strauss and Corbin‟s (1990) approach which is open to interpretation.  
Secondly, constructivist grounded theory facilitates a flexible approach to the 
methods of conducting grounded theory with the intention of developing exploratory 
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work in the field of disclosure of illness.  Thirdly, her approach takes into account 
the importance of the role of the researcher in the development of the theory.  
Fourthly, her approach is deemed to be emergent by focusing upon the need to return 
to the pragmatist roots of grounded theory by studying action and process which are 
relevant to disclosure of illness. In the next chapter (Chapter four) I go on to present 
the methods adopted in the study.  
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Table 7 Comparison of Glaser (1978) (1992) and Strauss & Corbin (1990) 
Procedural and Philosophical Differences 
 Glaser (1978*) (1992) Strauss and Corbin (1990,1998*) 
Philosophical 
Differences 
(Annells 1996, 
Charmaz, 
2000) 
Critical realist:  "Generated 
grounded theory really exists 
in the data" (p53). 
Open to Interpretation: Relativist search for: "A reality 
that cannot actually be known, but is always interpreted" 
(p22). 
Positivist search tor: argues: "an external reality that 
researchers can discover and record...through their 
analytic questions, hypotheses and methodological 
applications" (Charmaz, 2000, p513). 
Researchers 
Stance to 
the Data 
Positivist (etic) 
The theory should "emerge" 
and not be overly influenced 
by the researcher. A common 
understanding of the 
phenomenon is "out there". 
Open to Interpretation: 
"We create theory out of data enabling them 
(participants) to speak in voices that are clearly 
understood and representative" (* p56). 
Positivist search for:"an external reality that researchers 
can discover and record...through their analytic 
questions, hypotheses and methodological 
applications"(Charmaz, 2000, p513). 
Postpositivist: "giving voice to their respondents, 
representing them as accurately as possible, discovering 
and acknowledging how respondents views of reality 
conflict with their own, and recognizing art as well as 
science in the analytic product and process (Charmaz, 
2000, p510). Research 
Question 
An emerging account is there to    
be "discovered": "The research 
question is not a statement that 
identifies the phenomenon to be 
studied...out of open coding, 
collection by theoretical 
sampling, and analysing by 
constant comparison emerge a 
focus for the research" (p25). 
The phenomena is identified: "Underlying this approach 
to qualitative data is the assumption that all of the 
concepts pertaining to a phenomenon have not yet been 
identified or, if so, the relationships between the 
concepts are poorly understood or conceptually 
undeveloped"(p37). 
Common 
Procedures 
• Theoretical sampling 
• Constant comparative 
technique  
• Theoretical sensitivity  
• Writing of memos 
• Theoretical saturation 
• Core category 
• Theoretical sampling  
• Constant comparative technique  
• Theoretical sensitivity  
• Writing of memos  
• Theoretical saturation 
• Core category Theoretical 
Sensitivity 
"The first step in gaining 
theoretical sensitivity is to 
enter the research setting with as 
few predetermined ideas as 
possible" (*p3). 
"It is hard enough to generate 
one's own ideas without the 
"rich" derailment provided by 
the literature in the field" 
(P3I). 
Delay use of literature until 
theory has been developed. 
"To discover theory in data we need theoretical 
sensitivity, the ability to "see" with analytic depth what is 
there" (p76). 
"One can come to the research situation with varying 
degrees of sensitivity depending upon previous reading 
and experience with or relevant to an area" (p4). 
Literature may be used throughout the process: "an 
actual interplay of reading literature and data 
analysis"(p56). 
• Use of fieldwork diaries  
• Personal experiences of the researcher permitted Timing of 
Coding 
Coding does not begin 
immediately: the researcher 
should linger with the data 
what is important what is 
important will "emerge" 
Coding begins immediately 
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 Glaser (1978*) (1992) Strauss and Corbin (1990,1998*) 
Coding 
Procedures 
CODING 
Open coding: "coding the 
data in every possible way" 
(•p56). 
THREE LEVELS OF CODING (not necessarily 
sequential) 
Open coding: "The process of breaking down, examining, 
comparing, conceptualizing, and categorizing data" (p61). 
Axial coding: "specifying a category (phenomenon) in 
terms of the conditions that give rise to it; the context 
(it's specific set of properties) in which it is embedded; the 
action/interactional strategics by which it is handled, 
managed, carried out; and the consequences of those 
strategies" (p97).  Selective coding: "to selectively 
code for a core variable.. the 
analyst delimits his coding only 
to those variables that relate to 
the core variable in 
sufficiently significant ways to 
be used in a parsimonious 
theory" (*P61). 
 
Theoretical  coding: 
"theoretical codes conceptualise       
how the substantive codes may 
relate to each other as 
hypotheses to be integrated  
into a theory" 
This process identifies: 
• Categories: "concepts that stand for phenomena" 
• Dimensions: "the range along which ... properties 
of a category vary". 
• Properties: "characteristics of a category ... which 
defines and gives it meaning" (lOlp, 1998). 
 
Selective coding: "The process of selecting the core 
category, systematically relating it to other categories, 
validating those relationships and filling in categories 
that need further refinement and development" (p. 116). 
 
Theoretical coding: outlines the "core category" which is 
central to explaining the phenomenon. 
Additional 
Procedures 
Additional procedures are not 
necessary: "constant comparison" 
will produce a grounded theory: 
"Categories emerge upon 
comparison and properties 
emerge upon more comparison. 
And that is all there is to it" 
(p43). 
Additional constant comparative procedures can 
enhance "Theoretical Sensitivity" and guide theoretical 
sampling: "We intend to provide a number of 
techniques to assist you, the analyst to make use of your 
creative capacities and to further develop the theoretical 
sensitivity that may already be present within you" 
Theoretical comparisons as tools: (1) "Flip flop 
technique:" the concept is: "turned "inside out" or 
"upside down" to obtain a different perspective" (p94) (2) 
"Waving the red flag:" "certain words and 
phrases...such as "never," "always"... should be taken as 
signals to take a closer look" (p.92). (3) "Far out 
comparisons:" "making striking comparisons" (p82). 
Matrices: 
(1) Conditional matrix:"A diagram useful for 
considering the wide range of conditions and 
consequences related to the phenomenon" (pi 58). 
(2) Paradigm model: "In grounded theory we link 
subcatcgories to a category in a set of relationships 
denoting causal conditions, phenomenon, context, 
intervening conditions, action, interactional strategies, and 
consequences ... use of this model will enable you to think 
systematically about data and relate them in very complex 
ways. Unless you make use of this model, your grounded 
theory analyses will lack density and precision" (p99). 
Outcome A basic social process is 
discovered which: "Bxplains a 
considerable portion of the 
action in an area and relates to 
most categories of lesser 
weight used in or making the 
theory work" (*p5). 
Generated grounded theory 
 
"Generate a rich, lightly woven, explanatory theory that 
closely approximates the reality it represents" (p57). 
An explanatory general theory which explains how the 
phenomenon works in a range of contexts 
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 Glaser (1978*) (1992) Strauss and Corbin (1990,1998*) 
Criteria for 
Rigorous 
Grounded 
Theory 
Fit":   the  categories  of the 
theory "fit" or match the data 
"Work": the theory explicates, 
predicates and interprets what is 
going on in a substantive area. 
"Relevance": It is relevant to 
that area. 
"Modifiabiiity": "though basic 
social processes remain in 
general, their variation and 
relevance is ever changing in our 
world" (p5*). 
• Fit 
• Understanding 
• Generality 
• Control 
 
 
101 
4.0 Chapter Four: Methods 
4.1 Introduction 
This chapter presents an overview of the methods employed in accordance with the 
constructivist approach to grounded theory which takes into account the need to be 
flexible and so adopt an emergent approach to the data (Charmaz, 2006).  The 
research question with its focus upon a social process lent itself to this methodology.  
The research design, study population, and means of gathering the data are 
presented.  The process of data analysis is described and the principles of ethics 
applied to the study.  Finally, the procedures taken to ensure the study results are 
trustworthy are set out.  Issues arising from the methods are presented in the 
discussion and conclusions chapter (chapter six) in greater detail.  
4.2 Summary of the Methods 
Recruitment commenced in December 2006 and was completed in August 2007. The 
source of data was in-depth qualitative interviews.  Participants were recruited from 
two settings: patient support groups and clinical nurse specialist clinics.  A total of 
thirty-five qualitative interviews were conducted (fifteen people living with epilepsy, 
and twenty people living with type 1 diabetes).  Overall there were fewer men than 
women in the sample group (fourteen men compared to twenty one women).  Those 
recruited from the nurse specialist clinics tended to be younger with the majority 
aged between sixteen and thirty-five years old while most of those recruited from the 
patient support groups were aged between forty-six and seventy-five years old.  
There were also differences in occupational status across the study sites.  Many of 
those recruited from the clinical nurse specialist clinics were students, while those 
recruited from the patient support groups tended to be retired. The data were fully 
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transcribed and coded using a three step process: initial line by line coding, focused 
coding and constant comparative methods.  The qualitative data analysis programme 
QSR.N5 was used to manage the organisation of the data. 
Research Question: What is the role of disclosure to others in managing a long-term 
condition? 
4.3 Aims of the Study:  
The study was designed to explore the following:   
 the role that disclosure plays in managing a long-term condition in the lives 
of those living with type 1 diabetes or epilepsy 
4.4 Study Design  
A qualitative grounded theory research methodology was selected to provide insight 
to and clarification of the role of disclosure in the management of long-term 
conditions (Charmaz, 2006, Strauss and Corbin, 1990).  In addition, this 
methodology was considered to be pertinent to this study due to its focus on social 
processes and interactions and so particularly useful in analysing perceptions of the 
role of disclosure which inherently involves others (Blumer, 1969, Glaser and 
Strauss, 1967, Charmaz, 2006, Strauss and Corbin, 1990).   
The literature review (chapter two) highlighted that research on the role of disclosure 
from a psychosocial perspective is relatively limited.  Following the guidelines of 
constructivist grounded theory an exploratory qualitative approach was adopted to 
facilitate the opportunity for participants to raise topics relevant to them and to tap 
into their individual, personal accounts (Charmaz, 2006).  Open ended qualitative 
interviews fit the study well as they facilitate the capture of the dynamic nature of 
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disclosure such as potential changes over time:  “An interview goes beneath the 
surface of ordinary conversation and examines earlier events, views, and feelings 
afresh”(Charmaz, 2006, p26).  This approach has been used successfully in previous 
grounded theory studies on long-term conditions (Charmaz, 1990).   
4.5 Recruitment to the Study 
4.6 Rationale for Selection of Long-term Conditions Type 1 Diabetes and 
Epilepsy  
The decision was taken to focus on individuals living with either epilepsy or type 1 
diabetes (insulin dependent) as the literature review identified that few studies 
explored the role of disclosure across both conditions.  Two long-term conditions 
were selected to facilitate a comparison of key similarities as well as differences 
between and within the groups in order to build upon existing studies: earlier studies 
on disclosure tended to focus upon one long-term condition.  Such comparisons may 
also identify gaps in the provision of services.  As illustrated in the literature review, 
although both conditions are prevalent and require varying levels of self care, they 
remain hidden to some extent.  However they become visible when a diabetic has a 
hypoglycaemic episode, or an epileptic experiences a seizure.  
4.7 Selection of Recruitment Setting  
A pragmatic approach was taken as I sought access to those living with type 1 
diabetes or epilepsy from a range of ages, socio-demographic backgrounds and 
period of time living with the condition.  Participants were recruited from both 
patient support groups and clinical nurse specialist clinics in order to facilitate a 
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comparative approach across conditions and to gain access to a broad spectrum of 
experiences.  
4.8 Clinical Nurse Specialist Clinics 
Clinical nurse specialist clinics were identified as suitable recruitment sites for both 
pragmatic and theoretical reasons.  It was a pragmatic decision to recruit those with 
long-term conditions within the single setting of a clinic.  This study site also 
allowed access to patients who may not have attended patient support groups.  It was 
a theoretical decision because as noted in Chapter two (literature review) nurses play 
a key role in the provision of care for those living with long-term conditions.  
Recruiting from the clinics allowed me to explore patients‟ perceptions of the role of 
health care professionals with regard to disclosure.   
4.9 Patient Support Groups 
Similarly, participants for the study were recruited from patient support groups for 
pragmatic and theoretical reasons.  It was a pragmatic decision to recruit those with 
long-term conditions within a single setting and explore potential differences 
between attendees of support groups and clinics.  It was also a theoretical decision 
because as highlighted in the literature review, those who attend patient support 
groups may not be “typical” of those living with the condition.  Therefore, I sought 
to explore their reasons for attendance and the influence of the group, if any, on the 
decision making process concerning disclosure as well as exploring other issues 
raised during the interviews.  
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4.10 Description of Study Sites 
4.11 Patient Support Groups: Epilepsy 
Epilepsy Action is a registered charity in the UK.  The aims of the charity are: “to 
improve the quality of life and promote the interests of people living with epilepsy” 
(Epilepsy Action Website, 2005).  The Charity offers support and provides 
information to those living with epilepsy and to others with an interest in this 
condition.  Patient support groups are volunteer led.  Group meetings are held each 
month and an external speaker invited to address the group on relevant topics.  These 
are attended not only by those diagnosed with epilepsy but also by their friends and 
family.   
4.12 Patient Support Groups: Diabetes 
Diabetes UK is a registered charity.  The aim is to offer support and information, 
organise social events and raise awareness of diabetes.  Patient support groups are 
run by volunteers.  They meet each month and a speaker is invited to address the 
group on a topic of interest relevant to diabetes such as diet or exercise. They are 
attended by individuals not only diagnosed with either type 1 or type 2 diabetes, but 
also their friends and family.   
4.13 Clinical Nurse Specialist Clinic: Epilepsy 
The two clinics selected were held within two teaching hospitals in the South East of 
England.  In clinic one, patients were seen twice per month.  In clinic two the nurse 
had a higher case load, and patients were seen on a weekly basis.  Patients were 
referred to the clinical nurse specialists by consultant neurologists and on occasions 
by general practitioners.  The purpose of the clinic was to provide counselling, 
 
106 
information and support to those living with epilepsy on topics such as: seizures, 
surgery, medication, employment, and pregnancy.   
4.14 Clinical Nurse Specialist Clinic: Diabetes Clinic 
The clinic was set within a hospital in the South of England, and attended by those 
aged sixteen years and over.  The function of the clinic was to provide advice 
specifically to young adults on the management of diabetes in areas such as diet, 
exercise, insulin control and any other issues of concern.  The clinic was held 
fortnightly. 
4.15 Research Access 
4.16 Clinical Nurse Specialist Clinics 
This element of the study was set in three NHS teaching hospitals in the South of 
England (see table 2).  Since patients were being recruited from nurse specialist 
clinics, a number of procedural steps were required to facilitate this. Firstly, an 
application was made to the NHS Research and Development Department seeking 
approval for the study to take place, as set out in the Research Governance 
Framework for Health and Social Care Act (Department of Health, 2005g).  
Secondly, an application for an honorary contract was submitted to each NHS Trust.  
One trust stipulated that as part of this process I should also obtain clearance from 
the Criminal Records Bureau. Thirdly, as I was directly in contact with patients I was 
asked to complete an occupational health questionnaire.   
Permission to proceed with the study was obtained from the nurses.  However their 
stipulation to gain permission from the consultants in two of the proposed study sites 
(one Epilepsy, one Diabetes) led to delays.  As a consequence of these delays, and in 
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order to supplement recruitment, it was necessary for me to seek alternative study 
sites.   
4.17 Epilepsy 
I met with the clinical nurse specialist in epilepsy at a major teaching hospital to 
request permission to conduct the study in the clinic.  She acknowledged that 
disclosure of illness was an important topic and agreed to participate, pending ethical 
approval and permission from the relevant neurology consultants.   
4.18 Diabetic Clinic 
I met with the clinical nurse specialist in diabetes at a major teaching hospital to 
discuss the aims of the study and to request her permission for it to be conducted 
within the department.  She agreed to participate, pending approval from the lead 
consultant.  Permission was granted on the proviso that the study should not add to 
the workload of the clinic staff.  This was taken into account when planning the 
process of recruitment.  
4.19 Summary 
The study raised a number of issues regarding access to study sites by means of 
clinicians, despite having ethical approval in place.  Gaining research access to clinic 
attendees proved to be a time consuming and potentially sensitive process and raised 
interesting questions as to who is the „gate keeper‟ to patient access (reflections on 
this process are set out in chapter five).  As access was dependent upon an agreed 
process of recruitment the researcher had little control over this. 
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4.20 Patient Support Groups  
In this section I discuss the identification of patient support groups and issues 
regarding access.   
4.21 Epilepsy 
As there were no patient support groups in the local area, they were identified via the 
national charity Epilepsy Action.  An application was made to the Charity‟s research 
co-ordinator regarding the study.  This was a necessary process in order to obtain 
contact details of patient support group leaders.  Completing the application form 
was a detailed process requiring professional references and a copy of the letter 
giving ethical approval.  The application for research access was successful.  The 
Charity wrote to group leaders directly, and as a result I was invited by three support 
groups to present my study to potential participants at a group meeting. 
4.22 Diabetes 
The charity Diabetes UK was contacted to obtain details of the local group co-
ordinators.  Following a telephone discussion with the co-ordinators, information 
regarding the aims of the study was forwarded to them.  The study was then 
discussed at their committee meeting.  Permission to recruit from three diabetes 
groups was granted and I was invited to present my study at each group‟s meeting.  
4.23 The Recruitment Process 
This section presents the process of recruitment to the current study.  A pragmatic 
approach was taken in line with the wishes of the leaders of the patient support 
groups and the nurses.  Due to the different settings and issues over access, a range 
of methods of recruitment were employed (Table 2) presents an overview of the 
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process of recruitment.  Recruitment took place in two key settings: patient support 
groups and clinical nurse specialist clinics.  I will now discuss the process of 
recruitment to the patient support groups (epilepsy and diabetes respectively). 
4.24 Patient Support Group: Epilepsy 
I attended four evening meetings and delivered a brief presentation on my study. 
Attendees were then invited to ask questions. It was emphasised throughout the 
meeting that they were under no obligation to participate in the study but should they 
wish to, they should complete and return to me the form in the information pack with 
their contact details (appendix 2a) along with the personal data collection sheet 
(appendix 2b).  I reflected that having met the researcher, and been given the 
opportunity to raise questions on the study, that this might have allayed any fears and 
so made the prospect of participation less daunting.  Some groups consisted largely 
of friends and family members of those with the condition and as such were 
ineligible to participate in the study: this number was higher than anticipated. 
4.25 Patient Support Group: Diabetes 
I attended two evening meetings of the diabetes group when I introduced my study 
and provided attendees with an information pack(see appendices 3a,4a).  They too 
were invited to return the form enclosed in the pack complete with their contact 
details if they wished to participate in the study.  Again it was emphasised that 
attendees were not obliged to participate.  The key difference in this setting was that 
since there are two predominant types of diabetes (type 1 and type 2) it was 
necessary to clarify that the study was focussing only on type 1 diabetes.  This had 
implications for the recruitment process at the third site where the majority of group 
attendees were type 2 diabetics.  The group leader offered to contact those with type 
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1 diabetes directly to ask if they would be interested in participating in the study.  
4.26 Clinical Nurse Specialist Clinic: Epilepsy  
The recruitment process for the two clinics is set out.  At the first clinic, the clinical 
nurse specialist wrote the address of the patient on the pre-paid information pack 
(appendices 3b,4b) and envelope provided.  This was the most practical approach 
because it required specialist knowledge as to who was eligible for the study.  The 
researcher contacted the nurse regularly by telephone and face to face meetings, to 
enquire how many patients had been contacted.  She noted that she had forgotten to 
send the information packs due to work commitments.  Potential alternatives to 
minimise the workload incurred by the study were discussed.  However, she offered 
to continue to send out the packs.  Both the nurse and I kept a record of the number 
of information packs forwarded to the patients.  At the first clinic, out of fifteen 
information packs sent to clinic attendees, three agreed to participate. 
Access to this second epilepsy clinic was negotiated on 18th July 2007: recruitment 
ceased 28th August 2007.  The nurse assisted in the recruitment of those aged 
between eighteen and thirty five years as it was noted that there were few younger 
people in the sample group. 
4.27 Provision of Gift Vouchers to Participants  
Due to a low response rate, particularly in the epilepsy specialist nurse clinic, and 
following discussion with research colleagues, permission to offer participants a gift 
voucher was sought and granted by the Ethics Committee and local Research and 
Development Committees.  Consequently, participants received a fifteen pound gift 
voucher to compensate them for time taken to participate in the study.  Across all 
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recruitment settings, nine participants received a gift voucher.  
4.28 Clinical Nurse Specialist Clinic: Diabetes  
Recruitment commenced in this site on the 14th February 2007, and ceased on the 
22nd August 2007.  In order for me to prepare sufficient information packs for 
attendees at the clinic, I telephoned the day before it was due to be held to enquire 
about numbers attending.  When patients arrived at the clinic, they waited on average 
five minutes until called forward by the nurse for their appointment.  The nurse 
suggested that this would be the most appropriate point to approach possible 
participants for the study.  I clarified that they were attendees of the diabetic clinic, 
introduced myself, and briefly explained the aims of study.  I explained what being a 
participant would entail and invited them to take part, whilst emphasising that they 
were not obliged to do so and their decision would not affect their care in any way.  I 
then provided them with an information pack requesting their contact details if they 
wished to participate.   
4.29 Inclusion Criteria 
Broadly across all study sites, those aged sixteen years or over and diagnosed with 
either type 1 diabetes or epilepsy were eligible to participate in the study and invited 
to do so.   
4.30 Exclusion Criteria 
Those aged under sixteen years were excluded due to legislative restrictions and 
those who required the services of a translator were excluded due to a lack of 
resources.  In terms of clinical exclusions, on the advice of the nurse, those with 
learning disabilities and those who were not formally diagnosed with epilepsy were 
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excluded from the study. 
Table 2 Process of Recruitment to the Study  
Study sites Location Type of contact Response 
rate 
Patient Support 
Groups: Epilepsy 
Two groups in the 
South of England. 
Presentation to group by 
the researcher. 
Nine 
participants 
Patient Support 
Groups: Diabetes 
Three groups in the 
South of England. 
Two presentations to 
group by the researcher. 
One presentation by 
group leader 
Eleven 
participants 
Clinical Nurse 
Specialist Clinic 
Epilepsy  
Two teaching 
hospitals in the South 
of England. 
Patients receive postal 
invitation to participate 
(via the nurses). 
Six 
patients  
Clinical nurse 
specialist Young 
Adult Diabetic 
Clinic  
One teaching hospital 
in the South of 
England.  
Researcher invites clinic 
attendees to participate in 
the study.   
Nine 
patients  
 
4.31 Conducting the Qualitative Interviews  
This section presents the process of conducting qualitative interviews in the study; 
the interview setting, details on the format of the questions and establishing rapport 
with participants. 
4.32 Interview Settings 
The majority of participants chose to be interviewed in their homes (n=25).  
Interviews were held in a health centre; the most practical option for the attendees 
(n=3).  Some teenagers preferred the “neutral” setting of a central café (n=7).   
4.33 Question Format: Open-ended Qualitative Interviews 
In the interviews, participants were invited to describe their experiences of 
disclosure.  A topic guide was used with the key questions asked of every 
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interviewee (appendix 5).  The interviews were broadly guided by the following 
topics: 
 experiences of disclosing illness to others in different contexts (the 
workplace and their personal lives),  
 the outcome of telling others about the condition  
 exploration of the barriers to disclosure  
Participants were invited to recount their experiences of disclosure from the point of 
diagnosis to the present time in order to: “try to tap his or her assumptions, implicit 
meanings, and tacit rules” (Charmaz, 2006, p32) 
4.34 Establishing Rapport  
It has been argued that establishing rapport in the interview setting is crucial to the 
quality of information emerging from the data.  Charmaz (2006) states: “The 
interviewer is there to listen, to observe with sensitivity, and to encourage the person 
to respond” (p25).  The following steps were taken in an attempt to establish rapport.  
I dressed smartly but casually, in order to create an impression of informality.  
Participants‟ offers of refreshments prior to and during the interview were generally 
accepted.  Before the interviews commenced the participant was invited to discuss 
any queries regarding the study.  It was emphasised that the purpose of the interview 
was for the researcher to listen to their experiences and this would be conducted in 
an informal manner.  This appeared to be a successful course of action, because 
many explicitly expressed that for them, participating in the interview had been a 
positive experience. 
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4.35 Data Management  
This section presents details of the manner by which data were gathered, managed 
and processed.  
4.36 Use of a Tape Recorder 
Participants were asked to complete and sign a consent form (appendix 6) giving 
their permission to tape record the interview.  All participants agreed to this which 
enabled me to maintain regular eye contact with them and also concentrate on what 
they were saying rather than taking notes.  When the interviews took place in public 
cafes there was a great deal of background noise.  However, due to the quality of the 
digital recorder and because I was the one transcribing the tapes, this was less 
problematic than anticipated. 
4.37 Transcription of Interviews 
Interviews can be transcribed at different levels and so decisions need to be made 
about how much detail to record (Mishler, 1986).  He argues that transcription is not 
a simple process because the non-verbal elements of the interview such as expressing 
or emphasising ideas through movement of the body are difficult to capture.  The 
accuracy of the transcripts is vital in qualitative research, in terms of both the 
questions posed as well as participants‟ responses as Mishler (1986) notes: “…the 
analysis of speech is central to the use of interviews as research data…an accurate 
record is needed of the questions that interviewers ask and the responses that 
interviewees give (p.36).  In this study all the interviews were transcribed verbatim 
by the researcher as soon as was practical following the interview, in order to record 
an accurate version.  The interviews varied in length but an average of four hours 
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was spent per interview on their transcription (approximately one hundred and forty 
hours altogether).  To preserve participants‟ confidentiality and anonymity any 
identifying features mentioned in the interviews were removed.  
4.38 Use of Computer Package QSR N5 
A number of computer packages have been developed to assist in the organisation 
and analysis of qualitative data.  However there is some debate between qualitative 
researchers as to whether computer packages should be adopted (Seale, 2005).    
Some qualitative researchers have expressed fears that they will impose a rigid 
framework upon their analytical process given that they originated in the statistical 
quantitative paradigm (Seale, 2005).  The benefits of using such packages in 
grounded theory studies are being increasingly recognised (Seale 2005, Corbin 
2008).  Seale (2005) notes that their assistance in the process of data management 
facilitates theoretical sampling and “constant comparison” across cases and Corbin‟s 
(2008) updated version of Strauss and Corbin‟s (1990) grounded theory 
textbook“Basics” includes a new chapter setting out the relevance of computer 
software to conduct grounded theory analysis. 
Computer packages designed by Social Scientists can also facilitate management of 
the data by drawing together and highlighting data not initially apparent to the 
researcher when employing manual approaches to coding.  A further advantage of 
such packages is their transparency, allowing others to see the manner in which the 
coding process has been conducted and analysis reached (Green and Thorogood, 
2004).  For this study, the data package QSR N5 for Qualitative Data Analysis (QSR 
International Pty Ltd 1980-2000‟s) was selected for practical reasons.  The 
transcripts were transferred onto the computer package QSR N5.  This data 
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management package was particularly useful in the process of analysis because it 
enabled the management of large amounts of data in a standardised and transparent 
way, thus contributing to the “credibility” of the study (Charmaz, 2006)  
4.39 Methods of Data Analysis  
This section sets out details of the methods of data analysis reflecting on the 
researcher‟s role in this process. 
Compared to other models of grounded theory (Glaser and Strauss, 1967, Glaser, 
1978, Strauss and Corbin 1990), constructivist grounded theory offers flexibility in 
the methods employed to analyse data.  This perspective takes into account the role 
of the researcher in this process, allowing one to adopt an open, flexible, and 
therefore “emergent” approach to the data, thus facilitating fresh insights into the 
phenomenon of disclosure (Charmaz, 2006).  
4.40 Reflections upon my Role in the Analysis Process  
4.41 Theoretical Sensitivity 
A key tenet of constructivist grounded theory is that researchers must adopt a 
reflexive approach and consider their contribution to the theory (Charmaz, 2006).  
The methods of grounded theory are considered to be “neutral” but by contrast the 
researcher is not.  The researcher plays a key role in the coding process by 
identifying relevant data (Charmaz, 2006).  By using a constructivist approach, I was 
able to reflect upon and consider my role in the process of gathering the data in terms 
of coding, interview questions and analysis.  In this study, whilst the participant is 
the key informant, I pose the questions, and identify specific areas to be explored.  
Consequently my role is not “neutral” but rather my perspective is integral to the 
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analysis process and emerging data:“researchers are part of what they study, not 
separate from it”(Charmaz, 2006, p178).  The theory which emerges from the study 
is itself a “construction” developed by the researcher and the participants (Charmaz, 
2007).  In other words there is no single, end product which is “arbitrarily 
preordained.” 
4.42 Researchers Positionality 
As Cresswell (2003) notes it is important for the qualitative researcher to reflect 
upon their own role in the research and set out how they think this may “shape the 
study” (p182).  I therefore now briefly set out my personal biography and reflect 
upon on how it may have shaped the study.  My academic background is not clinical 
but rather lies in the field of Sociology of Health and Illness and Health Services 
Research.  At the point of commencing this research I had worked in the field of 
health services research with a particular focus upon patient experiences for over 
eight years.  I had conducted over one hundred qualitative interviews with 
participants living with long term or acute conditions.   However whilst I had spent 
much of my working life interviewing research participants living with illness I had 
limited personal experience as to what it is like to live with a long term condition or 
consider the question of disclosure.  During the course of conducting this research, I 
unexpectedly encountered health difficulties and for the first time had to consider the 
question of disclosure from a personal perspective.  I began to have to consider “who 
needs to know?” about my health condition, to what extent? and for what purpose?  
The methodological implications of this were, that I was not only interviewing 
participants as a researcher, I was interviewing them with an increasing personal 
experience of the challenge of disclosure myself.  Due to my interest in disclosure I 
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was able to acknowledge that I was following up particular points that participants 
made.  Put simply, my personal experience on disclosure is that it is not a 
straightforward or easy process and so I acknowledge that I was able to empathise 
with those who encountered difficulties in this area.  On one occasion after 
disclosing to someone that I was unwell, their response to me was: “You don‟t look 
ill!”  Participants in my study had also cited similar reactions. Thus, unexpectedly, 
disclosure has come to have both a professional and socially profound impact upon 
my life. This affected how I worked with respondents meanings by acknowledging 
my personal experience of disclosure and not trying to exclude these but using them 
to explore and build upon respondents accounts.  
Overall I believe my personal experiences of disclosure led me to a greater depth of 
empathy and possibly rapport with participants than may have otherwise been the 
case.  However my personal experiences of disclosure were relatively limited and 
newly acquired compared to the majority of the participants.  The participants whom 
I interviewed were diverse in terms of their age and length of diagnosis compared to 
myself.  As a white female researcher in her mid thirties I used my personal 
experiences of disclosure as important insights which I could draw upon whilst 
ensuring I still remained open to participants‟ perspectives.  
This section outlines the method of ongoing data analysis employed in this study in 
accordance with Charmaz‟s constructivist grounded theory (2006).  She notes that in 
the process of conducting analysis there is a desire to follow a “step by step” 
procedure.”  She warns however that this must be tempered by the need not to stifle 
the creative process (Charmaz, 2007).  I conducted all thirty-five interviews, and 
transcribed each once as soon as was possible following the completion of the 
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session.  Listening in detail to the recorded interviews, whilst conducting the process 
of transcription, was fundamental to the overall analysis process because it allowed 
me to immerse myself in the data.  Transcribing the interviews also gave me the 
opportunity to reflect upon not only the questions I posed, and the responses given, 
but also to note pauses or changes in the emotional pitch of the interviewee‟s voice.  
I therefore set out to look out for such cues in subsequent interviews.   
4.43 Theoretical Memos 
The writing of memos plays an integral part in the development of grounded theory 
since they can be used to note reflections on the data and compile questions in order 
to allow one to build upon and explore different ideas (Charmaz, 2006).  Memos 
can: “form the core of your grounded theory. Following up on ideas and questions 
that came up while you wrote them will push your work forward” (Charmaz, 2006, 
p94). In my study I used theoretical memos to record my thoughts on key issues 
which emerged during the course of the interviews.  In those instances when 
participants referred to their condition as either “controlled” or “uncontrolled” this 
was noted for additional exploration.  The process of writing memos was ongoing 
and crucial to the development of the process of data collection.  The following 
section deals with the process of gathering field notes throughout the study.  
4.44 Fieldnotes  
Fieldnotes are often used to record observations and reflections on the data, as part 
of the reflexive approach to the ongoing analytical process (Charmaz, 2006). 
Comparing fieldnotes to interviews, then line by line coding facilitates: “the logic of 
discovery as you begin to code the data” (Charmaz, 2006, p51).  The recording of 
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field notes was particularly relevant to this study when noting “the non-verbal 
communication” such as reflecting upon emotional responses or body language, to 
gauge participants‟ responses to particular questions.  Others have found it useful to 
record fieldnotes using a tape recorder or journal (Morse and Field, 1996).  As I 
often travelled by train to interview participants, I was able during the return journey 
to listen to the recording of the interview which I had just completed and note 
salient points on the setting, or emotions that had emerged during the session while 
they were still fresh in my mind.  It has been contended that using a tape recorder 
does not capture all interaction accurately such as: “the physical setting, the 
impressions the observer picks up or the non-verbal communication in an observed 
interaction” (Morse and Field, 1996, p91).   
The following examples indicate how field notes were used to gather non-verbal 
observations from the interviews.  For instance two of the interviewees had suffered 
physical injuries as a consequence of their epilepsy: one had a bruised face, the 
other a burnt arm. They described how the visual marks had led to enquiries 
regarding these injuries and that prompted them to disclose the nature of their 
condition explaining that it was due to harming themselves unintentionally during a 
seizure.  
4.45 Coding  
4.46 Initial coding  
In this section I set out the coding process adopted in this study.  The first step 
which Charmaz (2006) recommends is “initial coding” the logic of which is to: 
“remain open to exploring” the data (p47).  Comparing the data in this way enables 
the researchers to remain open to what participants perceive to be important 
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(Charmaz, 2006).  In this study the transcripts were carefully scrutinised and each 
line labelled noting when participants had raised key terms such as, “being 
diagnosed” and “learning to inject insulin.”  Once more during this process of 
analysis my role in this became apparent, as I selected the words to code.  Charmaz 
(2006) notes: “we may think our codes capture the empirical reality. Yet it is our 
view: we choose the words that constitute our codes” (p9).   
When reviewing the transcripts I adopted Charmaz‟s (2006) strategy of coding 
“actions” rather than “themes” such as “being diagnosed with epilepsy;” “learning 
about medication” and “learning over time.”  Charmaz (2006) states the reasoning 
behind this: “focus your coding on actions, you have ready grist for seeing 
sequences and making connections… not on individuals, as a strategy in  
constructing theory and moving beyond categorizing types of individuals” (p136).  
Using this approach it was possible to develop fresh insights into disclosure by 
focussing upon “actions” in order to examine how they relate to the overall 
phenomenon of disclosure.  
4.47 Focused Coding  
The next step was to conduct what is termed “focused coding.”  Charmaz (2006) 
defines this process as: “using the most significant and or frequent earlier codes to 
sift through large amounts of data” (p57).  This involved a process of extracting the 
key and “frequently used” codes and grouping them together.  For instance, the 
following examples of focused codes illustrate participants‟ perceptions of disclosure 
as a personal topic: “who needs to know?” and, “I wouldn‟t broadcast it.”  This 
produced numerous codes and these had to be distilled into the following major 
categories: “stigma”, “visibility”, “invisibility”, “disclosure”, “non disclosure”, 
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“information” and “identity” to facilitate management of the data. 
4.48 Axial Coding  
Axial coding examines the relationship between categories of the phenomenon in the 
data: “in terms of the conditions that give rise to it; the context (its specific set of 
properties) in which it is embedded; the action/interactional strategies by which it is 
handled, managed, carried out; and the consequences of those strategies” (Strauss 
and Corbin, 1990, p97).  Axial coding played the following role in this study.  When 
examining disclosure I considered contexts and settings of disclosure; to whom 
people disclosed and why, responses to disclosure and perceived reactions to 
disclosure.  This assisted in the process of clarifying the components or “properties” 
of disclosure in this study.  
4.49 Diagramming  
Throughout the period of data collection, a series of visual diagrams were prepared 
to explore the relationships between categories to discover potential links (Charmaz, 
2006).  For example “the rationale for disclosure and its intention or purpose”, and 
“barriers to disclosure” were set out in exploratory diagrams.  Examples of these 
are set out (see appendix 7) to illustrate their relevance to the analysis process.  
4.50 The Literature Review  
There is much debate in the field of grounded theory methodology regarding the 
timing and the role of the literature review (Glaser and Strauss, 1967, Glaser, 1978, 
Strauss and Corbin, 1990, Charmaz, 2006).  Some have argued that the literature 
review should be delayed until after the completion of data analysis in order to avoid 
being influenced by existing literature and so remain open to fresh insights (Glaser 
 
123 
and Strauss 1967, Glaser 1978).  Such influences may result in what has been 
termed: “received theory” (Glaser and Strauss, 1967, Glaser, 1978).   
On the other hand Charmaz (2006) notes that a literature review assists in identifying 
possible research gaps, thus setting out a clear rationale for the study, and also to 
clarify and build upon the data analysis.  In this study, I completed the literature 
review initially to set out the broad parameters of the area of research.  It was after 
having completed most of the analysis that I then reviewed the literature in order to 
remain open to new ideas and so minimise its influence on me (Charmaz, 2006).  In 
adopting this process, I was able to clarify the contribution of this study to the field 
of disclosure research for example: concordance with regard to medication and 
young people, and the role of the internet as a source of health information. 
4.51 Sampling  
4.52 Theoretical Sampling  
Theoretical sampling is a key element of conducting a grounded theory study and 
forms part of the process of theoretical saturation: “…to develop the properties of 
your category (ies) until no new properties emerge.  Thus, you saturate your 
categories with data and subsequently sort and/ or diagram to them to integrate 
your emerging theory” (Charmaz, 2006, p12).  In this study theoretical sampling 
was used to develop the concepts identified by participants as being relevant to 
disclosure, such as “visibility and disclosure”, “identity and disclosure” and “stigma 
and disclosure.”  These categories were raised by participants and therefore noted 
for inclusion in subsequent interviews to facilitate their development and 
“saturation” (Charmaz, 2006).  The process of achieving theoretical saturation is 
described as follows: “gathering fresh data no longer sparks new theoretical 
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insights, nor reveals new properties of these core theoretical categories” (Charmaz, 
2006, p113).  Whilst it was not possible to directly select participants for this study 
according to their views on disclosure the setting of patient support groups and 
nurse led clinics accessed a broad range of participants who varied in terms of 
characteristics.  These included gender, age, and length of time with the condition.  
Throughout the analysis process field notes and memos were kept to record my 
reflections on whether new properties of the categories were emerging.  I noted that 
by interview thirty five no new issues were emerging and I judged that theoretical 
saturation had been achieved. 
4.53 Process of Constant Comparison  
The process of constant comparison and the researcher‟s “engagement” in the 
process are key elements of grounded theory studies: “making comparisons between 
data, codes and categories advances your conceptual understanding because you 
define analytic properties of your categories” (Charmaz 2006, p179).  The process 
of constant comparison was applied on an ongoing basis as I compared and 
contrasted concepts relevant to the phenomenon of disclosure.  The purpose of this 
was to clarify the contents of the concepts and the properties of the categories.  For 
instance, in this study I coded “spontaneous” examples of disclosure and then 
compared them to examples of “unspontaneous” disclosure. I then reviewed the 
interview data to search for examples of disclosure, comparing and contrasting with 
examples of non disclosure and seeking to identify the salient characteristics of the 
phenomenon (Charmaz, 2006).  Using the process of constant comparison in my 
study enabled me to compare and contrast categories such as: “who needs to know?”  
In the next section I set out the principles of ethics applicable to this study. 
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4.54 The Principles of Ethics Applied to this Study  
An application was made to the local research committee (Oxfordshire Research 
Ethics Committee “A” reference (06/Q1604/79).  The study was approved at their 
meeting on May 2nd 2006.  A formal letter offering a favourable ethical opinion for 
the research project was provided on the 27th June 2006.  
There are four key ethical principles incorporated into the study design, these are: 
respect for autonomy, non-maleficence, beneficence, and justice (Beauchamp and 
Childress, 2001).  
4.55 “Respect for Autonomy” 
4.56 The Process of Seeking Informed Consent  
Underpinning the notion of “informed consent” is the principle that those taking part 
in research should not feel compelled to do so.  Rather, the decision should be taken  
voluntarily, in the complete knowledge of what the implications would be for the 
participant (Green and Thorogood, 2004).  In this study, individuals were enabled to 
make an informed decision in several ways: the provision of an information pack 
setting out the purpose of the study; the reasons for being invited to participate; the 
reassurance that they were not obliged to participate; and that opting not to take part 
in the study would not affect any aspect of their current or future provision of health 
care.  Those invited to participate were also given up to two weeks to consider 
whether or not to take part.  They were also encouraged to discuss the study with 
others prior to making a decision.  A contact telephone number was provided should 
they require any additional information along with a consent form confirming their 
agreement to participate and indicating that they had read and understood the 
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information sheet (appendix 4a,b).  Prior to formally commencing the interviews, the 
consent form was discussed and participants were invited to raise any concerns about 
the study.  The offer to note responses rather than record the interview was made, but 
all participants consented to the use of a tape recorder. 
4.57 “Non-maleficence:” to the Participants 
A second key ethical principal is “non-maleficence:”  “first, do no harm” to 
participants (Beauchamp and Childress, 2001).  The topic of disclosure of long-term 
conditions is one which I reflected may raise potentially distressing and sensitive 
issues as previous studies have identified (Jouard, 1971,Charmaz, 1990,1991, 
Rosenfield, 2000,  Beatty, 2004).  Taking this into account, the following steps were 
adopted to protect the participants.  As part of the consent process participants were 
reminded of their right to withdraw from the study at any time, that provision of 
health care would not be compromised and that the information they shared would 
remain confidential.  Following the interview they were offered the opportunity to 
receive a copy of the interview transcript to suggest amendments if desired.  If the 
participant became distressed during the interview, I would bring it to a close and 
switch off the tape recorder.  I ensured that I had an information sheet with the 
names of relevant local and national contacts if further support or information was 
required once the interview had ended (appendix 8).  
4.58 “Non-maleficence:” to the Researcher 
Recent studies have suggested that the process of conducting interviews can have an 
emotional impact on the researcher (Lalor et al, 2006, Craig et al, 2000, Lees, 1993).  
Guidelines have been developed to protect social researchers and an enquiry 
conducted to assess the overall impact of conducting qualitative research on 
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researchers well being (Craig et al 2000, Commissioned Enquiry 2007 Risk to well-
being of researchers in qualitative research). 
The multi-disciplinary literature identified that disclosure is a sensitive topic as it 
involves the divulgence of something which is essentially “private” (Charmaz, 1990, 
1991, Beatty, 2004, Jouard, 1971, Petronio, 2000, Derlerga et al 1993).  It has been 
argued that an emotional investment is required by the researcher: “the researcher, if 
more than merely competent, will be “in the work” emotionally as well as 
intellectually…others will be profoundly affected by experiences engendered by the 
research process” (Strauss, 1987, p10).  I found this to be the case in my study as 
many difficult issues emerged in the course of the interviews.  On occasions, 
participants recounted traumatic experiences of miscarriages; stillbirths; previous 
suicidal feelings; depression and anger at society for being judged by their condition. 
Some described how they perceived the condition to have been caused by having to 
cope with being bullied in school.  In some extreme cases difficulties in coming to 
terms with, and the process of managing the condition had led to the serious 
deterioration of the individual‟s health status such as gradual blindness or requiring a 
kidney transplant.  This raised questions as to the role of the interviewer.  My role 
was to listen but not exploit.  Grounded theory studies encourage the use of open 
ended interviews from which unanticipated topics may emerge, so to a certain extent 
I was prepared for this (Charmaz, 2000).  To minimise the impact on the researcher‟s 
well being I debriefed interviews that I had found difficult or emotionally draining 
with my research supervisor.  
 
128 
4.59 Participants’ Confidentiality and Anonymity   
Participants‟ confidentiality and anonymity were assured.  As Lees (1993) notes: 
“researchers must walk a tightrope careful neither to conceal too much, nor to 
disclose too little (p 206).  The confidentiality of the participants was assured when 
collecting the data and when documenting the findings of the research.  In this study 
all participants‟ names and addresses were stored in a locked cupboard.  The 
transcripts were given an identifying number, and names or other identifying features 
were removed or altered in order to maintain confidentiality.  The locations of the 
recruitment centres were anonymised to maintain confidentiality and clinicians‟ 
names removed to prevent identifying the setting of the interviews.  In the next 
section I go on to discuss the criteria adopted to evaluate the study.  
4.60 Evaluating the Research  
Qualitative research has been criticised for being overly subjective and not open to 
scrutiny.  This has led to considerable debate within the field of qualitative research 
concerning the most appropriate criteria and terms to adopt when evaluating such 
studies (Miles and Huberman 1984, Sandelowski 1993, Lincoln, 1995, Lincoln and 
Guba, 2000, Morse et al 2002).  It is therefore important to set out the methods 
employed.  Lincoln and Guba‟s (1985) key paper developed a framework assessing 
the “trustworthiness” of qualitative research recommending four criteria: credibility, 
transferability, dependability and confirmability.  These are defined as follows: 
 Credibility: the extent to which the findings are plausible and worthy of 
confidence 
 Transferability: the extent to which the findings of a study can be applied to 
another setting  
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 Dependability: the extent to which future research yields similar results 
using the same methods 
 Confirmability: an assessment of how well the findings are supported by the 
data collected 
I have considered adopting Lincoln and Guba‟s (1985) criteria.  However as noted 
earlier there has been much debate as to the appropriate means by which to assess 
qualitative studies and other researchers have subsequently drawn upon these terms 
seeking to develop their own frameworks.  The methodological framework of this 
study is constructivist grounded theory.  Therefore I have elected to follow the 
criteria recommended by Charmaz (2006): “credibility”, “originality”, “resonance” 
and “usefulness” to assess the value of a constructivist grounded theory study.  These 
criteria as they apply to this study are set out in further detail in the discussion and 
conclusions chapter (Chapter six).  
4.61 Credibility 
Credibility denotes the “trustworthiness” of the entire research process: data 
presented; the analysis; evidence produced to support claims made; and the breadth 
of data gathered (Charmaz, 2006).  Thus issues of credibility were considered 
throughout the research study to ensure the “usefulness” of the findings taking 
Charmaz (2006) suggested criteria into account:  
1. Does the research present intimate familiarity with the setting or topic? 
2. Are the range, number and depth of the data gathered sufficient?  
3. Were categories systematically compared? 
4. Do the categories cover a range of empirical settings? 
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5. Does the data gathered link rationally to the data analysis and subsequent 
arguments which emerge?  
6. Has sufficient evidence been provided in the study to enable a detached 
reader to concur with the findings of the study? 
This was demonstrated in the current study and set out in detail in the discussions 
and conclusions chapter (Chapter six).  
4.62 Originality 
Originality should be measured in terms of whether the study presents: “a new 
conceptual rendering of the data?” (p182) through the identification of fresh 
insights which challenge and extend existing knowledge of the empirical area.  This 
was demonstrated in the current study in the following ways.  Firstly, through the 
presentation of “fresh insights” into the process, and role of disclosure, and the 
development of a new conceptual framework (figure 4) of the role of disclosure in 
managing a long-term condition.  Secondly, the social and theoretical relevance of 
this work are reflected in the implications of the findings for health care practice, 
employers, and future research and are set out in further detail in the discussions and 
conclusions chapter (chapter six).  
4.63 Resonance  
Resonance refers to an assessment of the breadth and depth of the data, whether the 
categories are “saturated” and thus represent: “the fullness of the studied 
experience”(Charmaz, 2006, p182).  This was demonstrated in the current study by 
using two approaches.  Firstly, by the end of the period of data collection no new 
issues regarding disclosure were being raised in the interviews. This is termed 
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“theoretical saturation” (Charmaz, 2006).  Secondly, member checking was also 
used to assess the resonance of the study and the “fullness of the studied 
experience.”   
Member checking is part of the overall strategy of achieving “resonance” within a 
study.  The purpose of member checking is twofold: firstly, to gain feedback from 
the participants regarding the interpretation of the data collected, and secondly, to 
enable participants to have access to the data collected (Sandelowski, 1993).  There 
is however, a debate concerning the most appropriate timing of member checking, as 
to whether it should take place during, or post data collection (Miles and Huberman, 
1984, Sandelowski, 1993).  Sandelowski (1993) defines it as an ongoing process 
throughout the study.  Two key ways of member checking were employed in this 
study: firstly at the end of each interview the key issues which the participant had 
raised were summarized verbally to check that my understanding of their perspective 
was accurate.  At this point interviewees were invited to amend or add to the 
summary.  Secondly, participants‟ were given the option to review the transcripts at 
a later date, to remove or add anything as they wished. Opportunities to provide 
feedback to participants were also built into the study design in the form of a 
summary of the key findings to individual participants on completion of the study, 
and feedback to support groups. 
4.64 Usefulness  
The usefulness of the study is measured according to Charmaz (2006) in terms of its 
contribution and relevance to existing knowledge in the substantive area of research.  
This was demonstrated in the current study by examining the study findings and 
noting that: this study has: “built upon existing knowledge” by illustrating that 
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disclosure is a key process in the lives of those living with epilepsy and type 1 
diabetes.  The findings were also examined to assess the extent to which they have 
captured “generic processes”. The study findings were also examined to identify: 
“the need for further research in other substantive areas”  
4.65 Criteria for Rigorous Grounded Theory 
Debates exist as to the criteria to employ in order to gauge the rigour of the resulting 
grounded theory (Glaser and Strauss, 1967, Strauss and Corbin, 1990, Glaser, 1978, 
Charmaz, 2006).  Charmaz (2006) recommends employing Glaser‟s (1978) criteria 
of what constitutes a useful theory:“fit”, “work”, “relevance”, and “modifiability.”  
These are defined as follows:  
 Fit: “the categories of the theory “fit” or match the data”,   
 Work:” “the theory explicates, predicates and interprets what is going on in 
a substantive area”  
 Relevance: the theory is relevant to the substantive area.   
 Modifiability: “though basic social processes remain in general, their 
variation and relevance is ever changing in our world” (Glaser, 1978 p5). 
These criteria were adopted because they are useful for assessing the theory 
particularly as to how:  “the constructed grounded theory renders the data”  
(Charmaz, 2006, p182).   
4.66 Summary and Conclusion 
In this chapter I have set out the methods employed in this study in accordance with 
the constructivist approach to grounded theory (Charmaz, 2006).  The research 
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design, study population, and means of gathering the data have been presented.  The 
process of conducting the qualitative interviews, data management, method of 
sampling; data analysis; and the principles of ethics applied to the study.  Finally, the 
procedures taken to ensure the credibility of the study are presented taking into 
account debates within qualitative research as well as grounded theory.  In the next 
chapter I go on to present the results from the data analysis. 
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5.0 Chapter Five: Study Findings 
5.1 Introduction 
This chapter presents findings from the study data.  As discussed in the methods 
chapter (Chapter five) the data were derived from thirty-five qualitative interviews 
conducted with those living with either epilepsy or type 1 diabetes.   
Participants were recruited from two different settings: either nurse specialist clinics 
or patient support groups across the two different health conditions.  To highlight 
commonalities or differences across conditions a comparative approach was adopted 
to explore a range of perceptions of the role of disclosure.  Following the principles 
of constructivist grounded theory (Charmaz, 2006) the major categories identified in 
this study are drawn from participants‟ responses.  Each quotation is labelled with 
the participant‟s number and the identifying line number referred to as text units (tu).  
At the end of each section is a discussion of the key issues. The data identified the 
following key analytical themes: visibility and invisibility; stigma; process of 
disclosure and non disclosure; and perceptions of reactions from others.  Strategies 
of disclosure are not necessarily fixed but may be subject to change over time. 
Section one entitled the nature and process of disclosure presents commonalities 
regarding the nature and the process of disclosure across both conditions.  Section 
two: mediating issues around disclosure, presents a number of mediating issues 
which influence decisions around disclosure or non-disclosure.  Section three: the 
challenge of disclosure: “who needs to know?” presents an overview of the 
challenge of disclosure: “who needs to know?” identifying the role of disclosure in 
this context as access to self-care and social support.  The role of disclosure in the 
workplace is set out.  Section four: learning about disclosure: disclosure and the 
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role of time presents comparative data (across both conditions and recruitment 
settings) illustrating differing views and strategies around disclosure namely the 
process of: “learning about disclosure” over time.  Firstly, patient support group 
findings are presented identifying: the role of strategic disclosure: redressing myths 
about the condition in advance.  Secondly, nurse specialist clinics findings are then 
presented identifying: the role of non-disclosure: avoiding stigma.  Finally, Section 
five: Disclosure and the Role of information presents views on information needs, 
how information was sourced about their condition and the role of the patient 
support groups and nurse specialist clinics in the provision of information on topics 
including disclosure.  
Table 8 sets out the socio-demographic characteristics of the study participants.  
Illustrating differences between those recruited from the patient support group and 
the nurse specialist clinics.  Those recruited from the patient support groups had been 
living with the condition for a longer period of time compared to those recruited 
from the nurse specialist clinic.  There were also differences in age and differences 
in employment status.  
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Table 8  Socio-demographic Characteristics of Study Participants 
 
 Patient Support Group 
n=20 
Nurse Specialist Clinic 
n-15 
 Diabetes Epilepsy Diabetes Epilepsy 
 n=ll n=9 n=9 n=6 
Mean Age 58 yrs 45 yrs 19 yrs 39 yrs 
(range) (33-72 yrs) (18-63yrs) (17-22 yrs) (28-60 yrs) 
Mean Time Living 
with the Condition 
26yrs 24yrs 7yrs 19yrs 
Female 7 6 4 4 
Male 4 3 5 2 
Marital Status     
Single living at home 6  9  
Married/Co-habiting 14  6  
Employment Status     
Skilled Manual 2  1  
Manual 0  1  
Student 1  9  
Medically Retired 6  1  
Retired 9  1  
Unemployed 2  2  
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5.2 Section One: The Nature and Process of Disclosure of a Long-term 
Condition  
5.3 Introduction 
This section presents the study findings regarding the nature and process of 
disclosure. It illustrates that disclosure is a personal process for many and therefore 
is a process which participants prefer to control its timing and its role.   
5.4 The Nature of Disclosure  
Analysis of the interview data illustrated that for many of the participants their health 
condition was something that they regarded as highly personal: a private issue, not to 
be discussed freely.  Therefore decisions were made as “to whom to disclose” and 
“when”, as a female attendee at the nurse specialist clinic recounted:  
It‟s not really the sort of thing you tell people straight away … It‟s just not 
something you really come out with. 
Interview 29, tu:69, Female, Aged 17, diagnosed three years ago, recruited 
from young adult diabetes clinic 
Attendees at patient support groups also highlighted that for them too, disclosure was 
a highly personal issue:   
It‟s something that I haven‟t ever felt I needed to sort of: “shout from the 
rooftops!”  I suppose I‟m a confidential sort of person in a way and … personal 
things you don‟t necessarily disclose. 
Interview 4, tu: 211, Male, Aged 71, Diagnosed fifty-eight years ago, recruited 
from diabetes patient support group  
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Similar findings emerged for those participants living with epilepsy:  
It‟s just not one thing that you “broadcast.”  You don‟t really tell everybody 
your personal business anyway!  
Interview 1, tu:172, Female, Aged 18, Diagnosed one year ago, recruited from 
epilepsy patient support group  
I suppose I do feel it is a personal thing.  You know it‟s just “my illness.” 
Interview 30, tu:92 , Female, Aged 28, Diagnosed eight years ago,  recruited 
from epilepsy nurse specialist clinic 
Thus living with epilepsy or type 1 diabetes was perceived by participants to be a 
“private” matter and not something to be disclosed indiscriminately. 
Decisions then have to be made regarding whether there is a specific need to disclose 
and if so, to whom.  Indeed, for many participants, the act of disclosure is only likely 
to happen with „outsiders‟ if an acute episode such as an epileptic seizure or 
hypoglycaemic episode makes it necessary as the following extract illustrates:  
If you walked down the street and everybody you‟d bumped into you just said: 
“I‟m epileptic!” they‟d look back at you as if to say: “There‟s something 
wrong with that chap!” … If he was having an attack … you‟d think there was 
a need for him to tell us. 
Interview 2, tu: 283, Male, Aged 55, Diagnosed eighteen years ago, recruited 
from epilepsy patient support group.  
Therefore the term: “who needs to know?” appears to relate to the visual symptoms 
of the condition and the need for assistance. It also illustrates that disclosure has a 
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role to play.   
Similar findings emerged from those recruited from the diabetes patient support 
group:  
I tell people as and when it‟s necessary.  I would not broadcast it to the world 
„cos I don‟t think it‟s necessary … I tell people who I think might “need to 
know.” 
Interview 12, tu: 298, Female, Aged 60, Diagnosed nineteen years ago, 
recruited from diabetes patient support group. 
Others expressed frustration at having perceived their condition to be personal, the 
possibility of having an acute episode (epileptic seizure or hypoglycaemic episode) 
took away their sense of control in terms of disclosure: 
You‟re almost forced to tell people … in case you have a fit, in case you have 
a hypo (hypoglycaemic episode).  People need to be aware of it really.  
Sometimes you feel like you‟re having to bare your soul to people and let 
people know things that are quite private and personal. 
Interview 16, tu: 511, Female, Aged 38, Diagnosed twenty years ago, recruited 
from diabetes patient support group. 
Most participants wanted to have control where possible, over “when” to disclose 
and to “whom.”  This may be related to cultural reluctance to cross personal/private 
boundaries with people outside close family and friends, as a member of a patient 
support group recounts: 
In this country you don‟t ask other people about their health.  That‟s rude! 
That‟s impolite!  You still want to know, you‟re curious but where do you go 
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for the answers without … crossing these politically correct boundaries?  We 
don‟t discuss feelings, emotions, health in this country! 
Interview 3, tu: 278, Female, Aged 47, Diagnosed forty years ago,  recruited 
from epilepsy patient support group  
Therefore perceptions of health as being private and personal, in turn tapped into 
views on disclosure.  
5.5 Discussion of the Nature of Disclosure 
This study found that participants perceived disclosure to be something personal: 
only to be divulged for a reason.  This was a point also identified by Charmaz (1991) 
and Beatty (2004).  This finding is in line with studies in the field of psychology 
where others have found that disclosure is inherently personal because it reveals 
something of the “self” (Jourard, 1971, Rosenfield, 2000).  Participants reiterated 
that their health condition was a personal issue and so should not be freely discussed 
with others.  Yet, some felt “forced to disclose” due to a lack of control over their 
condition which in turn had a negative impact on their feelings and led to a loss of 
privacy.   
For many disclosure is not a straightforward process and typically, participants felt 
that disclosure had to have a functional role. This is concurrent with other studies 
which have examined long-term conditions and disclosure (Charmaz, 1991, Beatty, 
2004, Williams and Healy, 2001).   
I now go on to examine data concerning the diverse ways in which disclosure may 
occur.  
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5.6 The Process of Disclosure  
This section presents data concerning how the disclosure of having epilepsy or type 
1 diabetes may occur in ways other than direct, verbal disclosure such as differences 
in behaviour.  Participants emphasized that a central concern was the issue of 
visibility linked to managing their condition.  Opportunities to disclose emerged 
through indirect ways of managing the conditions, including: injecting insulin, 
restrictive dietary requirements or taking medication.   
Issues concerning management of the condition therefore became forms of 
disclosure to others.  For example, making a condition visible through the act of 
injecting insulin which for some participants was necessary as often as four times 
each day:   
I didn‟t like injecting in front of people.  I‟d normally go into an office … or 
just kind of slipped into the loos and did it quickly … I still don‟t like doing it 
in front of people because some people react … don‟t really like seeing it. 
Interview 25, tu:18, Male, Aged 19, Diagnosed 14 years ago, recruited from 
young adult diabetic clinic 
Disclosure may also be triggered in response to, or as a consequence of having to 
explain differences in behaviour such as dietary constraints, as a young adult with 
diabetes explained.  This led to the necessity of explaining why they had to eat at 
certain times: 
I say to people: “What time are we eating? (and) “What are we eating?”  I 
need to know „cos I need to know how much insulin to take.” 
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Interview 5, tu: 107, Female, Aged 60, Diagnosed nineteen years ago, 
recruited from diabetes patient support group. 
(If) someone asked if I wanted some certain food then I‟ll say: “No I‟m 
diabetic” … It will come up then. 
Interview 24, tu:52  Male, Aged 18, Diagnosed seven years ago, recruited from 
young adult diabetic clinic. 
Therefore managing dietary restrictions also became a form of disclosure.  
The following example illustrates how the need to take medication at a particular 
time became an opportunity for disclosure:  
I‟d sort of take my tablets at 4pm, my midday tablets and sort of just comment: 
“Oh you know must take my tablets „cos I have epilepsy.” 
Interview 3, tu:49, Female, Aged 47, Diagnosed forty years ago, recruited from 
epilepsy patient support group. 
Another form of visual disclosure identified in the current study was the medical 
bracelets worn by some participants.  The bracelets were engraved with the wearer‟s 
medical condition and an emergency helpline number in order to access information 
on their medication regime:  
I mean I wore a medical alert bracelet … then people saw that and asked: “Oh 
what‟s that for?” as well so yeah, it was definitely an encouragement to tell 
people. 
Interview 23, tu:58, Male, Aged 18, Diagnosed four years ago, recruited from 
young adult diabetic clinic 
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Therefore, on occasions the bracelets themselves became triggers for disclosure.  In 
the event of having an acute episode they appeared to play an important role in terms 
of explaining the behaviour to “strangers” and also to alert others to their medical 
needs:   
Sometimes you‟re on your own with people you don‟t know and the only 
reason they know you‟re diabetic is „cos I‟m wearing this like “Medical Alert” 
bracelet.  It says I‟m diabetic on it so if I‟m having a hypo (hypoglycaemic 
episode) they understand what‟s going on. 
Interview 23, tu:63, Male, Aged 18, Diagnosed four years ago, recruited from 
young adult diabetic clinic. 
I‟ve got my “Med-Alert” bracelet which is really invaluable because if it 
happens (epileptic seizure) in the street people could tell what I‟ve got. 
Interview 15, tu:138, Female, Aged 48, Diagnosed thirty-two years ago, 
recruited from epilepsy patient support group. 
The bracelets also appeared to play a role in providing a form of “back up” to the 
person and reduced fears particularly when they were alone or in the company of 
others who were unaware of their condition. 
In the following example a young student has been provided with a fridge to store 
her insulin in while in university which, as she explains, symbolises an opportunity 
for her to disclose to others: 
I wasn‟t going round to people saying “Hi my name‟s Emma, I‟m a diabetic!” 
but it was fairly easy because when I moved to university they gave me a 
fridge in my room.  So when people come round they‟re like: “Why have you 
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got a fridge in your room?” so I just said: “cos I have to keep medication in 
there.”  So it sort of came about that way. 
Interview 35, tu: 12, Female, Aged 22, Diagnosed nineteen years ago, recruited 
from young adult diabetic clinic.   
Thus broadening the concept of what “visibility” of a long-term condition 
constitutes: not only physical symptoms of the condition itself, but visible “objects” 
related to the management of the condition.   
For those living with epilepsy additional opportunities arose during the course of 
conversation in relation to driving: 
Things came up like if they asked me: “Do you drive?” I‟d just say:  “I do but 
actually my licence was taken off me because of this” (having epilepsy) … If 
they ask me more questions I‟d tell them about it. 
Interview 1, tu:141, Female, Aged 18, Diagnosed one year ago, recruited from 
epilepsy patient support group.  
The above quotes illustrate how their medical condition overlapped into their social 
environment. 
Sometimes disclosure emerged through the need to explain different “behaviour.”  
For example, within the context of school such as having to explain repeated 
absences.  The following quote describes how someone living with diabetes that was 
not medically “controlled” led to dangerously high blood sugar levels (diabetes 
ketoacidosis) requiring emergency treatment: 
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More people knew about it then (at school) … I had to explain, „cos my 
diabetes was out of control and I had so much time off school going “dka” 
(diabetes ketoacidosis) and everything. 
Interview 26, tu: 55, Female, Aged 21, Diagnosed eleven years ago, recruited 
from diabetes young adult clinic.  
Participants speculated on the possibility of people close to them disclosing to others 
as the following quotation illustrates:  
If they‟re real friends or family they‟re gonna know about it.  If not through 
you, through the other close family. You know it leaks out doesn‟t it?! 
Interview 17, tu 24, Male, Aged 67, Diagnosed thirteen years ago, recruited 
from diabetes patient support group  
These quotations highlight that disclosure is a process which is not easily governed.  
Participants recounted that due to a lack of medical control over their condition 
others indirectly found out about their condition. Conversely others recounted how 
once they had disclosed to family members they effectively had little control over to 
whom they in turn disclosed.  
5.7 Discussion of the Process of Disclosure 
The data identified that the process of disclosure is diverse and not straightforward 
and have identified the number of ways in which the process of disclosure may 
occur:  verbally, visually, or indirectly through the process of managing the 
condition.  Whilst disclosure occurs in a number of different ways mainly linked to 
the visible symptoms of the condition, a key finding of the current study is that the 
condition may become visible not only through symptoms, but through the 
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management of the condition itself.  Sometimes the process of disclosure is in 
response to routine questions, in relation to explaining issues of differences in 
behaviour, in terms of how they manage their condition.  Participants raised the point 
that how others responded to the disclosure was important because it played a key 
role in how they felt about having the condition and upon their identity.  This finding 
concurs with work which has suggested that how others perceive someone with an 
illness can be crucial as it may influence whether or not they see themselves as being 
“different” (Mason et al,  2001).   
The broad range of potential situations for disclosure has illustrated that controlling 
disclosure may be problematic.  Whilst the existing literature on disclosure has 
focussed upon planned, strategic, verbal forms of disclosure as a means of 
addressing issues of stigma (Charmaz, 1991, Joachim and Acorn, 2003), the findings 
illustrated that the need to disclose and the process of disclosure were inextricably 
linked to the practical management of the condition and in particular for those living 
with type 1 diabetes. 
The current study identifies a broader understanding of the concepts „invisible‟ and 
„visible‟ in relation to disclosure.  Studies of those without obvious “visible” 
symptoms have implied that individuals have a choice as to disclose or not because 
they appear “normal” to others (Joachim and Acorn, 2003, Vickers 1997, Joachim 
and Acorn 2000).  While other studies on disclosure stated that participants make 
decisions based on whether the condition will become more visible as the condition 
deteriorates over time (Lowton, 2004). 
The next section compares and contrasts findings from participants that attend 
patient support groups or nurse specialist clinics across both conditions (epilepsy and 
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type 1 diabetes) to further explore the different issues at play when making decisions 
around disclosure of one‟s health condition, termed: “mediating issues around 
disclosure.” 
5.8 Section Two: Mediating Issues around Disclosure  
5.9 Introduction 
This section presents data which illustrate that many participants found living with 
the condition to be challenging.  I go on to present data which illustrates that issues 
of health status and identity are taken into account with regard to disclosure.  
5.10 The Challenges of Living with a Long-term Condition  
Aside from the biomedical diagnosis, participants had to cope with the psychosocial 
implications such as the negative impact of the condition on their identity.  Both 
conditions (epilepsy and type 1 diabetes) are long-term and require ongoing 
management.  This means that there is a process of adjusting to living with the 
condition and integrating it into one‟s daily life.  The emotional impact of being 
diagnosed due to the enduring nature of the condition, and the sense of being 
“different” to others is conveyed.  
Those participants who had been newly diagnosed expressed their sense of shock 
when diagnosed with a long-term condition which could not be “cured” and would 
therefore require long-term management as the following quotation illustrates:  
It is a shock! … The nurse said “You know, you‟ve got to get used to it … It‟s 
not something you have for a little while and you get better … This is 
something that you have to cope with for the rest of your life!” 
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Interview 11, tu: 49, Female, Aged 66, Diagnosed three months ago, recruited 
from diabetes patient support group  
I think I went through various stages after I got it.  I don‟t think it really sunk 
in to start with … I didn‟t take it as seriously as maybe I should have done to 
start with right at the beginning … I wasn‟t really watching what I ate and so 
therefore my blood sugar was up and down … Its really difficult when you 
suddenly realize how much it affects your life … As long as you control it then 
it‟s fine but you do always have to be aware of it. 
Interview 27 tu:39, Female, Aged 19, Diagnosed six months ago, recruited 
from young adult diabetes clinic  
Participants‟ emotional response appeared to be strongly linked to the ongoing, 
enduring nature of the condition and the need to take the condition into account in 
their daily lives.   
The following quote by a young student clearly illustrates the degree to which being 
diagnosed and in particular the prospect of having to perform daily insulin injections 
impacted on her:  
I cried my eyes out! ... I just thought I couldn‟t do it! … I knew that I‟d have to 
inject … all the time for like the rest of my life.  That was the kind of the scary 
part 
Interview 29, tu: 24, Female, Aged 17, Diagnosed three years ago, recruited 
from young adult diabetes clinic  
When newly diagnosed with epilepsy similar feelings were identified: 
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I weren‟t too happy when I got told … I just lost confidence in myself.  I 
weren‟t very happy …it was hard! 
Interview 19, tu: 3 Female, Aged 21, diagnosed seven years ago, recruited 
from epilepsy patient support group  
Thus being diagnosed with the condition had a negative impact upon their emotions 
as they struggled to adapt to their new status. 
Younger participants in both groups and across both conditions highlighted that 
being diagnosed did not only affect them emotionally but also impacted on family 
members, as the following quotation highlights:  
I took it quite lightly really (the diagnosis of epilepsy) ... My mum found it 
really difficult to deal with … She was devastated, she was really upset! 
Interview 1, tu: 192, Female, Aged 18, Diagnosed one year ago, recruited from 
epilepsy patient support group 
Frequently this related to family members raising concerns about the potential 
limitations the condition might have on their lifestyle:  
My mum was really upset when she found out … All of my family were … 
My mum phones all the time and she‟ll always say:  “What‟s your blood sugar 
today?” … They knew the kind of lifestyle changes that I‟d have to make … 
also because of how young I am … It‟s at a difficult time in my life when 
you‟re at that age when you want to go out and drink and do all sorts of things 
… It‟s a difficult thing to manage with everything else. 
Interview 27 tu:136, Female, Aged 19, Diagnosed six months ago, recruited 
from young adult diabetes clinic 
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Thus being diagnosed with a long-term condition affected not only the person living 
with the condition but those around them, and in particular parents.  Parents it 
seemed were acutely aware of the potential restrictions that a long-term condition 
might have on their children and this appeared to provoke a strong emotional 
response.   
In the next section I refer to data which illustrated participants‟ perceptions of the 
limitations of living with a long-term condition.  
A number of participants highlighted that they were medically unfit to work due to 
their condition.  One young woman whose father also has epilepsy felt initially 
optimistic when diagnosed due to her perceptions that he was not overly affected by 
the condition because he remained in employment.  However she found that her 
condition placed greater limitations on her lifestyle than previously anticipated:  
Initially when I was diagnosed it was nowhere near as severe as it is now.  I 
suppose I thought: “Oh well my Dad‟s got epilepsy and most people with 
epilepsy are able to work or they have the odd seizure,” but they‟re stable.  
Whereas with me I find because it is unstable I think it just has more of an 
effect I guess … I‟m finding that difficult to deal with. 
Interview 33, tu: 106, Female, Aged 28, Diagnosed eighteen months  ago, 
recruited from epilepsy nurse specialist clinic 
The following quotation illustrates the difficulties faced in coming to terms with the 
perceived limiting effects of their condition: 
When I started having the fits … it just shatters your confidence.  I think that‟s 
the worst part of it … It‟s almost like being castrated not being able to work!  
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You don‟t feel like a man you know. 
Interview 21, tu: 34, Male, Aged 56, Diagnosed twelve years ago, recruited 
from epilepsy patient support group 
Thus the limitations that the condition placed upon them had a negative impact upon 
their self-esteem and their identity.  
Others found it exceptionally difficult to contemplate a future in which they would 
not be able to have full control over their mobility as one man living with epilepsy 
describes: 
The hardest thing of all was having to give up my driving, that literally brought 
tears to me eyes having driven from the age of seventeen … Several scans later 
they then told me that I would not be allowed to drive ever because they didn‟t 
think that they could sort of control the epilepsy. 
Interview 2, tu:50, Male, Aged 55, Diagnosed eighteen years ago, recruited 
from epilepsy patient support group  
Thus illustrates the emotional impact that such new limitations have on one‟s 
identity and the psychosocial implications of living with a long-term condition.  
5.11 Discussion of the Challenges of Living with a Long-term Condition  
The ongoing, persistent nature of both conditions was identified in the data and the 
suffering which many endured as a consequence.  The data has highlighted key 
concepts which typically emerge in studies of long-term conditions in relation to the 
negative impact on identity: “loss of self” Charmaz (1983) and “biographical 
disruption” (Bury, 1982).   
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These findings concur with Charmaz‟s (1983) study which describes the impact of 
having a long-term condition and the limitations as the “loss of self” and a form of 
suffering.  The concept “loss of self” is extended in the current study as the data 
illustrates that having a long-term condition may cause suffering not only for the 
individual but also those around them such as partners and family members also 
affected by the diagnosis.  
Bury (1982) describes the impact of being diagnosed with a long-term condition as 
“biographical disruption.” This was often manifested in the perceived unanticipated 
daily restrictions which participants faced such as being unable to work or no longer 
allowed to drive a car.  Since the condition is long-term, decisions around disclosure 
are ongoing as is the potential for “disruption” which in turn may have a negative 
impact on identity.  This study builds upon Bury‟s (1983) concept of “biographical 
disruption” by illustrating the potential ongoing nature of the “disruption.”   
I now go on to illustrate how issues of health status are taken into account in relation 
to disclosure.  
5.12 Health Status, Identity and Disclosure 
Participants appear to go through a complex process of assessing the impact of the 
condition.  Those who described their condition as “controlled” linked this concept 
to having limited hypoglycaemic episodes or epileptic seizures and therefore felt that 
the impact of the condition was easier to cope with.  This linked into the perception 
that the condition was predominantly “invisible” to others which in turn appeared to 
create greater choices over disclosure.  Conversely those whose condition was 
“uncontrolled” linked this concept to having frequent hypoglycaemic episodes or 
epileptic seizures at unpredictable times and appeared to have less choices around 
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disclosure as their condition was more “visible” to others.  For some, newly 
diagnosed, the unpredictable nature of the illness was a particular challenge.  These 
participants described how their condition made them feel different to others: 
It is unstable.  I think it just has more of an effect I guess … I‟m finding that 
difficult to deal with. 
Interview 33, tu:86, Female, Aged 28, Diagnosed eighteen months ago, 
recruited from epilepsy nurse specialist clinic 
Some found the process of managing the extreme symptoms of their condition 
difficult to the extent that some perceived diabetes as “taking over” their lives as the 
following quote from a young woman with “uncontrolled” type 1 diabetes described:  
For me it‟s difficult … got trouble with my eyes, got loss of feeling in my feet 
and everything and it was just constant: “Don‟t eat this, take more insulin, 
check your blood sugar, do this, do that.” … Things that constantly goes over 
and over in your head … the diabetes is taking over! 
Interview 26 tu: 267, Female, Aged 21, Diagnosed eleven years ago, recruited 
from young adult diabetic clinic  
Thus the constant nature of the daily management of type 1 diabetes emerged in the 
data as a burden for some due to the ongoing dietary considerations, the need to 
inject insulin, to check their blood sugar levels as well as cope with the symptoms 
associated with the condition.  The following quotation illustrates how having a 
condition that is considered to be “controlled” leads to greater choices and less 
limitations:  
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I rule it!, it doesn‟t rule me! and I won‟t be ruled by it! I‟ve never said: “I‟m 
not going to do that because I‟ve got epilepsy.” 
Interview 6, tu: 405, Female, Aged 51, Diagnosed thirty years ago, recruited 
from epilepsy patient support group  
Perceptions of being “in control” of the condition therefore appeared to be important 
to participants although some stated that they were prepared to take a risk: 
Sometimes I just wanna gamble on it and think If I don‟t tell „em nothing will 
happen and it will be ok. 
Interview 31 tu:107 Male, Aged 32, Diagnosed twenty-one years ago, recruited 
from epilepsy nurse specialist clinic 
In contrast others cited difficulties around the unpredictability of the condition.  
Some participants highlighted that a feature of their condition was that they may 
have a sudden acute episode for example a hypoglycaemic episode or epileptic 
seizure in such cases they would require assistance from others yet the timing or 
location of this could not be predicted as the following quotation illustrates: 
It‟s just the unknown isn‟t it?  That‟s the hardest part to accept … walking 
along the street and then suddenly it happens … A few times I‟ve crossed over 
the road and it‟s happened.  You could get knocked down couldn‟t you?  I was 
helped up by two old ladies, but I suddenly drop to the floor literally 
anywhere! 
Interview 15, tu: 355, Female, Aged 48, Diagnosed thirty-two years ago, 
recruited from epilepsy patient support group 
This illustrates the potential danger of having an epileptic seizure at an unpredictable 
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time or place. 
Others highlight that they require assistance from others and frequently have no 
memory of an acute hypoglycaemic episode: 
I‟ve had hypos (hypoglycaemic episodes) where I can‟t remember it 
happening, … I remember waking up but I don‟t remember how I‟ve got to 
that position and I‟ve only been able to come round because people have been 
able to help me or give me a Mars bar or give me a Lucozade or whatever. 
Interview 24, tu:63, Male, Aged 18, Diagnosed seven years ago, recruited from 
young adult diabetic clinic 
The above quotation illustrates how people living with diabetes may also have 
unexpected hypoglycaemic episodes in public places.  How others react appears to 
be relevant.  For example prompt assistance from others (potentially strangers) is 
required, to medically recover such as giving them a drink or something to eat. 
5.13 Discussion of Health Status, Identity and Disclosure  
The data highlight the link between issues of medical control over the condition and 
issues of visibility or invisibility.  Living with epilepsy or type 1 diabetes which was 
perceived to be “controlled” was typically perceived to be invisible to others and as 
having less of an impact upon their daily lives in terms of limitations. Such 
perceptions in turn linked into decisions over disclosure and also played a role in 
perceptions of the limitations upon their daily lives.  Many participants sought their 
condition to be controlled as this led to greater degree of perceived “invisibility” and 
greater integration with others.  Similarly invisibility made the disclosure less 
necessary. Difficulties in accepting the condition appear to play a role in terms of 
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difficulties around disclosing to others.  Participants who attended the nurse 
specialist clinics tended to cite difficulties in controlling their condition and also 
difficulties in disclosing their condition.  For some participants this was manifested 
in the prospect of the practical daily management of their condition for the rest of 
their lives which felt at times quite overwhelming.   
The long-term nature of the condition and also decisions around disclosure are thus 
illustrated in this section. The data suggest that those living with epilepsy 
experienced difficulties around the unpredictability of the condition.  This has been 
found in existing studies on the social aspects of epilepsy which have described how 
fear is associated with an unpredictable condition which requires an explanation 
(Trostle, 1998).   
In the next section I present data on how decisions around disclosure are made.  
5.14 Section Three The Challenge of Disclosure: “Who Needs to Know?”  
5.15 Introduction 
This section presents data illustrating the challenge of disclosure described by 
participants as a process of considering: “who needs to know?”  
It examines why participants felt others needed to know about their condition, and 
the perceived role which disclosure played in this context: gaining access to self-care 
(medical support) and social support.  Decisions have to be made whether to disclose 
or not across a range of settings.  It illustrates that in general participants felt that 
those close to them such as friends and family should be aware of their condition.  
Issues of choice over disclosure and dilemmas over disclosure are presented.  The 
role of disclosure in the workplace is also set out. 
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5.16 The Role of Disclosure: Access to Self-Care and Social Support 
As the following extracts highlight, the phrase “need to know” was commonly used 
by participants who decided strategically who needed to know about their condition: 
I tell people who I think might “need to know.” … Any organization that you 
belong to, especially where you‟re doing a lot of activity they need to know. 
Interview 12, tu: 299, Female, Aged 60, Diagnosed nineteen years ago, 
recruited from diabetes patient support group 
I think it‟s beneficial to tell people that you are kind of around a lot.  My best 
friend … I‟m with her a lot … if anything was to happen she‟d know what to 
do. 
Interview 1, tu: 165, Female, Aged 18, Diagnosed one year ago, recruited from 
epilepsy patient support group  
These quotations underline the key need for others to assist them in the case of an 
acute episode and suggests that by disclosing they are attempting to protect 
themselves and others in the case of an acute episode: 
It‟s important for anybody with diabetes … to let their family, friends (and 
people they might meet up with) know that they have it.  It could be a life 
saver in the end … If they suddenly have a hypo (hypoglycaemic episode) the 
people around them need to know what it is! 
Interview 14, tu: 410, Male, Aged 72, Diagnosed nineteen years ago, recruited 
from diabetes patient support group 
Participants reflected that family members needed to know not only for reasons of 
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social support, but for reasons of medical support as they reportedly assisted in the 
self-care of the condition as I go on to illustrate.  This was particularly the case with 
younger participants who relied more obviously on their parents.  These participants 
recounted in detail how their parents (particularly the mother) took on the role of 
managing prescriptions and overseeing their general health in order to avoid an acute 
hypoglycaemic episode: 
She‟s always making sure I‟m doing the right stuff: got the right prescriptions 
all topped up to make sure I never run out of insulin … Don‟t go out and get 
drunk too much! … She‟s had a massive impact! 
Interview 24, tu:67, Male, Aged 18, Diagnosed seven years ago, recruited from 
young adult diabetic clinic  
Sometimes this role is reversed when the affected person is herself a parent. Indeed 
one mother living with diabetes had explicitly taught her young daughter what action 
to take should she have a hypoglycaemic episode:  
My other daughter is very trained in knowing what to do … I said to her: “If 
you ever find mummy asleep and you can‟t wake her  up … What do you do?” 
She said: “I ring for an ambulance!”… and “What do you say?” She says: “I 
tell them that Mummy‟s asleep and won‟t wake up and that she‟s diabetic.” 
Interview 10, tu: 16, Female, Aged 34, diagnosed sixteen years ago, recruited 
from diabetes patient support group  
Partners also played a key role in self-care: both through recognising symptoms and 
assisting in their recovery from acute episodes.  For those living with diabetes the 
role of partners was noteworthy as illustrated by the following quotation:  
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Fiona (my wife) she‟s often said at night-time: “You‟re going low.”  I said: 
“Don‟t be so bloody silly I‟m not!” but you know she‟s usually correct … I‟ve 
really lost the warning signs. 
Interview 14, tu: 426, Male, Aged 72, Diagnosed nineteen years ago, recruited 
from diabetes patient support group 
This underlines the significant role of partners in self-care as the participant‟s wife 
warned him that he was at risk of having a hypoglycaemic episode, something which 
he was no longer able to determine.  Other participants highlighted the benefits of 
being in a relationship with someone with the same condition who could understand 
and assist in the ongoing practical self-care requirements: 
I‟m going out with a diabetic so it‟s a lot easier … because he knows you 
know if we go out somewhere that we have to eat at a decent time … Checking 
our sugar levels … you do it together … It‟s just a bit more easy you don‟t feel 
like the odd one out all the time … Some of my partners in my past have been 
very scared when I‟ve had a really bad hypo (hypoglycaemic episode) … My 
partner now he knows what it‟s like to have a really bad hypo.  So even if I 
have one he takes it all in his stride and he sorts me out. 
Interview 16 tu: 267, Female, Aged 38, Diagnosed twenty years ago, recruited 
from diabetes patient support group 
Such shared experiences also appeared to be significant in terms of identity because 
the individual no longer felt “different” to her partner as she had done so in the past.  
Others living with epilepsy highlighted that they felt safer having their partner or a 
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family member with them particularly in public places since they would know how 
to respond in the event of a seizure occurring:  
I very rarely go anywhere without my wife … the frequency that I do have fits, 
it makes you scared … to go out by yourself in case something does happen. 
Interview 32, tu: 96, Male, Aged 52, Diagnosed eight years ago, recruited from 
epilepsy nurse specialist clinic 
One older woman living with type 1 diabetes reflected that some men were in denial 
and had difficulty in accepting their condition.  Their wives played a vital role in 
supporting them in self-care:  
The men I know who have it rely on their wives.  Their wives do everything 
you know.  They remind them to have their jabs, they do their food and they 
tell people.  But the men behave as though it‟s not happening to them … I do 
think they‟re very frightened of admitting there‟s anything wrong with them! 
Interview 12, tu: 264, Female, Aged 60, Diagnosed nineteen years ago, 
recruited from Diabetes Patient Support Group 
These quotations raise the issue of dependence and responsibility placed upon their 
partners and the gendered nature of support within a family or relationship.  
Others highlighted the limitations that living with epilepsy placed upon their lives 
which they felt not only affected them, but their partner and family around them: 
I get a bit sorry for (my) husband and … son „cos there‟s some things I can‟t 
do for them … Obviously if I have an attack or something they‟ve gotta keep 
me under control … There‟s times when one of them can‟t go out „cos I can‟t 
be left here on my own. 
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Interview 18, tu:165, Female, Aged 49, Diagnosed thirty-four years ago years 
ago, recruited from epilepsy patient support group.  
The above extract illustrated that some participants perceived the condition to place 
an unfair burden upon family members.   
5.17 Discussion of the Challenge of Disclosure: “Who Needs to Know?”  
Participants described a process of assessing “who needs to know?” about their 
condition which suggests that such decisions are underpinned by a desire for privacy.  
This process of assessing “who needs to know?” has been identified in previous 
studies examining disclosure (Green and Sobo, 2000).  In the current study, those 
who needed to know were those whom participants were likely to see frequently in 
the course of their personal or social lives including friends and family.  This finding 
supports previous studies which report that the decision to disclose is dependent 
upon levels of intimacy: how well they are known to the discloser (Lowton, 2004, 
Green and Sobo, 2000).   
In the current study, the question of “who needed to know?” was linked to a specific 
role: the need to access not only social support but medical support.  The rationale 
for disclosure was generally linked to the symptoms of their condition and wanting 
others to know how to respond in the event of an acute episode such as a 
hypoglaecaemic episode or epileptic seizure where they would require assistance.  
For example in the event of a potentially acute episode someone would “know what 
to do.”  
These findings illustrate that the role of disclosure in this context is not only to 
inform others about having the condition, but also to minimise their concerns.  This 
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concurs with studies in the field of epilepsy.  Schneider and Conrad‟s (1980) concept 
of “preventive telling,” that “others know what it is” and, “what to do”.  The current 
study builds upon the concept of “preventive telling” by identifying the additional 
point that disclosers felt that their condition placed an unfair burden on those “who 
needed to know” due to the role that they play in supporting them: the concept is also 
relevant to those living with type 1 diabetes.  
For example, studies in the field of diabetes have identified that it is important to 
have “allies” to assist you to manage the condition (Paterson et al 1998).  In the 
event of a hypoglycaemic episode family members typically perform the role of 
“rescuers because they are also looking out for potentially dangerous signs of the 
condition (Paterson, et al, 1998).  Charmaz (1991) has stated that this planned form 
of disclosure constitutes “protective telling” but her concept does not address the 
need for practical assistance. 
Overall, disclosing to friends and family was perceived to be advantageous.  This 
finding concurs with studies in the field of psychology which state that outcomes of 
disclosure are more likely to be beneficial if they assumed a positive response 
(Pennebaker, 1990).   
In contrast difficulties around disclosure were reported more frequently outside of 
the context of family and friends such as the workplace.  I go on to set out the study 
findings illustrating the role of disclosure in the workplace. 
5.18 The Role of Disclosure in the Workplace 
Disclosure in the workplace presented participants with particular dilemmas. Issues 
of legislation and disclosure are presented.  The perceived reactions to disclosure 
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which may result in discrimination, feelings of difference, and stigma.  Some 
disclosed for reasons of health and safety. 
One woman reflected upon the complexity of disclosure in the context of workplace 
legislation:   
You don‟t have to disclose your medical condition however you can get into 
trouble if you haven‟t informed the employer afterwards and  then an accident 
happens, it‟s your responsibility but not theirs but then again … big changes 
were made because it is now the employers responsibility to make sure you are 
safe in the work environment not yours.  
Interview 3, tu: 356, Female, Aged 47, Diagnosed forty years ago, recruited 
from epilepsy patient support group 
Others cited how they felt they did not have a choice over whether or not to disclose 
in the workplace, yet this can be a difficult process particularly as highlighted earlier, 
their condition is perceived by many to be a personal matter: 
Something like epilepsy or diabetes … you have to disclose it.  You have to 
make your employers aware „cos they need to know if you have a hypo or a fit 
what to do and sometimes you do feel you‟re baring your soul to people and 
(they) know things that are quite private and personal.    
Interview 16 tu: 521 Female, Aged 38, Diagnosed twenty years ago,  recruited 
from diabetes patient support group 
The nature of a long-term and sometimes unpredictable condition means that 
participants may disclose for simple reasons of safety.  Thus as the interviewee 
below outlines, his fear of a sudden hypoglaecaemic episode relates not only to 
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personal safety but also to workplace legislation which makes the individual 
responsible for disclosing. 
Although not obliged to he felt an individual responsibility to disclose:   
I felt it was something people ought to know … It became a health and safety 
issue … If I passed out at my desk, they needed to know why I‟d passed out.  
Interview 4 tu: 40 Male, Aged 71, diagnosed fifty-eight years ago, recruited 
from diabetes patient support group  
Others felt that choice was not an option and they were obliged to disclose to 
employers for reasons of health and safety: 
It was a case of having to tell them at work.  I didn‟t have any choice … I was 
working in a factory, working around sort of milling machines … You could 
potentially fall into and take your head off if you weren‟t careful, let alone 
your arms or anything.  So you had to be really careful.” 
Interview 2 tu: 49 Male, Aged 55, Diagnosed eighteen years ago, recruited 
from epilepsy patient support group  
Despite legislation around disclosure in the workplace, some participants reported 
difficulties in completing a medical disclosure form when applying for jobs for fear 
of being rejected.  One woman faced a dilemma over disclosure and attempted to 
reassure her employers that her condition was “controlled” and therefore she did not 
constitute a “risk”:  
I knew I‟d got to declare it legally … but it does cause a problem because if 
people see it, they think “No, we don‟t want her!”  So I tended to write 
epilepsy and then in brackets “controlled.” 
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Interview 6 tu: 103, Female, Aged 51, Diagnosed thirty years ago, recruited 
from epilepsy patient support group 
This highlights that health status although taken into account when disclosing is on 
occasions qualified: the participants specifically states her condition is: “controlled”.   
Many felt that having epilepsy led to unfair discrimination in the workplace and 
cited examples of previous experiences:   
That‟s the whole bit of getting a job: telling them I‟ve got epilepsy.  I just get 
turned down every time. 
Interview 19 tu: 56 Female, Aged 21, diagnosed seven years ago, recruited 
from epilepsy patient support group 
Some had their employment terminated and this they felt was due to disclosure of 
their condition: 
(When) I got diagnosed (with epilepsy) … I was in hospital for a month.  Then 
I took the note to my employer and I was sacked on the spot! 
Interview 30 tu: 15 Female, Aged 28, Diagnosed eight years ago, recruited 
from epilepsy nurse specialist clinic  
Others, particularly those newly diagnosed chose not to disclose as they feared being 
treated differently by others as a consequence of the disclosure: 
They‟ve said: “Tell your employer” … I don‟t really want them to know … to 
be like “Oh John can‟t do that job because he‟s diabetic!” … I don‟t wanna be 
treated any differently to anyone else. 
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Interview 23 tu: 90: Male, Aged 21, Diagnosed four months ago, recruited 
from young adult diabetic clinic  
However as the following quote illustrates non-disclosure appeared to place a burden 
upon the individual: 
I felt that if I never told them about my epilepsy I could have got somewhere 
… I never told them … but I felt that I was being deceitful because I thought: 
“Well what if I do have a fit?  What are they going to do? I‟m not going to be 
covered by the insurance!” … So I was never really successful … I never 
stayed in the job for long.  
Interview 34, tu: 46 Female, Aged 31, Diagnosed twenty years ago, recruited 
from epilepsy nurse specialist clinic 
5.19 Discussion of the Role of Disclosure in the Workplace 
This section has identified the issues around disclosure in the context of the 
workplace.  Decisions around disclosure within this setting appear to be complex 
despite the existence of legislation on disclosure in the workplace (Disability 
Discrimination Act, 1995). 
Some felt that they were successful in getting offered the job because they had not 
disclosed their condition to the employer.  Conversely, those who choose not to 
disclose their condition, felt burdened by this and some left their employment in 
advance for fear of their condition being disclosed.  This finding concurs with the 
literature arguing that the process of “passing” as “normal” can lead to stress and 
embarrassment if the condition suddenly becomes visible, thus leading to 
“discreditation” (Goffman, 1963).   
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It also concurs with research which suggests that the workplace is a “high risk” 
setting for disclosure (Lowton, 2004). 
Issues of health status appeared to mediate decisions around disclosure of their 
condition although these were not straightforward. Across both conditions 
participants felt that the heterogeneity of the condition was not taken into account by 
employers.  Thus disclosers often expressed frustration at employers‟ responses to 
the disclosure.  Underlying these feelings were unmet expectations by the disclosers 
as many were seeking a more positive response from employers and for their 
condition to be taken into account in their ability to do the job.  This concurs with 
Beatty‟s (2004) findings who describes this form of disclosure in the workplace as 
“instrumental disclosure” the purpose of which is to influence the actions and 
responses of others towards the individual with the condition.    
A process of “covering” was identified as some participants disclosed their condition 
but noted that it was “controlled” (Goffman, 1963).  Issues of health and safety 
emerged as some disclosed as participants felt they had no choice but to disclose due 
to their condition.  Overall, most participants did disclose the condition in the 
workplace to their line manager.  This type of disclosure has been described in the 
literature as “partial self-disclosure” for example telling their line manager that they 
do have an illness (Munir et al 2005).  In the current study younger participants 
found that disclosing to the line manager the implications of the condition and 
potential limitations that it placed upon their ability to do the job difficult.  Munir et 
al (2005) has described this form of disclosure as: “full self-disclosure.”   
The findings illustrate a process of learning about disclosure over time.  Participants 
took previous experiences of disclosure into account when making decisions around 
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disclosure.  Previous perceived negative reactions to disclosure led to the avoidance 
of disclosure unless absolutely necessary.  Many participants associated the process 
of disclosure of their condition as reaffirming issues of difference and stigma.  
This has raised issues around the lack of advice and support for those having to 
disclose.  For many the intention of the disclosure, described in the literature as, 
“workplace adjustment:” a process of taking the condition into account was not met 
by their employers (Disability Discrimination Act, 1995).  This led many to express 
disappointment that their employers did not react as they desired and they linked the 
negative responses to the disclosure to the perceptions that the employers did not 
fully understand the full implications of having epilepsy or type 1 diabetes and the 
associated adjustments required in the workplace.  This has implications for the 
process of self-care in the context of the workplace.  
In summary, the following issues were considered when making decisions around 
disclosure or non-disclosure of their condition: past experience of disclosure, health 
status and identity.  Such issues were also highlighted in a study of cystic fibrosis in 
the workplace (Lowton, 2004).  In the next section I present findings to illustrate the 
process of: “learning about disclosure” over time.   
5.20 Section Four: Learning about Disclosure: Disclosure and the Role of Time 
5.21 Introduction  
This section sets out comparative data from participants recruited from the patient 
support group setting and nurse specialists clinics to illustrate the process of 
“learning about disclosure” over time.  Firstly I set out findings from the patient 
support group participants.  It examines the role of time and disclosure, illustrating 
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that feelings about disclosure are not necessarily fixed but dynamic and subject to 
change over time.  I illustrate how experiences of stigma are taken into account 
presenting data on epilepsy, stigma and disclosure.  A second role for disclosure is 
identified in this context: participants recruited from the patient support groups 
adopted anticipatory strategic disclosure, (redressing myths about the condition to 
others in advance), the role of which is to avoid stigma around the condition. 
In the second part of this section I set out comparative data from the nurse specialist 
clinic participants and illustrate a process of learning about disclosure leading to the 
adoption of non-disclosure in this context.  
5.22 Patient Support Group Findings: Disclosure and The Role of Time  
There appears to be a link between the role of time, accepting the condition and 
attitudes towards disclosure.  Those who were members of the patient support groups 
tended to cite feelings of acceptance of the condition. The data highlighted that 
feelings about disclosure are not necessarily static, but dynamic and subject to 
change.  
Time appears to play a significant role in terms of individual perceptions of 
disclosure and subsequent decision making.  Some cited how over time their attitude 
had changed from being reluctant to disclose to acceptance of the condition and a 
greater openness: 
(Now) I‟m involved in running a group … When I was younger … I didn‟t like 
to show, or tell anybody I‟d got it … Now I‟m that bit older, it‟s … something 
I‟m accepting. 
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Interview 15 tu 194, Female, Aged 48, Diagnosed thirty-two years ago, 
recruited from epilepsy patient support group  
Similar findings were identified across both conditions.   
The following quotes illustrate the profound effect that difficulties around disclosure 
may have on the subsequent management of the condition and therefore potentially 
on health status.  A member of a patient support group reflects on this: 
I was supposed to be testing my sugar levels all the time and I just didn‟t … I 
wanted to be the same as my friends.  I didn‟t want to have to keep saying to 
my friends: “Oh I need to go and eat something.  Oh I need to go and test my 
blood sugar levels” … while my friends are all footloose and fancy free … 
doing things spontaneously! 
Interview 16 tu: 61, Female, Aged 38, Diagnosed twenty years ago, recruited 
from diabetes patient support group 
However, such feelings about disclosure changed over time:  
I‟m a lot more comfortable at telling and I just think that comes with age 
anyway.  It doesn‟t bother me that I‟m diabetic anymore.  My lifestyle‟s 
changed as well you know so I‟m more in control of my diabetes. 
Interview 16 tu:373, Female, Aged 38, Diagnosed twenty years ago, recruited 
from diabetes patient support group 
You were embarrassed by it!  You were different from everybody else in those 
early days I suppose. 
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Interview 4 tu: 74, Male, Aged 71, Diagnosed fifty-eight years ago, recruited 
from Diabetes Patient Support group 
Over time this participant became more open, about the condition disclosing in the 
context of a social group as the following quotation illustrates:  
About six or seven years ago, I just thought that it was something that needed 
to be said … I just believed that I should tell them all  there was sort of to know 
about me I‟d been a member for maybe 12 years since then so that I knew 
everybody well I just sort of felt that they should know who was the person 
standing out front. 
Interview 4 tu:181,  Male, Aged 71, Diagnosed fifty-eight years ago, recruited 
from Diabetes Patient Support group 
Others highlighted that not disclosing in the workplace had led to difficulties, 
particularly for those who were not “in control” of their condition.  The following 
quote illustrates not disclosing to her employer in advance led to feelings of regret:   
Obviously it‟s come out, which probably made it worse … I just sort of 
collapsed on the floor … with antiques lying around … ceramics and paintings 
… I had two weeks notice and had to leave. 
Interview 15 tu: 91 Female, Aged 48, Diagnosed thirty-two years ago, 
recruited from epilepsy patient support group  
Another interviewee reflected back that in future she would disclose her condition to 
her employer, thus highlighting that feelings about disclosure may change over time: 
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If I apply for another job I‟m telling them up front I‟ve got it … to be fair to 
them really … „Cos it‟s not very good … if somebody collapses and you think: 
“Oh my God!  What‟s happening?!” 
Interview 15 tu: 141 Female, Aged 48, diagnosed thirty-two years ago, 
recruited from epilepsy patient support group  
5.23 Discussion of Patient Support Group Findings: Disclosure and the Role of 
Time  
Time appears to have played an important role in decision making in terms of how 
participants viewed disclosure and subsequently adopted strategies around it.  A 
number of participants highlighted that over time they found it easier to disclose.  
Others stated that over time there was an increase in the knowledge and the 
experience of the condition which gave them confidence to disclose.  This suggests 
that time may influence decisions and attitudes towards disclosure thus views on 
disclosure are not static.  Processes of adapting to living with type 1 diabetes or 
epilepsy were identified in the interviews (Paterson et al, 1998, Dovey-Pearce et al, 
2007, Scambler and Hopkins, 1986).  Indeed, literature on long-term health 
conditions has cited the important role of capturing changes over time regarding 
feelings about the condition (Charmaz, 2000).  Issues of control of the condition 
were raised by participants.  However some participants felt their condition had 
became more controlled over time, and equated this with changes in lifestyle.  
Evidence for this finding is supported in the literature on diabetes which describes 
how the process of controlling one‟s condition is dynamic and linked to changes in 
lifestyle, referring to a process of “learning to balance” the condition in one‟s life 
(Paterson et al, 1998).  
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Members of patient support groups reported adopting strategies of disclosure in 
order to avoid stigma around the condition thus highlighting that “learning about 
disclosure” is a key process which evolves over time.  The relationship between 
stigma and disclosure, for those living with epilepsy is now discussed. 
5.24 Patient Support Group Findings: Epilepsy, Stigma and Disclosure 
The data illustrated that participants recruited from the patient support groups felt 
that not only can having an acute episode be dangerous to themselves and others and 
require a need for others to help them, they also felt socially judged.  How others 
beyond friends or family perceived the symptoms appeared to play a key role in how 
people felt about having the condition.  Participants raised concerns that sometimes 
people mistake the symptoms of their condition for example, shaking or slurring 
words to be as a consequence of drugs or being drunk.  This led them to feel they 
were being unfairly judged by onlookers. 
One participant described how others ignored her when she had an epileptic seizure 
in a busy city train station:  
I remember having a seizure on (place) railway station … Luckily I had 
somebody with me … He told me afterwards people were quite literally 
stepping over my body pretending that I just wasn‟t there! … They were 
frightened of it and they would assume you know, drink, drugs. 
Interview 3 tu: 131, Female, Aged 47, Diagnosed forty years ago, recruited 
from epilepsy patient support group  
Many participants cited such negative reactions as experiences of being stigmatised.  
They felt that there was a stigma around the condition itself, in particular when they 
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had an acute episode.  Therefore not only did they have to cope with the physical, 
biomedical management of the condition but also the stigma, that is the social 
judgement of the condition manifested through others‟ reactions: 
There‟s a stigma attached to it because you can‟t see it obviously and you just 
fall on the floor … People don‟t know how to cope with it. 
Interview 15 tu:260, Female, Aged 48, Diagnosed thirty-two years ago, 
recruited from epilepsy patient support group  
Others felt that while these attitudes stemmed from historical prejudice, there was 
little doubt that such negative attitudes and connotations of the condition epilepsy, 
still existed in the present day.  Participants believed that the frightening and 
powerful image of someone having a seizure contributed to this: 
In the past (people) with epilepsy were thought to be possessed.  They were 
also thought to be mad! … I think that‟s part of where it comes from … People 
do think you are going to fall down, … have a major seizure and thrash around 
and froth and they‟re scared! 
Interview 6, tu: 132, Female, Aged 51, Diagnosed thirty years ago, recruited 
from epilepsy patient support group 
The following quote illustrates how a co-worker responded to the disclosure of 
epilepsy:  
She said: “Oh but you don‟t look epileptic!” and I said: “Well how am I 
supposed to look?” and she sort of shrugged her shoulders and said “Well I 
don‟t know, I thought you might fall down and froth a bit!” 
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Interview 6 tu: 346 Female, Aged 51, diagnosed thirty years ago, recruited 
from epilepsy patient support group  
Participants therefore reflected that others had strong mental images of what 
someone having an epileptic seizure might “look like.”   
5.25 Discussion of Patient Support Group Findings: Epilepsy, Stigma and 
Disclosure  
The data suggests that epilepsy has long been associated with negative historical 
beliefs.  Evidence for this finding is supported in the literature on socio-cultural 
understanding of epilepsy (Eisenberg, 1998).  Thus perceived stigma becomes a 
barrier to disclosure since perceptual images of the condition can lead to others 
socially judging them, thus resulting in stigma.   
Many participants feared then that by disclosing they would in turn be stigmatised 
and in the interviews there were numerous specific examples of this.  Indeed in this 
respect disclosure was perceived as something “risky” and potentially “discrediting” 
to their identity (Goffman, 1963).  Furthermore existing studies have identified what 
is termed “felt stigma” that is perceived stigma and “enacted” stigma which is actual 
experience of stigma (Scambler and Hopkins, 1986).   
Participants from the patient support group sample provided access to those who had 
lived with the condition for a relatively longer time (than those recruited from the 
nurse specialist clinics).  The data illustrated that reactions to disclosure when taken 
into account, led some to adopt the strategy of disclosing to others in advance.  This 
illustrated that these participants had “learned about disclosure” to avoid 
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misconceptions of their behaviour and redress myths associated with the condition as 
I go on to discuss.  
5.26 Patient Support Group Findings: The Role of Strategic Disclosure: 
Redressing Myths about the Condition in Advance  
The data illustrated a second role for disclosure: by disclosing in advance: 
participants sought to redress myths about the condition “preventive telling” to avoid 
perceived stigma, as the following quote illustrates: 
If you‟re with someone and they‟re having a seizure, they think: “They‟re on 
drugs or drinking.”  Better to tell people that you‟ve got it. 
Interview 19 tu: 150, Female, Aged 21, Diagnosed seven years ago, recruited 
from epilepsy patient support group  
In this case it could be argued that the intention of disclosure was to protect 
themselves from the misplaced judgment of others.  
Older people who were members of the patient support groups appeared particularly 
keen to avoid such stigma and often employed this strategy of disclosing to others in 
advance, an additional rationale being to gain necessary medical support: 
If you see somebody having a hypo (hypoglycaemic episode) … eventually 
they just collapse on the floor.   You think “Oh he‟s drunk!”  It‟s the automatic 
reaction!  There‟s a big difference between what a drunk needs at that moment 
and what somebody with type 1 diabetes needs … So … it became more 
important to me to tell people. 
Interview 14: tu: 164, Male, Aged 72, Diagnosed nineteen years ago, recruited 
from diabetes patient support group 
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Therefore, it was not only about stigma it was also for reasons of safety; that those 
around them knew about their condition, because they relied on outside help in the 
event of an acute episode.  This was found across both conditions:  
In case anything happens while you‟re in their presence … Tell them and 
explain to them.  Tell them what to do if I do go into one.  „Cos … they don‟t 
know whether to lie you on the floor or on your side … It‟s just a case of 
sitting you down and waiting till I come out of it.  
Interview 18, tu:165, Female, Aged 49, Diagnosed thirty-four years ago, 
recruited from epilepsy patient support group 
5.27 Discussion of the Patient Support Group Findings: The Role of Strategic 
Disclosure  
In this context the role of disclosure was to redress myths around the condition in 
advance.  Schneider and Conrad (1980) refer to this as “preventive telling”, the 
purpose of which is to avoid perceived stigma.  “Learning about disclosure” emerged 
as a key issue in terms of developing strategies over time based upon previous 
responses.  Those who had lived with the condition for a long time, particularly 
attendees at patient support groups appeared to develop strategies to manage the 
process of disclosure, in order to minimise the potential for stigma.  Other studies 
have found that disclosure can be typically planned in order to minimise negative 
reactions from others (Charmaz, 1991, Schneider and Conrad, 1980, Troster,1997).   
The findings of this study suggest that participants made “strategic” decisions 
regarding to whom to disclose.  Decision making around disclosure appeared to be 
linked to assessment of the risk of being stigmatised as a consequence of disclosure.  
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This finding reflects earlier work which highlights the link between stigma and 
decision making around disclosure in order to avoid “discreditation” (Goffman, 
1963).   
In part two of this section I now present comparative data from the clinical nurse 
specialist clinic participants and highlight how similarly the process of “learning 
about disclosure” emerged in this setting.  The challenges around disclosure, the 
rationale for non-disclosure and participants‟ adoption of concealment of their 
condition are presented.  The third role of disclosure is identified in this context to 
be: non-disclosure as a means to avoid stigma.  
5.28 Clinical Nurse Specialist Clinic Findings: Challenges of Disclosure 
Participants described a process of learning about disclosure over time.  In particular 
the challenges they faced around the timing of disclosure.  Previous negative 
reactions to disclosure played a key role in their perceptions and strategies they 
adopted concerning disclosure.   
5.29 Timing of Disclosure  
Younger participants, particularly those who were newly diagnosed expressed 
apprehension at the prospect of disclosing their condition to potential partners.  In 
the following quotation, the young woman recently diagnosed with epilepsy reflects 
on this: 
One of the girls at uni has epilepsy as well.  She says that she really struggled 
to tell a long-term boyfriend … Trying to tell him all about her epilepsy was 
she found difficult … I haven‟t been seeing anybody … I suppose that would 
be quite difficult trying to share that with somebody. 
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Interview 1 tu: 181, Female, Aged 18, Diagnosed one year ago, recruited from 
epilepsy patient support group 
Similar dilemmas emerged with regard to the timing of disclosure to potential 
friends:  
Once you get to know somebody then you tell them … There‟s no point telling 
every Tom, Dick and Harry your problems unless you are actually gonna be 
friends with them and then you‟re gonna know for a long time. 
Interview 26 tu: 240, Female, Aged 21, Diagnosed eleven years ago, recruited 
from young adult diabetic clinic  
Participants expressed concerns around “finding the right moment” to tell.  
This appeared to be dependent on how well they knew the individual: 
It‟s sort of finding like the right moment as well.  I always think if I turned 
round and said “Hi my name‟s Emma blah, I‟m diabetic.”  That‟s sort of 
defining myself as it (diabetic) … Whereas it‟s just something that happens to 
be there. 
Interview 35 tu 62: Female, Aged 22, Diagnosed nineteen years ago, recruited 
from young adult diabetic clinic   
It‟s also hard to drop into the conversation … Say for example … I‟m talking 
about football to someone I‟ve just met, to then turn round to them and say 
“Oh yeah, by the way, I‟ve got epilepsy.”  They take a step back and sort of 
like then they‟re careful. 
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Interview 31, tu:75, Male, Aged 32, Diagnosed twenty-one years ago, recruited 
from epilepsy nurse specialist clinic 
For those newly diagnosed it was an important decision because the disclosure 
underlined feelings of “difference” and potentially jeopardised social acceptance: 
You don‟t want it to change how people feel about you.  You want to tell them 
„cos it‟s important to you but you don‟t want them to feel differently about you 
or to feel sorry for you.  I don‟t really like telling people just because it then 
makes you different and you‟re not!  It‟s really hard to explain. 
Interview 27 tu: 53 Female, Aged 19, Diagnosed six months ago, recruited 
from young adult diabetes clinic 
I‟ll tell someone once I sort of know them well enough to sort of have a bit of 
faith in them.  So that I know that … they wouldn‟t sort of react in a negative 
way.  I wait until I‟m sure that they‟re sort of able to handle as much as I can 
handle it.  
Interview 23 tu:79, Male, Aged 21, Diagnosed four months ago, recruited from 
young adult diabetic clinic  
The above quotations illustrated that individuals took others‟ reactions into account 
when making decisions around the appropriate time to disclose.   
Participants across both conditions highlighted that decisions to disclose or not 
emerged frequently in the context of seeking travel insurance.  Many cited how they 
could only gain medical insurance from specialist companies thus bringing their 
condition to the forefront:   
I don‟t think about it a great deal … Trying to get travel insurance and things 
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like that, that‟s the only time it ever really becomes a problem … The only 
people you can really get insurance off of is from the Diabetes UK people … 
Sometimes I fib about that … „cos if I break an arm, I‟m always fairly 
confident that nothing diabetes  related is gonna happen if I‟m away.  
Interview 35, tu 93: Female, Aged 22, Diagnosed nineteen years ago, recruited 
from young adult diabetic clinic   
Some therefore chose not to disclose their condition to travel insurance companies as 
they felt it was unlikely that the condition itself would lead to complications whilst 
on holiday.  The following quotation highlights difficulties encountered around 
misconceptions concerning medication for those living with epilepsy: 
Some epilepsy drugs that I‟ve been on are classed as an antidepressant … 
They‟ve (travel insurance companies) come back to me and said: “How long 
have you been depressed for?” … when I said to them: “It wasn‟t for 
depression.  It was medication for me epilepsy.” … So then I‟ve had trouble 
and I‟ve just not had medical insurance at all.  They‟re not listening to you … 
It‟s just so frustrating!  „Cos I need the medical insurance!  And it‟s like when 
I go on holiday I have the same problem again.  I have to pay more and I think 
why?  I‟m fine!  It‟s not like I have an ailment where I‟ve got a limited short 
life span!  It‟s not like that at all. 
Interview 34, tu: 115 Female, Aged 31, Diagnosed twenty years ago, recruited 
from epilepsy nurse specialist clinic 
The ongoing, enduring nature of the condition makes disclosure a difficult process to 
negotiate for many, not only to partners but to “outsiders” such as in the context of 
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disclosure to seek travel insurance.  Other studies have highlighted the difficulties 
encountered around disclosing a long-term health condition to potential partners, due 
to fears of a negative reaction (Lowton, 2004)  
I now go on to present data concerning participants perceived responses to disclosure 
which were often deemed to be negative.  Reactions are often linked to issues of 
visibility and images of what someone with the condition might “look like.”  
Participants felt such reactions illustrated a lack of understanding regarding the 
heterogeneity of both conditions.  Such reactions were reportedly the rationale for 
their subsequent adoption of the strategy of deliberately choosing not to disclose 
their condition.   
5.30 The Rationale for Non-disclosure: Perceived Negative Reactions  
Disclosure did not always lead to a perceived positive response from employers.  
Typically participants felt this was due to a lack of understanding around the 
potential difficulties encountered living with diabetes.  Some reported feelings of not 
simply fear of the consequences of neglecting self-care, but also guilt as sometimes 
their condition required additional time away from work to attend hospital 
appointments: 
I feel guilty for having to ask for time off, but if I don‟t go (to the hospital) 
then my diabetes goes out of control … I end up having time off being sick 
anyway ... but you say to somebody nowadays: “I‟ve got diabetes” and they 
just go: “ok!” because they don‟t understand … Then you say: “I need the time 
off for the hospital and you go to the eye hospital …“But why?!”  They 
(employers) expect you to have diabetes and it‟s all fine and normal and that‟s 
it! 
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Interview 26 tu: 85 Female, Aged 21, Diagnosed eleven years ago, recruited 
from young adult diabetic clinic  
Others felt that disappointing responses from employers were due to a lack of 
understanding around the implications of living with the long-term condition. As one 
respondent recalls: 
There were a number of times where I‟d had a full-blown seizure and I would 
phone in work and say: “Actually I‟m sorry, I‟m not well enough to come in.” 
… She‟d (the manager) phone in a couple of hours and say:  “Oh can you 
come in now?”  She didn‟t have an awareness that actually I‟d feel pretty lousy 
for the rest of the day. 
Interview 33 tu:39 Female, Aged 28, Diagnosed 18 months ago, recruited from 
epilepsy nurse specialist clinic 
Everybody‟s got an illness who works but I suppose with epilepsy they‟re 
scared „cos they don‟t know what‟s going to happen! 
Interview 30 tu 38 Female, Aged 28, Diagnosed eight years ago, recruited from 
epilepsy nurse specialist clinic  
Participants recruited reflected upon perceived reactions when they did choose to 
disclose their condition to others.  The quotations provide valuable insights into the 
process of disclosure and the reactions of others‟ to disclosure.   
Mental images of the condition could be perceived as negative markers by some 
attendees of nurse specialist clinics as the following quotation illustrates: 
I feel that once you say you‟re an epileptic – it‟s about what their opinion and 
perspective is about epilepsy.  They haven‟t got a clue about what a fit is 
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really.  They think it‟s aggressive, they think you‟re a loony, … you‟re mad, 
you‟re crazy, you‟re gonna have outbursts!  
Interview 34 tu: 53 Female, Aged 31, Diagnosed twenty years ago, recruited 
from epilepsy nurse specialist clinic  
Difficulties were experienced in disclosing due to others‟ reactions which did not 
take into account the heterogeneity of the conditions: 
I‟m not keen on telling people about my epilepsy as there are many types of 
epilepsy.  Due to the different types all having the same name, to an 
uneducated person they tend to tar us all with the same brush.  
Interview 31, Male, Aged 32, Diagnosed twenty one years ago, recruited from 
epilepsy nurse specialist clinic (added in by letter) 
Many described “being asked the same questions” to be a typical response to 
disclosure:   
They always ask me the same questions: “Do you have to take injections?” and 
“Does it hurt?”  That kind of drove me mad being asked those two questions 
constantly for a few years of my life. 
Interview 25, tu:16, Male, Aged 19, Diagnosed fourteen years ago, recruited 
from young adult diabetic clinic 
This response caused frustration and led many younger participants to avoid the 
process of disclosure where possible because they perceived it as burdensome.  
A further complication of disclosure for those living with diabetes is that there are 
two types: type 1 and type 2. Some participants highlighted that there appears to be 
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greater public understanding of diabetes type 2, as opposed to type 1 diabetes. This 
led to frustration for those disclosing as one participant emphasises: 
When you tell them they‟ll say stuff like: “Oh you can‟t eat sugar then?” or 
“You have to eat sugar?” or some people think there two types: one where you 
don‟t have enough sugar, and one where you have too much sugar and like: 
“Which one do you have?”  I‟m like: “It doesn‟t work like that!”  
Interview 29 tu: 64, Female, Aged 17, Diagnosed three years ago, recruited 
from young adult diabetes clinic   
There appears to be a link between what others know about the condition and how 
they respond to the disclosure.  In some instances the discloser felt that they were 
being unfairly judged for having a “self-inflicted” condition: 
A lot of people associate it with being quite overweight and being unhealthy … 
Completely the opposite to what I was, and still am … I guess there‟s some 
stereotypes. 
Interview 23 tu: 40, Male, Aged 21, Diagnosed four months ago, recruited 
from young adult diabetic clinic 
This raises issues of information needs, as the response of others was perceived to be 
linked to their understanding of the condition.  Put simply, when others knew little it 
made the process more difficult for the discloser: 
If you just had one person that actually knew what diabetes was it would be so 
much simpler to tell people! … You wouldn‟t have to tell em what it‟s all 
about.  You wouldn‟t have to explain why you have injections?  Why you do 
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blood tests?  Why you land in hospital?  They‟d just know it‟s one of those 
things that needs to be done! 
Interview 26 tu: 147, Female, Aged 21, Diagnosed eleven years ago, recruited 
from young adult diabetic clinic 
Some felt that the general lack of information on epilepsy and lack of “high profile” 
role models made disclosure more difficult:  
With epilepsy there‟s just such a lack of information in the public arena … 
You never hear of famous people with epilepsy! 
Interview 33 tu:89, Female, Aged 28, Diagnosed eighteen months ago, 
recruited from epilepsy nurse specialist clinic 
Younger participants, discussed how they had been advised to tell others for 
insurance purposes.  However, many cited that this was not a simple act: 
All I‟ve been told is: “You have to let them know, you have to let them know!” 
Not why? “Just tell them! It‟s easy!” … It‟s been hard telling them! 
Interview 34, tu: 110 Female, Aged 31, Diagnosed twenty years ago, recruited 
from epilepsy nurse specialist clinic 
Some living with epilepsy feared that they would be stigmatised for having disclosed 
the condition: 
I just want people to take me for who I am … „Cos it feels like I‟ve got a stamp 
on me head that says: “I‟ve got epilepsy!” 
Interview 31, tu: 115, Aged 32, Diagnosed twenty-one years ago, recruited 
from epilepsy nurse specialist clinic 
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5.31 Discussion of Clinical Nurse Specialist Clinic Findings: Challenges around 
Disclosure 
The data presented above has illustrated that previously perceived negative reactions 
appear to play a role in perceptions of the role of disclosure and strategies around 
disclosure.  Those to whom they disclosed did not understand the implications of 
having the condition were for the discloser or for them.  With reference to 
employers, participants felt they often did not understand the medical implications of 
living with the condition for the discloser this impacted on the practical application 
of self-care such as the need to attend hospital appointments or periods of recovery 
following epileptic seizures.   
Participants found that disclosure may lead to negative consequences such as 
repeatedly being asking the “same questions,” and feelings of stigmatisation such as 
being treated differently, which is in line with the work of Goffman, (1963).  They 
highlighted that there appeared to be a significant gap in information with many 
discussing the necessity for raised public awareness of the conditions.  
Previously perceived negative reactions to disclosure led some to avoid the process 
altogether as I go on to illustrate. 
5.32 Clinical Nurse Specialist Clinic Findings: The Role of Non-disclosure: 
Avoiding Stigma   
5.33 The Process and Role of Non-disclosure (Type 1 diabetes participants)  
This section presents findings which illustrate that some chose to conceal the process 
of medical management of their condition, in order to protect themselves from 
stigma, particularly those living with type 1 diabetes whose process of management 
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such as injecting insulin was perceived as “visible.”  The process of visibly injecting 
appeared to represent a form of unwelcome disclosure and as such was to be hidden 
as the following quotation indicates: 
I go to the toilet.  I don‟t do it (inject insulin) in front of anyone else! … If they 
don‟t know what you‟re actually doing - they might think you‟re a druggy! 
Interview 26 tu:126 Female, Aged 21, diagnosed eleven years ago, recruited 
from  young adult diabetic clinic  
I think it‟s quite a taboo thing isn‟t it like needles?!  Everybody associates it 
with the spread of diseases! ... I‟d never sit on a bench and just do it (inject), in 
public. 
Interview 23 tu: 86, Male, Aged 21, Diagnosed four months ago,  recruited 
from young adult diabetic clinic  
Fear of social stigma led to a process of concealment which in turn affected self-
care:  
It‟s even worse when you go out clubbing for the night as well „cos that‟s one 
of the places I wouldn‟t take my injection with me „cos the drug dealing and 
that kind of stuff that you expect in the night club. 
Interview 26 tu:138 Female, Aged 21, diagnosed eleven years ago, recruited 
from young adult diabetic clinic  
As the following example in the workplace illustrates for some this link of 
maintaining a “healthy identity” was related to concealing ways of managing the 
condition, for example non-disclosure meant not allowing others to see them 
injecting their insulin:  
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I‟ve kept it quiet at work, just done my injections at the loo at lunch. 
Interview 23 tu: 91: Male, Aged 21, diagnosed four months ago, recruited from 
young adult diabetic clinic 
Whilst many did disclose their condition to their employers, many younger 
participants chose to hide the process of managing the condition.  This had a 
negative impact upon her health status as the following quotes illustrate: they didn‟t 
want to be seen as “different:” 
I just didn‟t want to be seen to be different … Having to say: “Look I need to 
eat, I can‟t come to a lunchtime meeting” … I would try and hide it under the 
carpet and just get on with it quietly myself … I was having to rearrange my 
life around my work … and not be doing things that I should have been doing 
with my diabetes like having regular meals and stuff. 
Interview 16 tu: 197 Female, Aged 38, Diagnosed twenty years ago,  recruited 
from diabetes patient support group 
In this context concealment appears to play a role of social management for example 
protecting oneself from stigma.  
Some younger participants preferred their family members disclosing on their behalf 
as they found it a difficult process at the time of diagnosis: 
I think I got my mum to tell them by phone. I didn‟t know what to say. 
Interview 29 tu: 64 Female, Aged 17, Diagnosed three years ago, recruited 
from young adult diabetes clinic   
As the following quotation from a young woman illustrates, some chose to avoid the 
process of disclosure altogether: 
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I only let my mum do it (disclose) … Bad reactions … It also upsets me quite a 
bit … „Cos I know all the things that are wrong with me. 
Interview 26 tu: 277, Female, Aged 21, Diagnosed eleven years ago, recruited 
from young adult diabetic clinic 
Thus for some, disclosure represents an ongoing burden to be avoided: reflecting the 
emotional impact of living with the condition, and the perceived negative responses 
of others, leading many to state such reactions to be the rationale for their subsequent 
non-disclosure of the condition.  
5.34 Discussion of Clinical Nurse Specialist Clinic Findings: The Process and 
the Role of Non-Disclosure  
The data presented above illustrates that the process of managing the condition had 
not only biomedical connotations but social connotations.  Many younger 
participants living with type 1 diabetes described the process of injecting insulin as 
having profound social connotations such as negative links to illicit drug use.  
Therefore injecting became not only an act of medical management but a potentially 
“discrediting” form of disclosure to others (Goffman, 1963).  This process of 
deliberate concealment is referred to as “passing” the purpose of which is to become 
part of the “normal” group and not be treated differently (Goffman, 1963).   
Others chose to deliberately avoid verbally disclosing their condition to others and 
asked their parents to do so. Again the process of disclosure was to be avoided 
because it appeared to compound feelings of difference.  Protecting their identity as 
“normal” appears to be the key rationale for this behaviour.  This linked to 
difficulties of accepting the condition and fear of the reactions of others, such as 
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stigma, based upon misconceptions or myths.  Such feelings are significant because 
they have implications for managing the condition which may lead to the 
deterioration of health status and in particular for those living with type 1 diabetes.  
Evidence for this finding is found in other studies on the management of type 1 
diabetes, which suggest that difficulties accepting the condition and feelings of 
difference tend to affect the management of the condition (Paterson et al, 1998).  The 
data identified issues around non-disclosure of one‟s health condition and similar 
findings are highlighted in other studies (Goffman, 1963, Charmaz, 2002, 
Sandelowski, 2004).  Goffman (1963) argues that not disclosing is a strategy by 
which to manage or avoid issues of stigma.  
I now go on to discuss commonalities and differences identified in the data from 
patient support group participants and nurse specialist clinic participants with regard 
to: “learning about disclosure” disclosure and the role of time.  
5.35 Discussion of patient support group and nurse specialist clinic findings 
Learning about Disclosure: Disclosure and the Role of Time  
The study findings illustrate differences across the participants recruited from the 
patient support group and nurse specialist clinics in relation to their views on 
disclosure.  For example those recruited from the patient support groups recounted 
how many had changed over time from not disclosing their conditions towards 
adopting the strategy of disclosing their condition to others in advance.  Participants 
were particularly keen to avoid stigma where possible and had adopted this strategy 
based on previous negative responses to unanticipated disclosure.  Thus they used 
strategic disclosure to redress myths about the condition to others in advance, and so 
avoid perceived stigma and gain medical support where appropriate.  Such feelings 
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appeared to reflect a greater acceptance of living with the condition moving from the 
personal perception of disclosure as being “my problem” towards it being others‟ 
problem: “their problem.”  This is further discussed in the discussion and 
conclusions chapter (Chapter six).   
Conversely those recruited from the nurse specialist clinics whilst still “learning 
about disclosure” tended to conceal their condition based on perceived negative 
reactions.  Disclosure was for many younger participants a difficult process leading 
to compounding feelings of difference and stigma and so to be avoided where 
possible.  They did not typically disclose their condition to others where possible.  
Such differences in the strategies around disclosure do illustrate that those living 
with long-term conditions are not heterogeneous and strategies for disclosure are not 
fixed by dynamic and subject to change over time.   
In the next section I go on to present findings which participants across both 
recruitment settings raised on issues of information.  
5.36 Section Five The Role of Information and Disclosure  
This section presents findings from the study on the role of information and 
disclosure and sources of information.  This includes the need for additional 
information on the conditions at the point of diagnosis, the role of patient support 
groups in the provision of information, the role of the internet in the provision of 
information, the role of clinical nurse specialist clinics in the provision of 
information.  Findings are presented from participants recruited from the clinical 
nurse specialist clinics setting out their views on patient support groups and the 
provision of information via the clinics.  
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It illustrates the perception of a lack of information at the point of diagnosis and the 
gap in information on disclosure: this led some to seek information from patient 
support groups.   
The following quotes illustrate how participants when diagnosed frequently had little 
pre-existing knowledge of the conditions: 
I didn‟t know anything about epilepsy when I found out I had it.  It was quite a 
shock really. 
Interview 1 tu:39, Female, Aged 18, Diagnosed one year ago, recruited from 
epilepsy patient support group 
Others cited that they had no idea what the implications of having the condition 
would be as the following quotation illustrates: 
I didn‟t really know much about it … How it was going to affect me? 
Interview 23, tu:8, Male, Aged 21, Diagnosed four months ago, recruited from 
young adult diabetic clinic  
Another issue raised by participants was they felt following diagnosis they did not 
receive the necessary support from clinicians: 
I remember being quite shocked the day I was diagnosed … It was very much 
like: “Oh well here‟s your tablets, you‟ve got epilepsy, come  back and see me 
in six months and have these tests in the meantime” and that was it!  I mean 
whilst I didn‟t think like …“Oh my God it‟s like cancer!” or really severe but 
… I did think well this is quite a life changing condition! 
Interview 33, tu:106, Female, Aged 28, Diagnosed eighteen months ago, 
recruited from epilepsy nurse specialist clinic 
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It appears that one of the reasons participants sought information was a 
dissatisfaction with that provided by healthcare professionals particularly at the point 
of diagnosis.  The following participant living with type 1 diabetes reflected that this 
was and still remains an ongoing issue: 
I mean there is a major problem with education of newly diagnosed diabetics 
… I mean apart from being shown how to draw up insulin and inject it that was 
all I was told! … I would have preferred to have sat down with somebody who 
knew all about it who would tell me exactly what it was, why diabetes 
happens?  „Cos I hadn‟t a clue! 
Interview 14, tu: 140, Male, Aged 72, Diagnosed nineteen years ago, recruited 
from diabetes patient support group 
Those living with epilepsy frequently highlighted difficulty in locating sources of 
information about the condition in comparison to other long-term conditions:  
There‟s a real lack of information … If I go into a bookshop … there will be 
reams of books on diabetes or various other conditions … On epilepsy you‟ll 
be lucky if you find one book!  
Interview 33, tu:73, Female, Aged 28, Diagnosed eighteen months ago, 
recruited from epilepsy nurse specialist clinic 
The perceived lack of information led some to seek out patient support groups to 
gather further information as I go on to discuss.  It is highlighted that not all 
participants felt that the group setting was relevant to them.   
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5.37 Patient Support Group Findings: The Role of Patient Support Groups   
Those who were members of a patient support group explained that the purpose of 
their attending was to gather views and knowledge from those who also had the 
condition.  The belief seemed to be that only those living with a long-term condition 
could fully „understand‟ the nature of it.  The role of the patient support group 
involves more than gaining information.    
As the following quotation illustrates, groups can give people a sense of how to 
manage their conditions in ways that receiving medical information can not:  
You‟ve been given the clinical information but know very little else about it.  
You‟re frightened it‟s going to put so many restrictions on your lifestyle … 
You realize by talking to other people who‟ve lived with it for years that … it‟s 
not going to be a restriction … just a different way of doing things ... That … 
takes a big load off other people‟s shoulders and … realizing as well that 
they‟re not all alone. 
Interview 3, tu: 304, Female, Aged 47, Diagnosed forty years ago, recruited 
from epilepsy patient support group  
Other members commonly highlighted that they shared experiences with others and 
gained comfort in the knowledge that others were facing similar issues including 
feelings of stigma, as the following quotes illustrates: 
It‟s helped me come to terms with some of it…Some of the things that used to 
happen to me I used to think I must be the only one! … When you get talking 
in a group you realize it‟s happening to other people as well.  That kinda helps.  
You know you‟re not the freak you thought you were!” 
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Interview 21 tu: 181, Male, Aged 56, Diagnosed twelve years ago, recruited 
from epilepsy patient support group 
I don‟t know many other diabetics because they keep themselves to themselves 
… You know we‟re all in the same boat, let‟s all talk about it! ... They‟re all 
there because they want to share any experiences. 
Interview 13, tu: 176, Female, Aged 61, Diagnosed twenty-nine years ago, 
recruited from diabetes patient support group 
The group setting thus provided an opportunity to meet with their peers which was 
particularly beneficial to some in reducing feelings of social isolation.  Those living 
with diabetes also expressed the benefits they felt when sharing their experiences of 
living with the condition as they did not often have the opportunity to discuss such 
issues.  
However attending the group itself was not necessarily a straightforward process.  
The following quote illustrates that amongst those attending patient support groups a 
level of acceptance of the condition exists.  One woman reflected that attending the 
meeting is in itself a form of disclosure and this some may find difficult: 
A lot of people wouldn‟t even come forward and step over the pathway to 
come into the group.  As soon as they walk in you know they‟ve got epilepsy 
… I think they‟re scared that you‟re “announcing yourself” as epileptic. 
Interview 15 tu:328, Female, Aged 48, Diagnosed thirty-two years ago, 
recruited from Epilepsy Patient Support Group  
I now go on to discuss data which illustrates that some felt the group settings were 
not appropriate for all those living with a long-term condition.  
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Indeed, some of those who attended a patient support group commented that they 
were aware that it was mainly older people who attended.  There was a commonly 
held view by older participants that younger people living with long-term conditions 
may not wish to attend since it may emphasise the notion of being “different” to 
others.  This was something that many group members had experienced when they 
were younger as the following quote illustrates:  
There weren‟t any youngsters there (at the meeting), none at all … They want 
to get on with life –and you feel it‟s an old fogies complaint … You perhaps 
still feel and share the embarrassment that I did in those early days, that you‟re 
different! 
Interview 4, tu: 441, Male, Aged 71, Diagnosed fifty-eight years ago, recruited 
from diabetes patient support group  
Group leaders were aware that few younger people attended and were actively 
seeking ways to address this:  
I think young people are the ones that we really need to make contact with … 
Explain to them how to disclose it and why it‟s better to let other people 
understand.  
Interview 3, tu: 494, Female, Aged 47, Diagnosed forty years ago, recruited 
from epilepsy patient support group  
Others cited difficulties reaching out to younger people in terms of how to contact 
them, they were aware the format of the group meetings may not appeal to them: 
It seems old fashioned to them people sitting around drinking cups of tea just 
having a discussion.  I think they like things to be hip and trendy and when 
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they see a group of over 50‟s sitting around they feel … they‟re back in the 
school situation again … My idea is to somehow ask some of these people, but 
the medical people won‟t give you the names of the people that are involved. 
Interview 17, tu:50, Aged, 67, Male, Diagnosed thirteen years ago,  recruited 
from diabetes patient support group 
Thus younger people living with long-term conditions may require groups or 
information sources tailored to their specific needs which are likely to be different to 
those of older people living with the same conditions.  
5.38 Patient Support Group Findings: The Role of the Internet 
Group attendees speculated that now younger people need not attend patient support 
groups to seek information because it can be sourced via the internet as the following 
quotes illustrates: 
Today they‟ll look on the internet … They can be there reading all about it and 
the drugs … It doesn‟t mean that they have to go out then, or even join these 
groups! 
Interview 15 tu: 336, Female, Aged 48, Diagnosed thirty-two years ago, 
recruited from epilepsy patient support group  
There‟s a lot more help. You have the internet which you can go on and trawl 
through. 
Interview 13, tu: 233, Female, Aged 61, Diagnosed twenty-nine years ago, 
recruited from diabetes patient support group 
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However in this study younger participants did not cite the internet as their primary 
source of information concerning the condition as the following newly diagnosed 
diabetic describes: 
I‟ve been on the (patient support organization) website a couple of times … 
I‟ve got a really good book which I look at quite a lot.  It just tells me 
everything! 
Interview 27 tu:125, Female, Aged 19, Diagnosed six months ago, recruited 
from young adult diabetes clinic 
Participants preferred to use it to as an additional source of information on specific 
issues such as health insurance as the following quote illustrates: 
I‟m going off to America to go to university out there … and at the moment 
we‟re in the process of looking for health insurance and we wanted to find out 
as much information as we could so we went on the Diabetes UK website.  
Interview 24, tu:38 Male, Aged 18, Diagnosed seven years ago, recruited from 
young adult diabetic clinic. 
Further exploration of reasons why younger people did not attend patient support 
groups is now presented by examining the views of the nurse specialist clinic 
interviewees. 
5.39 Clinical Nurse Specialist Clinic Findings: Views on Patient Support 
Groups  
Those participants who were recruited from the clinical nurse specialist clinics were 
not currently attendees at patient support groups.  Some had attended them in the 
past, but had opted not to return.  There were two main reasons given for non-
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attendance at the groups.  Firstly, younger participants highlighted the age gap, so 
whilst they were also living with the same long-term condition (type 1diabetes or 
epilepsy) participants cited that this was all they shared in common with those 
attending.  Secondly, they cited that they did not feel the need to attend a group at 
that point in time.  
The following quote comes from a young woman living with epilepsy highlighting 
the relevance of the age gap: 
I did go to a local support group.  I was the youngest by about thirty  years … I 
didn‟t necessarily feel “Oh I‟ll go back again.”  I just found they couldn‟t 
necessarily relate to the issues that I had.  
Interview 33, tu: 47, Female, Aged 28, Diagnosed eighteen months ago, 
recruited from epilepsy nurse specialist clinic 
Others stated that they simply had not felt the need to talk to others in the same 
situation as one newly diagnosed diabetic illustrates:  
I haven‟t really got anyone to talk to about it - because I don‟t know  anyone 
(with type 1 diabetes) … It doesn‟t … bother me at all. 
Interview 23 tu: 48, Male, Aged 21, Diagnosed four months ago, recruited 
from young adult diabetes clinic  
Participants also highlighted the heterogeneity of those living with the condition, 
sensing that members of the group may not all share the same experiences:  
Ok I could talk about it, so could somebody else, but we‟re not all gonna be the 
same … I don‟t wanna know what other people have! 
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Interview 34, tu: 90, Female, Aged 31, Diagnosed twenty years ago, recruited 
from epilepsy nurse specialist clinic  
I now go on to present data which illustrates participants‟ perceptions of the role of 
nurses as providers of information on medication issues and disclosure.  
5.40 Clinical Nurse Specialist Clinic Findings: Information Needs and 
Disclosure 
This section presents findings on the nurse specialist clinics in terms of the role of 
disclosure and emerging information needs.  
The following quotations illustrate how participants felt that the nurse specialist 
clinics offered a valuable setting in which to discuss queries about their condition: 
I go about every sort of four to six months … It‟s good just to kind of touch 
base … I prefer to do that than just go to my GP (general practitioner) and 
discuss it with them … I feel that at the clinic they‟ve got a more in depth 
knowledge of my particular needs and  situation. 
Interview 25, tu:29, Male, Aged 19, Diagnosed fourteen years ago, recruited 
from young adult diabetic clinic  
They obviously know what the condition is and how you suffer it and really 
they know the ins and outs don‟t they?  So it‟s easier. 
Interview 30, tu:64, Female, Aged 28, Diagnosed eight years ago, recruited 
from epilepsy nurse specialist clinic  
Also nurses offered a much welcome source of contact regarding issues of 
medication, as some felt they did not gain much information from the neurologist 
when diagnosed:  
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I had quite a few questions I wanted to ask about epilepsy … medication and 
things like that … I have found her (the nurse) a lot more supportive than a 
consultant … When I was diagnosed with epilepsy the first neurologist I saw 
he was very sort of matter of fact about it like sort of: “Well we think it‟s 
epilepsy and we‟ll start you on this medication.” and that was it!  Like it was 
nothing! 
 Interview 33, tu:13, Female, Aged 28, Diagnosed eighteen months ago, 
recruited from epilepsy nurse specialist clinic 
The following quotation illustrates that participants found that the nurses also offered 
a source of ongoing social support and information to help them come to terms with 
living with epilepsy:  
She (the nurse) puts your mind really at rest because I was thinking: “Well I‟m 
going nuts!  You know I‟m gonna be in straight jacket and a padded cell 
soon!”  She puts you totally at ease … Any queries we‟ve got no matter what 
they are we can phone the nurse to have a chat with her.  She‟s brilliant like 
that!  I thought I was the only person in the world … and she made me feel 
like: “Well I‟ve got two hundred and forty patients (with epilepsy) so what the 
hell are you worrying about?”  It does help. 
Interview 32, tu: 42, Male, Aged 52, Diagnosed eight years ago, recruited from 
epilepsy nurse specialist clinic  
Due to the difficulties some had encountered in disclosing to others, participants 
suggested that being advised on disclosure by medical professionals, at the point of 
diagnosis would be valuable: 
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When you first get told you‟re a diabetic that would be the time to tell you how 
to approach somebody about telling them you‟ve got diabetes … You think: 
“Well how do I tell somebody? … For me it‟s a big thing!” but for them it‟s 
nothing because they don‟t have to deal with it! I do!  
 Interview 26 tu: 275, Female, Aged 21, Diagnosed eleven years ago, recruited 
from young adult diabetic clinic 
Some sought greater guidance from health care professionals: 
It would be useful if they did say to people:  “Well actually this is how you 
could broach it.” … They could say: “Well actually here‟s some leaflets 
specially designed … for relatives or friends, or … some guides that you can 
give to employers.” 
Interview 33, tu: 107, Female, Aged 28, Diagnosed eighteen months ago, 
recruited from epilepsy nurse specialist clinic 
A similar point was raised by one young man attending the epilepsy nurse specialist 
clinic who stated simply: 
I wish I could just hand „em a piece of paper that explains it all!  
Interview 31, tu: 141, Male, Aged 32, Diagnosed twenty-one years ago, 
recruited from epilepsy nurse specialist clinic  
The burden of disclosure would then be removed from the discloser and the 
necessity of having to reveal personal details. 
5.41 Discussion of The Role of Information and Disclosure 
Issues emerged for those newly diagnosed in particular with the condition in terms of 
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seeking information. Others have argued that people living with epilepsy need more 
information at the point of diagnosis (Prinjha et al, 2005) and a randomized 
controlled trial illustrated the benefits of the provision of information to those newly 
diagnosed with epilepsy via nurse specialists (Ridsdale et al, 2000). 
Nurses offered a much needed source of information regarding medication issues 
and an ongoing source of support for participants across both conditions attending 
the clinics.  However, more information on methods of disclosing to others was 
raised as a key issue, particularly for those newly diagnosed.  Many highlighted that 
nurses would be well placed to offer this information.   
Being a member of a patient support group appears to alleviate feelings of isolation 
and feelings of burden through the process of talking to others with the same 
condition.  The data has highlighted that many participants chose to join patient 
support groups where they felt accepted and free to disclose within a safe 
environment.  This section identified that younger interviewees from the nurse 
specialist clinic did not typically feel comfortable attending patient support groups.  
In contrast, participants recruited from the patient support groups who had lived with 
the condition for longer had changed their mind about the need to be with others in 
the same situation.  Those who were recruited from the nurse specialist clinics were 
not regular attendees at patient support groups.  Thus group settings are not 
appropriate for all living with a long-term condition.  However they did cite 
information needs, around the process of disclosure.  Attendees highlighted that 
nurses provided valuable ongoing support regarding medication issues as well as 
social support.  The benefits of nurse specialists in epilepsy and diabetes as well as 
other conditions have been reported elsewhere (New et al, 2003, Ridsdale et al, 
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2000, Daly and Carnwell, 2003).  Participants also felt that nurses are well placed to 
offer specific information needs particularly for those newly diagnosed.  A point 
illustrated in a study of epilepsy nurse specialists (Ridsdale et al, 2000).  The 
question of gaining information and support from medical professionals about how 
to go about disclosing one‟s medical condition emerged.  The nurses as a point of 
contact therefore played a dual role of offering both medical and social support and 
reduced feelings of isolation of living with the condition.  Having information in the 
form of health education leaflets was felt to be vital in that they could serve to 
alleviate the perceived burden of disclosure. 
I now go on to set out the conclusions to the study findings.  
5.42 Summary and Conclusions   
In conclusion the decision to disclose is not straightforward as there are a number of 
mediating issues to be taken into account aside from stigma as has been the prime 
focus of previous studies (Goffman, 1963, Schneider and Conrad, 1980, Troster, 
1997).   
This study has provided insight into six key elements from which a conceptual 
framework of disclosure has been developed.  This framework is set out and 
discussed in detail in the following chapter (chapter six).  
The six key elements are:  
Firstly, the findings having provided insight into the nature of disclosure, 
illustrating that participants viewed health status as personal and so disclosure has to 
play a functional role.  Secondly, the findings have provided greater insight into the 
process of disclosure, illustrating that it may occur in a broad range of ways, not 
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only directly (verbally) but indirectly (visibly through acute episodes, injecting, 
dietary restrictions, “objects” associated with the management of the condition).   
This study has also provided insight into the process of non-disclosure, the means 
by which participants actively concealed their condition such as concealing the 
biomedical aspects of managing the condition.  Thirdly, the study revealed that the 
context of disclosure is an important issue which participants raised when 
considering to whom to disclosure: three settings were identified: friends and family, 
partners and the workplace.  Fourthly, this study has identified mediators of 
disclosure, illustrating a range of factors taken into account when disclosing: 
personal, previous experiences of disclosure, fear of stigma, medical control, 
acceptance of the condition, planned/unplanned, temporality visibility, context, 
denial.  Fifthly, this study has provided insight into the role of disclosure in 
managing a long-term condition.   
This study identified three predominant roles for disclosure illustrating that 
disclosure is a key concept in the lives of those living with long-term conditions: (1) 
access to Self-care and Social Support: enabling participants to manage their 
condition medically in terms of self-care and gaining social support.  An 
important finding of the current study is that perceptions of disclosure are not 
necessarily “fixed” but subject to change over time, as participants “learned about 
disclosure”.  For example the current study identified a shift from participants 
recruited from the patient support group who previously had adopted the strategy of 
(2) non disclosure: concealment of the condition to protect one’s identity from 
stigma) towards choosing to disclose to others in advance (3) strategic disclosure: 
redressing myths about the condition in advance to avoid perceived stigma.  
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Finally this study has provided insight into the role of disclosure in relation to Living 
with a long-term condition, illustrating that learning about disclosure is a key 
element of living with a long-term condition the overarching challenges of living 
with a long-term condition; enduring, managing the medical, managing the social 
elements of the condition such as identity, living with limitations, managing 
disclosure “who needs to know”, “learning about disclosure” over time moving from 
personal perception of disclosure as “my problem” towards it being others‟ problem 
“their problem.” 
The next chapter presents an in-depth discussion of the study findings taking into 
account the broader literature and policy and practice implications.  The process of 
disclosure and non-disclosure, mediating issues around disclosure, and the role of 
disclosure in the lives of those living with epilepsy or type 1 diabetes are discussed.  
The three roles identified are set out in the discussion.  The conceptual framework of 
disclosure is further discussed in the following chapter (Chapter six).  
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6.0 Chapter Six: Discussion and Conclusions 
6.1 Introduction 
Part One of this chapter, discussion of the study findings, discusses the study 
findings in relation to the literature and broader policy and health care agenda.  It 
sets out the nature of disclosure; mediating issues around disclosure; the role of non-
disclosure; three roles of disclosure; the process of learning about disclosure; 
disclosure in the context of the workplace; the role of information, and the 
conceptual framework of the role of disclosure. 
Part Two of this chapter, study reflections, implications and conclusions, sets out 
the lessons learned from the process of conducting the study and reflections on the 
process of adopting the methodology constructivist grounded theory (Charmaz, 
2006).  It also presents the implications of the study findings for health care practice; 
policy and education, and future research.  Finally, the summary and conclusions of 
the thesis are presented. 
6.2 Part One: Discussion Of The Study Findings 
6.3 Introduction 
This section discusses the study findings in relation to the existing literature 
concerning the nature of disclosure.   
6.4 The Nature of Disclosure  
The study findings suggest that for many people disclosure of a health condition 
involves the divulgence to others of what is considered very personal information.  
This finding is supported by other studies which have also argued that disclosure of 
one‟s health status is regarded as highly personal (Charmaz, 1991, Beatty, 2004).  
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Similar findings have emerged within the discipline of psychology illustrating that 
disclosure is a process which reveals something personal: of the “self” (Jourard 
1971, Derlerga 1979, Rosenfield 2000).   
However, I found that not only does disclosure of having epilepsy or type 1 diabetes 
constitute divulging personal details, as others have argued, this study further 
illustrates that specifically due to the personal nature of disclosure and notions of 
personal and public boundaries there had to be a clear reason for disclosing, 
therefore it must play a specific role for the individual.  In contrast, existing studies 
have tended to focus on the role of disclosure in relation to management of stigma 
(Goffman, 1963, Scambler and Hopkins, 1980, Troster, 1997, Green and Sobo, 
2000).  Yet, this study illustrates that disclosure plays a much broader role.  I go on 
to later discuss the diverse roles which disclosure plays as identified in this study.  I 
would argue in this study that the nature of disclosure is a personal matter and so the 
context of disclosure is deemed extremely important to participants.  Therefore, 
indiscriminate disclosure was considered inappropriate, a point also made by 
Pennebaker (1990) whose work emphasises the problems of disclosing to the „wrong 
person‟.  In the next section I go on to discuss the study findings in relation to the 
existing literature regarding what is disclosure and the diverse nature by which 
disclosure may occur.  
6.5 What is Disclosure? The Process of Disclosure  
In this section firstly I discuss how disclosure occurs in the form of self-care, 
secondly I discuss how the process of self-care itself often becomes a trigger for 
disclosure, and thirdly I discuss how disclosure is therefore a process which is 
difficult to control.   
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6.6 Visibility and Self-Care 
This study found that the process of self-care itself constituted forms of disclosure.  
For example, people living with type 1 diabetes injected insulin, or took medication 
in the case of participants living with epilepsy.  Also attending a patient support 
group; managing dietary restrictions; or wearing a medical alert bracelet constituted 
a form of disclosure.  This finding has extended current research concerning the 
visibility of a long-term condition by illustrating that it does not only include the 
visible symptoms of the condition as others have argued (Joachim and Acorn 2000, 
2003).  The necessity of maintaining daily treatment regimes against a backdrop of 
feelings that disclosure is highly personal raised a number of dilemmas for 
participants, notably the fear of bringing personal issues into the public domain.  
This was particularly the case for younger participants who were “learning about 
disclosure” through others‟ reactions.  This study‟s extension of what constitutes 
“visibility” of a long-term condition is a key point because it broadens understanding 
of how disclosure occurs and thus greater insight into potential difficulties 
concerning managing decisions around the timing of disclosure.  For example 
existing research has argued that disclosure decisions are made in terms of the 
physical symptoms of visibility or invisibility of a long-term health condition 
(Joachim and Acorn 2000, 2003).   
The findings identified that “triggers” or “opportunities for disclosure” frequently 
emerged in the lives of those living with epilepsy or diabetes and decisions had to be 
made about how to respond which I now go on to discuss.  
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6.7 Self-Care: Triggers for Disclosure 
Triggers for disclosure were often linked to the process of self-care or were 
manifested in others‟ “questions”.  For example, those living with epilepsy cited that 
being asked routine innocuous questions such as: “do you Drive?” offered an 
opportunity to disclose because many were not permitted to drive due to having the 
condition.  Similarly, opportunities for disclosure emerged for those living with type 
1 diabetes when responding to questions from others which linked into the self-care 
of their condition, such as, being offered cake, and having to refuse and explain that 
this was because they had type 1 diabetes, or in the case of university students, 
responding to questions as to why they had a fridge which stored their insulin in their 
university room.  These examples of opportunities for disclosure extends current 
research on unplanned “spontaneous disclosure” by illustrating it occurs during 
everyday life as well as after having received particularly bad news about the 
condition.  In her study of people living with long-term conditions Charmaz (1991) 
defined spontaneous disclosing as follows: “Full expression of raw feelings, open 
exposure of self, and minimal or no control over how, when, where, what, and whom 
to tell.  People spontaneously disclose when they receive startlingly bad news or 
perceive dramatic changes” (p.119).  The current study showed spontaneous 
disclosure occurred in a much broader range of situations.  The range of potential 
ways in which disclosure may occur as identified by the participants, highlights that 
it is not always possible to plan disclosure in advance which I now go on to discuss.  
6.8 Control over Disclosure 
As stated earlier this study revealed that unplanned disclosure did not only occur 
through having an acute episode such as an acute hypoglaecaemic episode, or 
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epileptic seizure.  In contrast other studies have argued that it is possible to control 
disclosure by making “strategic decisions” based upon the potential visibility of the 
condition and so decisions are therefore linked to perceptions of “medical control” 
and stigma as a result of “visibility” (Goffman, 1963, Schneider and Conrad, 1980, 
1981, Charmaz, 1991, Joachim and Acorn, 2000).  Furthermore, Goffman (1963) 
refers to, “the discredited and the discreditable” suggesting that disclosure decisions 
are primarily linked to the visibility of the condition and subsequent stigma.  He 
argues there is therefore a decision to be made concerning disclosing information to 
others or not: “To display or not to display; to tell or not to tell; to let on or not to let 
on; to lie or not to lie; and in each case, to whom, how, when, and where”(Goffman, 
1963, p.57). 
Yet this study has identified a diversity of opportunities for disclosure, thus 
illustrating that adopting anticipatory strategies concerning when to disclose may be 
difficult to employ.  However, research in the field of epilepsy has argued that 
stigma may be avoided by adopting the concept of “preventive telling” which 
constitutes: “purposeful mention of their disease” (Troster, 1997, p1228).  
Furthermore, Charmaz (1991) has also argued that those living with long-term 
conditions may employ strategies of: “protective disclosing:” the purpose of which 
is:“to control how, what, when, and who people tell about their illness” (p.119) this 
therefore also suggests that disclosure is possible to plan.    
Other studies of those with “invisible” symptoms have argued that as a consequence, 
individuals have a choice whether or not to disclose because they appear “normal” to 
others (Joachim and Acorn, 2003).  However, such strategies do not take into 
account that disclosure may occur through ways of managing the condition as 
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identified in the current study.  The data illustrated that the process of disclosure and 
therefore the role of disclosure is broader than Goffman‟s (1963) term “information 
management” suggests.  This is a key finding of the current study as many studies on 
disclosure have subsequently employed this term (Schneider and Conrad, 1980, 
Admi, 1995, Green and Sobo, 2000, Troster, 1997, Joachim and Acorn, 2000).  For 
example, Schneider and Conrad (1980) refer to the link of “managing information” 
to controlling the stigma associated with the condition epilepsy.   
Whilst stigma did emerge as a significant factor in the mediating of decisions to 
disclose or not disclose, this study identified that participants took a broader range of 
issues into account which I go on to discuss in the next section. 
6.9 Mediating Issues around Disclosure  
This section presents a discussion of the range of issues which emerged as important 
in decision making concerning disclosure which I have termed: “mediating issues”.  
These include: the challenges of living with a long-term condition, health status, 
identity and disclosure.  I then go on to discuss the relationship between disclosure, 
stigma and self-care.  
6.10 Challenges of Living with Long-term Conditions 
Being diagnosed with epilepsy or diabetes does not simply have medical 
implications but also important social implications such as stigma (Troster, 1997, 
Eisenberg, 2007, Gabe et al, 2004, Tak-Ying Shiu et al 2003).  This was supported 
by the current study, where not only did participants have to manage the new status 
as a “person with diabetes” or “a person with epilepsy” and the biomedical regimes, 
they also had to manage the social implications of the conditions, including dealing 
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with stigma.    
Participants across both conditions highlighted the challenges of living with a long-
term condition not only in terms of the “medical implications” of the condition but 
also the social implications as Bury et al (2005) have argued.  Participants revealed 
that, the moment of being diagnosed represented an emotional impact which had a 
subsequent negative effect upon their identity.  Those newly diagnosed with diabetes 
described feeling “overwhelmed by the disease” supporting Paterson‟s (2001) 
findings.  For example, the interviews with younger participants revealed that the 
prospect of facing an ongoing process of daily management was perceived to be a 
burden.  This also supports the work of Bury (1982) who has referred to this as 
“biographical disruption” and Charmaz (1983) who has referred to it as “loss of 
self.” 
The data suggest that those who are younger find the process of disclosure difficult, 
as they cited problems in coping with the symptoms of the condition and the 
enduring suffering due to feelings of difference to others, and all of this in addition 
to the negative reactions of those to whom they disclosed.  The responses of others to 
the disclosure of the condition played a key role in terms of not only their views on 
disclosure but in turn upon their perceptions of living with the condition and thus 
their identity.  The current study builds upon existing work on identity because it 
illustrates that the process of self-care appears to play a potentially burdensome role 
on the person‟s identity.  For example, tensions between managing the condition and 
the ongoing enduring nature of having diabetes while seeking to have a “normal” life 
were highlighted in the data and support Paterson et al‟s (1998) work which refers to 
the process of “learning to balance.”  There is sometimes considerable tension 
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between the medical discourse of seeking to control one‟s blood sugar and an 
individual‟s goal of having a balanced life (Paterson, et al 1998).  Many participants 
found the unpredictability of the condition difficult to come to terms with and again 
this appeared to play a role in decision making around the timing of disclosure.  
Issues of acceptance and denial also played a key role in coming to terms with being 
diagnosed with a long-term condition and are perceived as important when 
complying with their treatment regimes or not.  This finding supports the work of 
(Telford et al, 2006) who has argued that when those living with long-term 
conditions do not adhere to treatment regimes they may be criticised by health care 
professionals as being “in denial.”  In contrast they argue the need for health 
professionals to take into account: “the wider social context of people‟s lives as well 
as the medical aspects” (p458).  This underlines the importance of taking 
psychosocial issues into account in the lives of those living with long-term 
conditions as difficulties in accepting the condition appear to play a role not only in 
terms of concordance to treatment regimes, but furthermore in terms of challenges 
around disclosing to others (Markinker and Shaw, 2003, Medicines Partnership, 
2008).  This finding builds upon the work of Telford et al (2006) by illustrating that 
disclosure issues are another aspect to take into account when considering 
concordance to treatment regimes (Markinker and Shaw, 2003, Medicines 
Partnership, 2008).  I now go on to discuss the relationship between health status, 
identity and disclosure.  
6.11 Health Status, Identity and Disclosure  
Disclosure had profound implications for participants‟ identity because it potentially 
led to what others have referred to as a “double stigma”: not only are they revealing 
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they have a long-term condition, they are reliant on others‟ perceptions of the 
condition which may be positive or negative (Green and Sobo, 2000).  Others‟ 
responses were often deemed to be negative which in turn reinforced, “being 
epileptic” or “being diabetic” as a negative identity.  This finding supports 
psychological literature which has argued that disclosure is strongly linked to 
identity issues because it represents a: “verbal message about the self” (Derlega and 
Grzelak, 1979, p60).    
The ongoing nature of both conditions was identified in the data as was the suffering 
which many endured.  Difficulties around controlling the condition tended to affect 
how participants perceived the condition.  Those whose condition is less controlled 
found that it had a greater impact upon their daily life.  Younger participants 
described the ongoing process of daily management to be a burden that affected not 
only themselves, but also their families and partners.  A similar point was found in 
Dovey-Pearce et al‟s (2007) study on young people with diabetes.  It is clear that 
those living with a long-term condition must not only cope with the biomedical 
diagnosis but with the social implications and potential changes in family and 
relationship dynamics and it takes time to learn how to cope with these changes.  I 
now go on to discuss the relationship between disclosure, stigma and self-care.  
6.12 Disclosure, Stigma and Self-Care: What is the link? 
A link between disclosure, stigma, self-care and subsequent potential negative 
effects upon health status was identified.  Many perceived the process of self-care as 
a means by which they risked being “discredited” (Goffman, 1963).  This had 
implications for practical self-care issues.  For example, those living with type 1 
diabetes highlighted the difficulties they faced around the process of injecting insulin 
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due to others‟ reactions.  Negative associations around injecting any form of drugs 
led, they felt, to some people judging them and possibly branding them as “illicit 
drug users.”  Such references are more frequently found in studies of HIV/AIDS than 
diabetes (Green and Sobo, 2000).  This finding suggests that current understanding 
of what constitutes a stigmatised long-term condition is arguably broader than may 
be assumed since this study has identified that the person living with the condition 
may become stigmatised through the process of managing the condition itself.  The 
current study argues that the concealment of the self-care processes of a condition, 
subsequently impacts on the individual‟s health status.  In this study, disclosure for 
many younger participants was perceived as an additional burden, due to perceived 
negative responses such as being stigmatised.  These findings provide additional 
insight into the role of disclosure, and concordance, as patients may choose not to 
follow medical advice from health professionals because it conflicts with their desire 
to keep their condition private.  This supports the work of Kyngas and Hentinen 
(1995) who found that younger people with diabetes have difficulties complying 
with their treatment regime because of their fear of stigma.  This has also been 
identified in a small study of people with diabetes in Hong Kong (Tak-Ying Shiu et 
al, 2003).  In this study participants did not wish to disclose because they felt that 
they would then only be known by “the condition”, rather than as the person who 
also happens to have a long-term condition.  Participants were concerned that others 
may treat them differently, or even be fearful of them.   
The findings provide insight into the issues of stigma raised by those living with type 
1 diabetes since there is relatively little research on the link between type 1 diabetes 
and stigma, compared to epilepsy which is strongly associated with stigma 
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(Schneider and Conrad, 1980, Scambler and Hopkins, 1986, Troster, 1997, 
Eisenberg, 2007).  Although stigma appears to be a key element which may mediate 
decisions to disclose, this focus on particular “stigmatised” groups has limited the 
generalisability of the findings of such studies.  Disclosure as a concept appears to be 
of relevance across a broader spectrum of long-term conditions.  In this study, 
simply having a long-term condition led many to feel “different” to others, as 
Goffman, (1963) and Gabe et al, (2004) have argued.  However, questions of stigma 
appeared to affect in particular younger people; a distinction which is not always 
recognized in other studies (Goffman, 1963, Joachim and Acorn, 2000).   
6.13 Learning about Disclosure: Disclosure and the Role of Time  
Findings concerning responses to the disclosure illustrated that participants drew 
upon previous experiences of disclosure and had adopted strategies of disclosure or 
concealment accordingly: a process I have referred to as “learning about disclosure.”  
Existing studies in the field of disclosure research typically refer to a lack of 
certainty concerning others response to the disclosure, describing it as “a double 
edged sword:” whilst it may result in support, it comes at the cost of disclosure 
which may lead to stigma and discrimination (Williams and Healy 2001, 
Pennebaker, 1990, Fesko, 2001).  
I now go on to discuss one of the three roles of disclosure identified in this study: the 
role of non-disclosure, the purpose of which was to avoid being stigmatised and 
which was typically adopted by younger participants recruited from the nurse 
specialist clinics.  
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6.14 Clinical Nurse Specialist Clinic Findings: The Role of Non-disclosure: 
Avoiding Stigma 
This section presents a discussion of the role of non-disclosure: avoiding stigma.  I 
then go on to discuss the process by which participants concealed their condition: the 
process of non-disclosure and finally the rationale for non-disclosure.  
Overall, it was striking that younger participants often chose not to disclose in order 
to maintain “normality” and avoid being stigmatized.  Those recruited from the nurse 
specialist clinics were typically younger and tended to adopt strategies of non-
disclosure through concealment of their condition.  The concepts of concealment of 
long-term conditions have been identified in other studies (Goffman 1963, Schneider 
and Conrad, 1980, Charmaz 2002, Sandelowski et al, 2004).  This study extends this 
work by illustrating that such strategies are not necessarily “fixed” but rather appear 
to be dynamic and subject to change over time.  I now go on to discuss the process of 
non-disclosure: the means by which participants attempted to hide their condition.  
6.15 The Process of Non-disclosure 
For those who anticipated unwanted or negative reactions to disclosure, the findings 
have illustrated the means by which they sought to conceal their condition.  For 
example, some participants living with type 1 diabetes described the process of 
concealing their condition by injecting their insulin in a place where others could not 
observe such as the public toilets in a restaurant. Others described how they chose 
not to carry their insulin needles with them on a social evening to a nightclub for fear 
of a bag search when they felt they risked being unfairly labelled as an illegal drug 
user. Some living with epilepsy described how they “took a gamble” by not telling 
others that they had the condition as they did not wish to be excluded from 
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participating in certain activities which others may judge to be “too risky” for them. 
This process of hiding something discreditable has been referred to by Goffman 
(1963) as “passing”, the intention of which is to remain part of the “normal” group.  
This appears to be linked to living with a condition which is unpredictable and 
weighing up the consequences of non-disclosure to be overall more beneficial than 
choosing to disclose.  In the current study some participants did disclose but 
explained that their epilepsy was “controlled.”  Goffman, (1963) has referred to this 
process of not concealing the condition completely but attempting to minimise its 
importance as “covering”.  
I now go on to discuss participants rationale for choosing to conceal their condition, 
illustrating that such decisions stemmed from prior perceived negative responses to 
disclosure.   
6.16 The Rationale for Non-disclosure 
Participants in the current study revealed that for those who had experienced 
negative or unwanted reactions to disclosure, the role of non-disclosure constituted 
an important tool in the management of a long-term condition, a point also made by 
Charmaz (2002).   
Participants in this study recounted that epilepsy has long been associated with 
negative historical beliefs and such perceived stigma associated with epilepsy was a 
barrier to disclosure.  This finding extends existing research on stigma and epilepsy 
as it illustrates stigma was not only based upon negative historical beliefs but also 
upon others visual images of what epilepsy “looks like” (Eisenberg, 2007, Scambler, 
1989).   
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The study findings highlighted that a common response to disclosure was that others 
had strong “visual” images of what people with either epilepsy or diabetes might 
“look like”.  For example a diabetic would be overweight or an epileptic would 
“froth at the mouth.”  Sometimes this led others to question the validity of their 
disclosure as they stated: “you don‟t look like an epileptic.”  This finding taps into a 
broader discussion on the stereotyping of certain illnesses in terms of what someone 
with the condition “looks like” (Peters, 2008).  This illustrates that such difficulties 
are not only confined to conditions such as epilepsy but other long-term conditions. 
The current study also found that inaccurate public perceptions of the causes of 
diabetes emerged as a key element in decisions to disclose or not disclose.  
Participants in this study felt that type 2 diabetes has a higher public profile than type 
1 diabetes.  When they disclosed their condition they felt that responses were based 
on the perceptions of type 2 diabetes as being linked to an unhealthy lifestyle and so 
having the condition was deemed to be “their fault.”   
Participants across both conditions sought to explain that having the condition was 
not their “fault”, a process also identified in a study of those living with lung cancer 
(Ziebland et al, 2004).  The perceptions of the lack of information amongst the 
general public on both conditions resulting in negative reactions, led to the discloser 
having not only to disclose their condition, but also having to dispel “myths” around 
the conditions.  This point has been raised in other studies on epilepsy (Beatty, 
2004).  For example in the current study they cited that upon disclosing a frequent 
response was being asked “the same questions.”  Such perceived negative reactions 
led many to avoid the process of disclosure altogether, particularly younger people 
as they felt not only did they firstly have to disclose the condition but secondly they 
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then had to go on to respond to questions about the condition and “educate” others as 
to the implications of living with the condition.  For the participants such reactions 
constituted a “double burden” because the condition was long-term and therefore 
such negative reactions to disclosure were potentially ongoing and to be avoided 
where possible.  
The lack of public campaigns about epilepsy and the lack of high profile role models 
with the condition was raised by participants in this study. This supports existing 
work which argues that there is a link between public disclosure and public 
understanding of the condition and stigma because despite many people living with 
the condition, epilepsy in particular does not have high profile and is often “a hidden 
condition” (The All Party Parliamentary Group on Epilepsy, 2007).  This study 
found that participants discussed the need for more public education because in their 
view it could assist both the discloser and those to whom they disclose thus reducing 
the burden.  This supports the need for a programme of education in schools and the 
workplace on Epilepsy as suggested by The All Party Parliamentary Group on 
Epilepsy Report (2007).  As stated earlier the high profile given to type 2 diabetes 
conversely led to a lack of understanding of the hetereogeneity of the condition 
which impacted on participants decisions to disclose type 1 diabetes.  
Disclosure to others and receiving a perceived negative response has a potentially 
negative impact upon participants‟ emotional health.  This finding contrasts with 
studies which have argued that not disclosing illness to others may have a negative 
impact on the individual with the illness.  For example, psychological studies by 
Pennebaker et al (1986, 1988,1990) have argued for the beneficial elements of 
disclosure and this does not take into account that negative reactions to disclosure 
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are equally possible and may include a negative impact upon health, such as stigma, 
discrimination and “feeling judged.”  Charmaz (1983) has referred to the impact of 
living with a long-term condition as constituting “loss of self.”  In this study I am 
building upon this concept by arguing that the act of disclosure itself may contribute 
to “loss of self” because negative responses have a strong impact upon issues of 
identity in the lives of those with a long-term condition.  Studies on non-disclosure 
of long-term conditions in the literature have predominantly focused on potentially 
transferable long-term conditions such as HIV (Sandelowski et al, 2004, Green and 
Sobo, 2000).  Whilst this is helpful it has left a gap in understanding in terms of 
perceptions of disclosure of non-transferrable conditions such as epilepsy and 
diabetes.  The debates around non-disclosure are typically linked to moral and legal 
debates linked to the health implications of non-disclosure for “others” rather than 
the impact of others on the non- discloser (Edward Rutledge, 2007, Marks et al, 
1991, Smeon and Crosby, 2004, Green and Sobo, 2000).  The impact of non-
disclosure could have implications for the non-discloser‟s health status in the event 
of an acute episode: others may then not know what is wrong with on the individual 
or how to help.  An additional difficulty identified in this study was that due to not 
disclosing their condition some people had a limited source of social support.   
Having discussed reasons for non-disclosure or “who doesn‟t need to know”, I go on 
to discuss the process and rationale by which participants identified “who does need 
to know?” and the role of disclosure in this context.  
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6.17 The Challenge of Disclosure: “Who Needs to Know?” and Why? 
6.18 The Role of Disclosure: Access to Self-care and Social Support 
In this section I discuss the challenge of disclosure: “who needs to know?”  I discuss 
disclosure of long-term conditions to friends and family or partners and the intended  
role of disclosure in this context.  I go on to discuss the second role for disclosure 
identified in the current study (across both recruitment settings and conditions), the 
purpose of which was to access to Self-care and Social Support.   
In this study it became clear that participants did make decisions about to whom to 
disclose.  They frequently referred to the process of disclosing to those who „need to 
know‟ about their condition.  Typically decisions concerning “who needs to know?” 
are characterized by disclosure having a “role” and illustrates an anticipatory form of 
disclosure.   
Verbal disclosure is a key process which enables participants to manage their 
condition medically in terms of self-care and in gaining social support.  For example, 
the data suggest that those living with epilepsy experienced difficulties around the 
unpredictability of the condition.  Existing studies which have explored the social 
aspects of epilepsy have described how an unpredictable condition which requires an 
explanation is associated with fear (Trostle, 1998).  This suggests in this context that 
the role of disclosure is concerned with minimising fear and a sense of burden in 
others (Charmaz, 1991).   
6.19 Who needs to know? 
The concept of “who needs to know?” also emerged as a particularly important 
question for those living with type 1 diabetes because those around them often 
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played a key role in assisting with the management of the condition.  Family 
members and partners typically performed the role of “rescuers” in the event of a 
hypoglycaemic event and acted as “back up” to the person with diabetes by looking 
out for potentially dangerous signs of the condition.  This confirms Paterson, et al‟s 
(1998) findings of the importance of “allies”.  Other studies also suggest that the role 
of disclosure may be to garner support from others and that having a condition 
affects not only the person but those around them (Charmaz, 1991, Williams and 
Healy, 2001).  Participants felt that when others knew about their condition, they 
would be able to “help them” thus reducing the psychosocial impact of managing the 
condition themselves. Social support may play a positive role in one‟s physical and 
emotional health (Wang et al, 2005).  It seemed important that they were not “alone” 
with the condition and the majority of participants stated that their friends and family 
knew about their condition. This was reflected in the current study and indeed the 
majority of participants stated that they felt “protected” by their friends or family.  
There was a link between those whom they saw frequently and those who knew 
about their condition.  In this context, disclosure appears to play a “dual role” not 
only for the person “to whom they disclose”, but also for the discloser.  Firstly, 
because disclosing reassured the discloser that others “would know what to do” in 
the event of an acute episode and secondly, because those to whom they disclose 
were generally grateful that they had been told stating that they would rather know in 
advance.  The findings concur with studies in the field of psychology which state 
that responses to disclosure are more likely to be beneficial if they assume a positive 
response (Pennebaker, 1990).  
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There also appeared to be a clear distinction between disclosing to friends and family 
and people outside of this circle who were deemed to be more “risky.” This supports 
other studies which have linked “who needs to know?” to issues of risk.  For 
example, Lowton‟s (2004) study of disclosure of cystic fibrosis which has linked the 
setting of disclosure to varying levels of “risk.”  Risk she claims is linked to levels of 
intimacy such as how well they know the person and also to an assessment of the 
potential implications of non-disclosure including “low risk situation,” “medium risk 
situation” and “high risk situation” (Lowton, 2004).  Furthermore, Green and Sobo 
(2000) identified the term “who needs to know?” in a study of disclosure of 
HIV/AIDS to be linked to perceptions of the intimacy and goal of the relationship. 
The findings of the current study suggest that the term “who needs to know?” might 
be transferrable to other long-term conditions.   
6.20 Disclosure to Partners  
Younger participants raised the issue concerning the challenge of disclosing their 
condition to their partners during the initial stages of the relationship.  In this setting 
fears were expressed around how a potential partner would react to the disclosure.  
Many feared a negative reaction and felt that the timing of the disclosure was crucial.  
This illustrates the key role which partners play in the management of a long-term 
condition and how the condition can become “disruptive” (Bury, 1982).  Earlier 
work in the field of psychology suggests liking someone makes one more likely to 
disclose to them (Jourard, 1971).  
In the next section I discuss the findings from the patient support group participants 
and illustrate how perceptions of disclosure may change over time as they appear to 
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be linked not only to perceptions of identity of living with the condition but also 
perceptions of the medical management of the condition.   
6.21 Learning about Disclosure and the Role of Time  
6.22 Patient Support Group Findings  
In this section I discuss the process of “learning about disclosure” over time 
illustrating how over time shifting identities can lead to shifting views on disclosure.  
Finally I discuss the patient support group findings illustrating how over time they 
had changed from no disclosure towards adopting strategic disclosure.  This is the 
third role of disclosure identified in the current study the aim of which is to disclose 
in advance to others and so redress myths about the condition in advance.  
The study findings suggest that time plays a key role in disclosure and thus “learning 
about disclosure” is an important process.  Views on disclosure appear to mirror the 
varying changes in both medical and social perceptions of the condition.  Learning 
about disclosure appears to be part of the process of adapting to and living with a 
long-term condition: the process of adaptation or life transitions over time.  
This finding is supported in the work of Charmaz (1983) who refers to the role of 
time and living with a long-term condition, thus describing the changing nature of 
the condition.  As both conditions under study are long-term, decisions around 
disclosure are also long-term and therefore enduring.  Disclosing is as Charmaz 
(1991) suggests, an ongoing, indeterminate process.  However, this study found that 
participants adopted strategies of disclosure were not necessarily “fixed” but diverse, 
situation specific and subject to change over time.  The data identified that feelings 
may change over time as participants recounted a process of adjustment to living 
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with the condition (Sharpe et al 2006, Paterson, et al 1998) and further supported by 
Paterson (2001) who discusses the “shifting perspective model of chronic illness”.   
6.23 Shifting Identities, Shifting Views on Disclosure  
The data illustrate that changes in the identity in the lives of those living with either 
epilepsy or type 1 diabetes are linked to their views on whether to disclose their 
condition to others or not.  Studies have argued that long-term conditions do pose 
challenges to the identity of those living with long-term conditions which are 
typically deemed to be negative (Charmaz, 1983, Bury, 1982, Schneider and Conrad, 
1980, 1981).  In contrast this study suggests that a shift may occur from such 
negative perceptions of the condition towards a process of adaptation which is in 
turn linked to their likelihood to disclose or not disclose.  Studies within a 
sociological framework have argued that when living with a long-term condition 
changes in the perception of one‟s identity may occur as: “the person learns new 
definitions of self and often relinquishes old ones” (Charmaz, 1983, p170).  For 
example, I found that older participants had often changed their views on disclosure 
and were reportedly more open about their condition, compared to when they were 
younger (Paterson, 2001).  This change appears to be linked to shifting identities 
which in turn impact upon their views on disclosure (Paterson, 2001). 
Studies on young people living with diabetes have identified that perceptions and 
experiences of living with diabetes may change over time (Rasmussen et al, 2007, 
Dovey-Pearce et al, 2007).  For example Rasmussen et al (2007) refers to: “life 
transitions” in the lives of those living with diabetes and how the: “changing social 
and emotional conditions during life transitions have a major impact on their 
diabetes management” (p18).  Furthermore Paterson et al (1998) have referred to the 
 
229 
process of: “adapting to and managing diabetes” referring to the process of 
“learning how to manage diabetes.”  Changes in the process of managing their 
condition are they argue not fixed but rather dynamic and subject to change 
(Paterson et al, 1998, Thorne and Paterson, 1998).  
Those who were older tended to have expressed a sense of having adapted to or 
come to terms with the condition.  Paterson (2001) describes this as “wellness in the 
foreground” which facilitates a focus on things outside the illness (in other words 
their identity is not solely defined by the condition itself) compared to “illness in the 
foreground” which represents a focus on the condition itself.  This model of chronic 
conditions illustrates how perceptions and attitudes towards the condition may 
“shift” over time (Paterson, 2001).  
In this thesis changing perceptions of risk appeared to be linked to the participant‟s 
identity with regard to coming to terms with having a long-term condition and 
having negotiated disclosure over a period of time.  Other studies have also noted the 
transient and changing nature of what they refer to as the “risk assessment” 
associated with disclosure (Green and Sobo, 2000).  This perception of the changing 
nature of risk regarding disclosure was identified as participants reflected that they 
had negotiated reactions to disclosure over many years and “no longer cared” what 
others thought of them.  Thus they had learned “ways of managing the risks 
associated with disclosure” In some cases the way of managing this “risk” was to 
choose not to disclose to others.  As participants learnt about their condition, they 
appeared to be simultaneously learning about disclosure.  This focus upon disclosure 
as an additional process to take into account builds upon work on diabetes which has 
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argued that those living with diabetes tend to: “manage their diabetes by adapting to 
it rather than by coping with it” (Kelleher, 1988, p153).   
Whilst studies have referred to the process of adapting to or learning about their 
condition over time, the role of disclosure in this process is largely overlooked.  
However, in this study difficulties brought issues of disclosure to the forefront.  This 
finding is supported by the work of (Paterson, 2001) whose meta-study of qualitative 
research on long-term conditions led to the development of the shifting perspectives 
model of chronic illness this is defined as: “an ongoing, continually shifting process 
in which people experience a complex dialectic between themselves and 
their“world” (p23).  Disclosure sometimes led to additional feelings of “burden” or 
“suffering” and thus I argue may contribute to placing “illness in the foreground”.  
Studies of epilepsy have also identified a process of adaptation to the condition over 
time.  For example, Schneider and Conrad (1980) in their study of disclosure of 
epilepsy has referred to the process of “learning to be discreditable” as based upon 
others negative reactions to epilepsy.  Scambler and Hopkin‟s (1986) study of 
epilepsy have referred to a process of “coming to terms with stigma.” Glaser and 
Strauss (1967) referred to living with a long-term condition as an “illness trajectory” 
whereby the person goes through a number of different stages as the condition 
improves or gets worse.  Abram (1972) has referred to the psychology of chronic 
conditions as involving the need to adapt to: “long standing conflicts, adjustments, 
and psychosocial situations to which he must adapt” (p659).  Therefore the current 
study which has identified the process of learning about disclosure builds upon 
existing work in the field of long-term conditions.   The findings in this thesis have 
illustrated that learning about disclosure and specifically how to “manage” disclosure 
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appears to be a key part of living with a long-term condition.  Therefore disclosure 
taps into key concepts of living with a long-term condition identified in previous 
studies (Goffman, 1963, Charmaz, 1983,1991, Joachim and Acorn, 2000, Bury et al, 
2005).  These include stigma, self-care, invisibility, visibility as well as identifying 
information needs and it plays a key role in the process of learning to adapt to living 
with a long-term condition. 
In the next section I discuss the patient support group findings to illustrate the role of 
strategic disclosure: redressing myths about the condition in advance.  
6.24 Discussion of Patient Support Group Findings: The Role of Strategic 
Disclosure: Redressing Myths about the Condition in Advance  
In this section I discuss a third role of disclosure identified in the current study: 
redressing myths about the condition in advance.  This is a strategy that aims to 
disclose the condition in advance, in order to avoid perceived stigma and manage 
risks.  This study builds existing work on the concept of anticipatory “preventive 
telling” (Schneider and Conrad, 1980, Troster, 1997) through illustrating that such 
strategies are not necessarily fixed but may be subject to change over time.  This 
finding was particularly striking in the patient support group sample.  This study 
identified that those recruited from the patient support groups (across both 
conditions) who tended to be older and had lived with the condition for a longer 
period of time had also experienced stigma, but had adopted strategies of telling 
others in advance in an attempt to negate issues of stigma.  The role of the support 
groups in helping participants cope with stigma is further discussed in the following 
section of this chapter.  Within this context, once more the role of disclosing to 
others in advance was adopted in order to manage risks.  
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In the next section I discuss how participants sought out information about their 
condition, with particular reference to the role of the patient support groups and 
nurse clinics in the provision of information. I also go on to discuss information 
needs for those newly diagnosed and the timing of provision of information on 
disclosure. 
6.25 Disclosure and the Role of Information   
6.26 Sources of Information: The Internet  
Patient support group attendees were aware that younger people living with the 
condition did not typically attend the groups.  They reflected that the internet and the 
information which it contains on health conditions may be sufficient and thus explain 
why they did not attend.  This study did not find that younger participants used the 
internet as a key source of gaining information or as a means to discuss their 
condition with others despite studies that suggest that some young people use 
internet discussion groups regarding diabetes (Davison et al 2000, Zrebiec and 
Jacobson, 2001,  Rasmussen et al 2007).  
Younger participants recruited from the nurse specialist clinics emphasised that they 
did not wish to become members of patient support groups: some had attended in the 
past and found that the groups did not meet their needs.  They did raise similar issues 
to older participants including stigma and learning about the practical daily 
management of their condition.  Many younger participants cited that they did not 
feel the need to be with others with the same condition: they preferred to manage the 
condition by themselves.  It has been argued that the process of attending a patient 
support group may lead to an unwanted focus upon the illness: as in order to take 
part in group discussions, a focus upon the illness is required.  This process is a 
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further example of “shifting from wellness to illness in the foreground” (Paterson, 
2001).  This may explain why younger people do not wish to attend the groups as 
many did not see or wish their condition to be “in the foreground” (Paterson, 2001). 
However, an alternative explanation may lie in the study findings that not all 
participants from nurse specialist clinics were even aware of the patient support 
groups in their area.  A similar issue was raised by Krizek et al (1999) in a study of 
patient support groups for those living with cancer.  
6.27 Sources of Information: Nurse Specialist Clinics 
Participants from the nurse specialist clinics highlighted that nurses provided 
valuable ongoing support regarding medication issues as well as social support.  
Current evidence suggests specialist nurse clinics play a beneficial role in the 
management of diabetes (New et al, 2003), and information on epilepsy (Ridsdale et 
al, 2000).  Furthermore, the benefits of nurse specialists provision of information in 
comparison to general practitioners has been reported elsewhere (Daly and Carnwell, 
2003). It was however striking in the current study that interviewees reported that 
nurses did not routinely offer advice on disclosure.  Participants did gain some 
information on the issues of disclosure in the workplace, in terms of legislative 
issues but other social settings were not discussed.   
The timing of provision of information may be important as those who are newly 
diagnosed may have different needs to those who have lived with the condition for 
longer.  This may relate to issues around acceptance of the condition. It may 
therefore be useful to divide information to meet the needs of those newly diagnosed 
and those at a later stage (Breau and Norman, 2005).  From a practical perspective, 
nurses are well placed to offer advice regarding information needs for clinic 
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attendees, not only in terms of the medical management issues in their lives but also 
in terms of the social implications of being diagnosed with a long-term condition.  
Other studies have identified the benefits of nurse specialists in the provision of 
information to those newly diagnosed with epilepsy (Ridsdale et al, 2000).  Many 
participants suggested the development of health education leaflets to assist them in 
the process of disclosing may prove beneficial as it would remove the burden of 
continually having to explain the condition in detail to others on an ongoing basis. 
The implications of the findings for health care professionals are discussed later in 
this chapter.  
One of the key findings for those who attended patient support groups was the view 
that the group represented a “safe place” where others could “understand” their 
difficulties in a way that no one else could.  Many of the participants from the 
support group sample reported that they had experienced stigma and were aware 
there was a strong perception of stigma associated in particular with epilepsy.  This 
has been identified in other studies on epilepsy (Schneider and Conrad, 1980, 
Jacoby, 1994, Eisenberg, 2007).  The patient group performed the role of gaining 
social support and acceptance as well as learning more about medical management.  
This finding concurs with literature on social support which argues that those with 
living with similar conditions may be able to offer one another social support 
(Davison et al, 2000).  A similar finding emerged in a study of cancer and patient 
support groups (Taylor et al, 1986).   
In the next section I discuss the key findings of disclosure in the workplace setting. 
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6.28 Discussion of Key Findings on Disclosure in the Workplace 
Participants reported that the workplace was perceived as a particularly difficult 
context in which to disclose and supports other research which has referred to the 
work place as a: “high risk situation” (Lowton, 2004).  Previous studies have 
identified stigma associated with epilepsy in the workplace (Jacoby, 1994).  This 
study has provided insight into the rationale for disclosure and the rationale for non-
disclosure in the workplace, an area which has been neglected (Munir et al, 2005).   
“Learning about disclosure” emerged as a key process in terms of decision making in 
the context of the workplace.  Previous experiences of disclosure in the workplace 
were employed to make decisions as to whether and in what way the condition 
should be disclosed, a finding which supports the work of Lowton (2004) concerning 
cystic fibrosis.  In this study participants reported regrets over not disclosing in the 
workplace and reflected on times when having an unanticipated diabetic or epileptic 
episode became the form of disclosure.  Participants stated that in the future they 
would ideally disclose to their employers and co-workers in advance in order to 
minimise the shock to others of such acute episodes.  This changing view of 
disclosure decisions again illustrates the important process of “learning about 
disclosure” in terms of personal strategies to adopt in the future.  Conversely, other 
participants in this study believed that they had been discriminated against in the past 
because of their condition and would choose not to disclose in the future.  These 
findings suggest such strategies around disclosure or non-disclosure are not “fixed” 
but rather dynamic and subject to change based on what Green and Sobo (2004) term 
“risk landscapes.”  
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Health is typically considered to be a personal matter and this perception contributed 
to difficulties around the process of disclosure. This finding is supported in the work 
of psychological studies which have argued that disclosure is fundamentally a 
personal issue (Jourard, 1971), including in the workplace (Beatty, 2004).  This 
supports research which highlights that those living with epilepsy are more likely to 
be unemployed (The All Party Parliamentary Group on Epilepsy, 2007).  Indeed it 
has been argued that those living with long-term conditions are less likely to be in 
full time employment (Department of Health, 2008).   
Most participants in this study did disclose their condition in the workplace to their 
line manager.  However they often expressed frustration that their employer or co-
workers did not understand the implications of the condition on their working lives.  
This finding suggests that there may be different levels of disclosure and raises the 
question as to who is responsible for disclosure, in terms of what employers “need to 
know.”  For example in this study I found that participants often did not wish to 
“educate” others about the condition yet felt co-workers and employers should know 
more.  This frustration appeared to be compounded by the ongoing nature of 
disclosure for those moving jobs who found such negative responses to be an 
ongoing burden.  Munir et al (2005) has referred to the process of telling their line 
manager that they do have a long-term condition to be: “partial self disclosure”.  The 
study also identifies a second type of disclosure described as “full self disclosure” 
(Munir et al, 2005).  This refers to the process of the employee disclosing to the line 
manager in terms of explaining the implications of the condition and potential 
limitations of the condition upon their ability to do the job.  In the current study the 
data illustrates that younger participants found “full self-disclosure” difficult and 
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were often frustrated at employers‟ responses.  Those disclosing often did not see it 
as their role to go into detail as to the implications of the condition.  This raises the 
point that there may be different perceptions of the role of disclosure for the 
employee, when compared to the employer.   
For example, some felt unable to disclose that they would not be able to attend 
lunchtime meetings due to the need to eat at particular times and thus missed key 
meals.  Some younger participants cited that they had effectively struggled to daily 
manage their type 1 diabetes and difficulties around disclosure had played a part in 
this.  They were now living with serious side effect such as kidney disease and eye 
damage due to difficulties they had faced in managing their condition (Department 
of Health, 2007b).  Participants reported frustration at how the need to self-care for 
example insulin injections pushed the personal matter of health into a public domain 
when many wanted to retain the choice over disclosure.   
In summary this study identified a range of issues which were taken into account 
when making decisions around disclosure in the workplace.  These included current 
health status, identity and the condition, perceived reactions of staff, safety, and 
perceptions of legislative issues.  Similarities were found to Fesko‟s (2001) study of 
disclosure of HIV in the workplace in which a range of factors were considered to 
play a role in whether to disclose or not. These include: current and predicted future 
health status; personal acceptance of the illness; culture of the work environment; 
consideration of risk factors such as discrimination; stigma; ability to cope with 
potential negative impact of disclosure, need to maintain privacy, and consequences 
of non-disclosure which may be negative and thus lead to a lack of support. 
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The study findings illustrate that what constitutes visibility and invisibility in a long-
term condition is a complex question as they are not fixed.  Yet Vickers (1997) 
argues that decisions around disclosure in the workplace are particularly difficult 
primarily for those living with “invisible” long-term conditions. Health status and 
perceptions of the severity of the condition were taken into account such as the 
likelihood of the condition becoming “visible.”  Yet in this study such decisions 
were less clear but some participants chose to adopt the strategy of not disclosing 
and thus risking unplanned disclosure during an acute episode. This was considered 
a risk worth taking by some as it avoided perceived negative reactions to the 
disclosure such as being treated differently, and enabled participants to maintain a 
“healthy”, “normal” identity.   
Thus in the current study, non-disclosure appears to be linked not only to risk 
assessment but also to minimising the impact on their identity, in particular how to 
avoid stigma (Williams and Healy, 2001).  Some felt they had no choice but to 
disclose however this is not an easy decision and public misconceptions concerning 
the stigmatization of epilepsy and type 1 diabetes played a role in this study.  In this 
study participants stated they feared people would treat them differently following 
disclosure and draw upon such misconceptions of epilepsy.  This finding is 
supported by studies which have identified that co-workers do fear working with 
someone with epilepsy (Jacoby et al, 2004). 
Currently, studies on disclosure in the workplace are set in an North American 
context, which has different employment laws (Dyck, and Jongbloed, 2000, Fesko, 
2001, Beatty, 2004).  They have also tended to focus on potentially transferable 
conditions such as HIV/AIDS (Fesko, 2001).  This study has found that stigma is a 
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key concern for those living with type 1 diabetes as well as those conditions which 
are historically associated with stigma.  The implications of the study findings for 
employers are presented later in this chapter.   
In the next section I discuss the development of the theoretical conceptual 
framework of the role of disclosure.   
6.29 Development of Conceptual Framework  
Drawing upon the interviews I developed a conceptual framework of the role of 
disclosure to others (figure 4).  Disclosure was found to be a dynamic process linked 
to a number of mediating issues. 
The conceptual framework of disclosure has six elements:  
1. Nature: the essence of disclosure, (what?). 
2. Process: the manner in which disclosure occurs, (how?). 
3. Context in which disclosure occurs, (where?). 
4. Mediators of disclosure.  
5. Role of disclosure, (why?)  
6. Living with a long-term condition. 
These six elements set out are now discussed:  
1. The Nature of Disclosure: health status is personal and so disclosure has to 
play a functional role 
2. The Process of Disclosure: disclosure may occur in diverse ways; 
 directly (verbally) 
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 indirectly (visibly through acute episodes, injecting, dietary 
restrictions, “objects” associated with the management of the 
condition). 
3. The Process of Non-disclosure: the means by which participants actively 
concealed their condition such as:  
 concealing the biomedical aspects of managing the condition 
4. The Context of Disclosure: three settings were identified: 
 friends and family  
 partners 
 workplace   
5. The Mediators of Disclosure: illustrating a range of factors taken into 
account when disclosing: personal, previous experiences of disclosure, fear 
of stigma, medical control, acceptance of the condition, planned/unplanned, 
temporality visibility, context, denial.  
6. The Role of Disclosure: identifying three predominant roles of disclosure:  
i. Access to Self-care and Social Support: 
 enabling participants to manage their condition medically in 
terms of self-care and gaining social support. 
ii. Strategic Disclosure:  
 redressing myths about the condition in advance to avoid 
perceived stigma.  
iii. Non-disclosure: 
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 concealment of the condition to protect one‟s identity from 
stigma.  
7. Living with a long-term condition: the overarching challenges of living 
with a long-term condition; enduring, managing the medical, managing the 
social elements of the condition such as identity, living with limitations, 
managing disclosure: “who needs to know”, “learning about disclosure” 
over time: moving from personal perception of disclosure as “my problem” 
towards it being others‟ problem: “their problem.” 
 
 
242 
Figure 4 Conceptual Framework of the Role of Disclosure in Managing  a 
Long-term Condition 
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Figure 5 The Role of Disclosure in Self-care and Living with a Long-term 
Condition 
 
The figure above illustrates how disclosure plays a role in the process of self-care 
and how this overlaps into living with a long-term condition.   
Disclosure plays a key role in management of a long-term condition in several ways: 
 through gaining access to self-care and social support 
 non-disclosure is used to protect the individual‟s identity from anticipated 
stigma and so in itself forms a self-care strategy 
 fear of reactions to disclosure inhibits self-care regimes leading to 
concealment and possible negative impact on the individuals‟ health status 
The role of disclosure is currently absent from governmental policy documents on 
self-care (Department of Health 2008, 2005a,b, 2001a).  However learning about 
disclosure plays an integral part of the lives of those living with a long-term 
condition: to manage the process of self-care.  Thus as Bury et al (2005) notes it is 
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important to take the psychosocial elements of living with a long-term condition into 
account such as dilemmas around disclosure, alongside policy strategies on self-care 
which simply tell individuals “what to do” (Department of Health, 2008, 
2005a,b,2001a). 
In the next section of this chapter (part two) I go on to discuss the process of 
evaluating the findings of this research study.  
6.30 Part Two: Study Reflections, Implications And Conclusions 
6.31 Introduction 
In the second part of this chapter I set out: the criteria for evaluating the current 
study, the lessons learned from the process of conducting the study, reflections on 
the strengths and limitations of adopting the methodology constructivist grounded 
theory and the implications of the study findings for health care practice, policy and 
education, employers and future research are presented.  Finally, the summary and 
conclusions of the study are presented.  
6.32 Evaluating the Research  
In this study I have drawn on the specific criteria identified by Charmaz (2006) 
which are: originality, resonance and usefulness to assess the value of this 
constructivist grounded theory study.  Firstly I consider the “credibility” of the study 
(Charmaz, 2006). 
6.33 Credibility 
According to Charmaz (2006), credibility is concerned with whether the results are 
plausible in terms of the data presented, the analysis, the evidence presented for 
 
245 
claims made and the breadth of data gathered.  Credibility of a study is crucial not 
only in terms of the data gathered but to the entire research process.  
Charmaz (2006) presents six criteria with which to judge whether a study is credible. 
1. Does the research present intimate familiarity with the setting or topic? 
2. Are the range, number and depth of the data gathered sufficient?  
3. Were categories systematically compared? 
4. Do the categories cover a range of empirical settings? 
5. Does the data gathered link rationally to the data analysis and subsequent 
arguments which emerge?  
6. Has sufficient evidence been provided in the study to enable a detached 
reader to concur with the findings of the study? 
I now go on to discuss how the current study fits each criterion.   
The data meets these criteria in the following way: 
1. The research presents intimate familiarity with the topic through a 
presentation of a multi-disciplinary literature review of disclosure, the 
presentation of new insights into disclosure and a range of discussion and 
implications of the study taking the existing literature on disclosure into 
account and comparing this to the new empirical findings in this study. 
2. The sample group consisted of a range of participants living with the 
condition, diverse in terms of age, length of time since diagnosis and 
severity of condition (health status) resulting in a broad range of 
perspectives on disclosure. Therefore, I was also able to tap into both 
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retrospective views of disclosure and prospective anticipated difficulties 
concerning disclosure.  
Thirty-five in-depth qualitative interviews were conducted with participants 
recruited from patient support groups, and nurse specialist clinics. To 
facilitate depth to the data I conducted the interviews in a location which 
suited the participants, typically these took place in their homes.  These 
interviews lasted on average around one hour and so facilitated a relatively 
lengthy interview with sufficient time to explore areas of relevance to the 
participants‟ covering a broad range of topics.  In order to gauge the depth 
of the data gathered, the preliminary findings were discussed on an ongoing 
basis with colleagues to discuss the emerging categories.  
3. The process of constant comparison was employed to compare different 
categories.  For example strategies of disclosure and means of disclosing 
were compared as described in depth in the methods chapter.  
4. In the current study participants were recruited from two key settings: either 
patient support groups, or nurse specialist clinics.  However, experiences of 
disclosure emerged in the course of the interviews that had occurred in a 
range of empirical settings including: school, the workplace, friends and 
family, partners, and spouses providing experiences from a range of settings 
thus meeting the criteria.   
5. In this study the emerging data was considered against existing literature on 
disclosure and long-term conditions.  Turning to the literature enabled me to 
draw upon key concepts within the field of long-term conditions research 
and build upon existing studies. The logical links between the data and 
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subsequent analysis were further ensured by ongoing discussion with 
colleagues about the data and emerging categories. 
6. The findings were discussed regularly in an ongoing way with colleagues 
until it was felt sufficient evidence had been provided.  Preliminary work on 
the study was also presented to colleagues as well as at two international 
research conferences.  This provided a useful forum in which to discuss 
others views of the findings of this study.  
I now move onto the second criteria identified by Charmaz (2006) the “originality” 
of the study. 
6.34 Originality 
Charmaz (2006) presents four questions as criteria by which to judge the 
“originality” of the study.  These are:  
1. Do the categories present fresh insights? 
2. Is there: “a new conceptual rendering of the data?” (p182) 
3. What is: “the social and theoretical relevance of this work?” (p182) 
4. To what extent will the grounded theory: “challenge, extend, or refine 
current ideas, concepts and practices?” (p182). 
I now go on to discuss how the current study fits each criterion. 
1. In this study I have presented “fresh insights” into the process, and role of 
disclosure: the process of disclosure may occur in diverse ways, not only 
verbally, but indirectly through the management of the condition, three roles 
for disclosure were identified which are: (1) access to self-care and social 
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support, (2) non-disclosure (concealment) of the condition to protect one‟s 
identity from stigma. (3) redressing myths about the condition in advance: 
“preventive telling” to avoid perceived stigma, illustrating that disclosure 
plays a key role not only the medical management of the condition but also 
in the social management of the condition. These findings build upon 
existing work which is relatively limited in this field.  A key finding is that 
views on disclosure are dynamic and subject to change over time thus 
extending existing work in this area. The implications of the study are 
further set out later in this chapter. 
2. Charmaz (2006) argues originality should be measured in terms of whether 
the data presents: “a new conceptual rendering of the data” (p182).  This is 
represented in this study in the new conceptual framework (figure 4) of the 
role of disclosure in managing a long-term condition.  The framework sets 
out the process of disclosure, nature of disclosure, and range of mediating 
issues.  This provides clarification of the role of disclosure in the lives of 
those living with type 1 diabetes and epilepsy, illustrating that disclosure is 
of relevance to a broad set of those living with long-term conditions.  This 
study‟s clarification of the relevance of disclosure may facilitate further 
fruitful exploration in the context of other long-term conditions in the 
future.   
3. The social and theoretical relevance of this work are reflected in the 
implications of the findings for health care practice, employers, and future 
research and are set out in further detail in later in this chapter. 
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4. Finally I set out in detail how my grounded theory will: “challenge, extend, 
or refine current ideas, concepts, and practices?” (Charmaz, 2006, p182).  
The view that self-care is a straightforward process as set out in policy 
documents that 70-80% of those living with a long-term condition may self 
care (Department of Health, 2005a) is challenged by the findings of this 
study which illustrates that despite the integral role of disclosure in the lives 
of those living with a long-term condition in terms of self-care and gaining 
social support many participants faced difficulties when disclosing.  The 
findings that disclosure is a key element also extends current understanding 
of the challenges of living with a long-term condition, illustrating that 
disclosure is an important concept in this field.  Therefore issues of 
disclosure are not only relevant to those conditions which might be termed 
stigmatised but broader conditions.  
I now go on to consider the “resonance” of the study taking the criteria 
recommended by Charmaz (2006) into account.  
6.35 Resonance 
Charmaz (2006) presents four questions for consideration and how the current study 
fits each criteria is discussed. 
These are:  
1. To what extent do the categories present: “the fullness of the studied 
experience?”(Charmaz, 2006, p.182).   
2. Have you:“revealed…taken for granted meanings?” (p182).    
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3. To what extent have links been made between: “larger collectivities or 
institutions and individual lives, when the data so indicate?” (p183). 
4. “Does your grounded theory make sense to your participants or people who 
share their circumstances? Does your analysis offer them deeper insights 
about their lives and worlds?” (p183)   
I now go on to discuss how the current study fits each criterion. 
1. There were two elements to the process of examining: “the fullness of the 
studied experience”.  Firstly, by the end of the period of data collection no 
new issues regarding disclosure were being raised in the interviews. This is 
termed “theoretical saturation” (Charmaz, 2006).  Secondly, member 
checking was also used to assess the resonance of the study and the 
“fullness of the studied experience.”  The purpose of member checking is 
twofold: to gain feedback from the participants regarding the data collected 
and to enable participants to have access to amend the data (Sandelowski, 
1993).  In the current study I employed two key ways of member checking.  
a)  At the end of each interview I summarized verbally the key issues which 
the participant had raised to check that my understanding of their 
perspective was accurate.   Interviewees were invited to amend or add to the 
summary.  b)  Participants were given the option to review the transcripts, 
to remove or add anything as they wished. Six of the thirty-five participants 
requested a copy of the transcript and these were posted to them.  Two 
added further comments.  One specifically asked if I would delete a section 
of the interview which he regretted disclosing and the other articulated that 
she must have been extremely nervous in the interview and reflected that 
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the content of conversations can appear very differently when typed up and 
presented for review.  Four participants enclosed a positive note to say they 
were happy with the contents of the transcripts and wished me well for the 
study.   
2. In this study I identified a range of views on disclosure. The “taken for 
granted” meanings identified were: that disclosure is not generally seen as 
an issue when it actually is, and may become the source of difficulties in 
their lives.  In particular its key role in terms of the process of the self-care 
regimes in their daily lives and its overlap into both their social, private and 
working lives.  The role of time was identified in this study to be a mediator 
of views on disclosure. 
3. Links were made between: “larger collectivities or institutions and 
individual lives”.  In this study disclosure was identified as being of 
relevance in the lives of those living with long-term conditions in a broad 
range of settings.  These included issues of disclosure and self-care in the 
workplace as well as personal relationships with spouses, friends and 
family. The study identified the “need to tell” personal information about 
their health in the public and potentially risky setting of the workplace.   
4. The extent to which the analysis “offer them deeper insights about their 
lives and worlds” was achieved through the process of reflecting back upon 
the key issues participants raised in the interviews to the participants.  
Furthermore, some participants initially felt that they had little to say on 
disclosure but following the interview reflected that disclosure had in fact 
been of relevance to them.  Opportunities to provide feedback to 
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participants were also built into the study design in the form of a summary 
of the key findings to individual participants on completion of the study, 
and feedback to support groups.  Some participants raised the point that a 
health education leaflet on how to disclose would be particularly helpful 
and the need for greater publicity campaigns on long-term conditions thus 
illustrating the study tapped into their concerns.  
I now go on to consider the “usefulness” of the study taking Charmaz (2006) criteria 
into account. 
6.36 Usefulness  
Charmaz (2006) offers four questions to consider whether the study has 
“usefulness.”  These are: 
1. The extent to which the analyses may be applied in people‟s “everyday 
worlds”?  
2. Does the study‟s theoretical categories capture: “generic processes?” Have 
these generic processes have been analysed for: “tacit implications?” 
3. Does the analysis identify the need for additional research in other: 
“substantive areas?” 
4. How do the study findings build upon existing knowledge? 
I now go on to discuss how the current study fits each criterion. 
1. This study has identified that disclosure might be applied to peoples 
“everyday” situations because it plays a key role not only in the medical 
management of their condition, but also in the social management of their 
identity.  Evidence from the study may be used to provide information for 
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support groups, clinics and professional staff.  Further work may be 
conducted to assess its utility.  
2. The study findings captured “generic processes” as follows: “learning 
about disclosure” as a key temporal element in the lives of the participants 
was identified across both epilepsy and type 1 conditions.  Charmaz (2006) 
goes on to question whether these generic processes have been analysed for 
“tacit implications?” In this study I examined the process of “learning about 
disclosure” and identified that the “tacit implications” of this process are 
that disclosure plays a key but often hidden role in the lives of those with 
living with type 1 diabetes or epilepsy in terms of both the social and 
medical management of their condition and identity.   
3. The analysis identified “the need for further research in other substantive 
areas” as follows.  The potential for further research has been identified in 
this study in terms of raising awareness of the role of disclosure in terms of 
the link to self-care of the condition and also in terms of the broad range of 
ways in which disclosure itself may occur.  Research might be conducted on 
other long-term conditions, and examine the concept of disclosure further in 
relation to the role of time.  Examples of other substantive areas include:  
further research in the field of sociology of health and illness on the role of 
disclosure in individuals lives and further research in the field of 
psychology on the role of disclosure in relation to health conditions.  
4. This study has “built upon existing knowledge” by illustrating that 
disclosure is a key process in the lives of those living with epilepsy and type 
1 diabetes.  The study has identified three key roles for disclosure a) the role 
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of disclosure as access to self-care and social support, b) the importance of 
strategic disclosure applied in redressing myths about the condition in 
advance to avoid perceived stigma, (c) non-disclosure also plays a role as 
others choose not to disclose at all, in order to protect one‟s identity from 
stigma.  Disclosure has been identified as a dynamic process subject to 
change over time.  The implications of the study are set out later in this 
chapter in detail.   
In the next section I go on to discuss the “lessons learned” from the process of 
conducting the study in terms of the potential limitations identified in the study.  
6.37 Lessons Learned from the Process of Conducting the Study 
In this section I consider the lessons learned from the process of conducting the 
study namely: the limitations of the study, reflections on the application of 
constructivist grounded theory and consideration of ethical issues. 
The study raised a number of issues regarding gaining access to study sites once 
ethical approval was secured. In particular this raises issues of gaining access to 
study sites via clinicians, a time consuming and potentially sensitive process. The 
process of seeking access to the study sites was frequently blocked by clinicians, 
thus illustrating the degree of medical control.  These issues raise the question as to 
who is the “gate keeper” to patient access within the nurse specialist clinics and 
illustrate the nature of power relations in the workplace.  I reflected that being a PhD 
student at an external institution possibly did not merit the study a key priority in the 
context of their busy work lives.  In summary, these issues of access illustrated the 
busy nature of clinical work and the potential difficulties of seeking to conduct a 
study in a clinical context without some form of prior “link.”   
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I now go on to discuss some of the potential limitations identified in the study.  
Firstly I discuss the sample group. 
6.38 Limitations of the Study  
6.39 Sampling Issues 
Limitations emerged in terms of practicalities in adopting theoretical sampling, in 
particular recruiting those with specific viewpoints on disclosure to the study 
because I had effectively no control over who would choose to participate in the 
study.  Whilst participants were given the opportunity to recount their views of 
disclosure, when following up issues raised in interviews such as feelings of 
stigmatisation I sometimes felt I may be imposing others views upon them, such as 
questioning: “have you ever felt different to others?” and thus not giving each 
participant a fresh voice.   
The sample group was recruited to the study by varied means.  In the epilepsy clinic 
it was the nurse and in some cases the consultant selected who was to be invited to 
participate. Therefore, those included in the study may be atypical of the range of 
people living with the conditions.  I found during the course of this study that 
recruitment from the clinics was slower than anticipated and when I proposed 
offering a gift voucher the nurses felt that it would be an appropriate token in 
appreciation of participants‟ time.  However I reflected that this incentive may have 
been the primary reason for participation rather than the genuine desire to take part 
in the study.  
It could be argued that those who choose to participate in a research study about a 
topic such as disclosure of long-term conditions may not be typical of all people 
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living with the condition.  For example, overall more perceptions of disclosure were 
negative than positive, and it may be because those who did not perceive any 
difficulties around disclosure chose not to participate.  In this way then, positive 
experiences of disclosing to others may be under-represented in the current study.  
Due to the voluntary nature of the groups those attending the patient support groups 
may not seen as “typical” of the broad range of people living with the condition.  
However they were selected upon the basis that they would have a particular 
perspective on disclosure and this proved to be the case as they did mention the 
benefits of peer disclosure.  The sample from the patient support groups tended to be 
older and female but this was counterbalanced by recruitment in terms of both 
gender and age through the nurse specialist clinics.   
I now reflect upon the strengths and potential limitations in the application of the 
methodology constructivist grounded theory to this study (Charmaz, 2006). 
6.40 Reflections on the Process of Adopting the Methodology Constructivist 
Grounded Theory 
Firstly I discuss the strengths of using this approach.   
6.41 The Strengths of Constructivist Grounded Theory 
I reflect upon six key aspects of this approach:  
 the role of the researcher 
 ethical issues for the participant and the researcher 
 the process of coding  
 an emergent approach 
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 theoretical sampling  
 the timing of the literature review 
6.42 The Role of the Researcher 
Charmaz (2006) argues that the techniques themselves are neutral: the researchers‟ 
role is key.  To clarify, constructivist grounded theory is defined as follows: 
“Constructivism means seeking meanings – both respondents‟ meanings and 
researchers‟ meanings” (Charmaz, 2000, p524).  Therefore, a key tenet of 
constructivist grounded theory is that researchers‟ must adopt a reflexive approach to 
consider their contribution to the emergent theory (Charmaz, 2006).  
My contribution to theory is set out.  In this study I was able to consider my role in 
the process of gathering the data in terms of coding, interview questions and analysis 
and I now go on to reflect upon this process.  I also reflected that sometimes the 
unexpected emerged during the course of the interviews as Charmaz (1991) notes.  
This was the case in the current study, raising the question of the researcher‟s role in 
managing this as I go on to discuss.  
Before conducting the study I had little prior knowledge of type 1 diabetes or of 
epilepsy. I did not know of anyone in my personal life with either condition.  This 
meant that as I was interviewing participants I was simultaneously learning about the 
conditions and was thus able to build up knowledge on issues which were important 
to my participants and allow data to emerge without preconceptions which might be 
unhelpful or steer my data analysis in specific directions.  This allowed me to be 
open in my approach and gain fresh insight into the areas.  During the process of 
conducting this study I did become more emotionally involved in the research as 
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events in my personal life began to raise questions around disclosure and certainly 
throughout the research process I developed a greater understanding of disclosure on 
a personal level.  It could be argued that this is not surprising given that disclosure is 
perceived from a psychological perspective as a deeply personal, potentially emotive 
topic (Jourard, 1971, Rosenfield, 2000).  Charmaz (2006) argues that as researchers: 
“…we construct our grounded theories through our past and present involvements 
and interactions with people, perspectives and research practices” (p10).  
Furthermore Strauss (1987) notes that researchers may become involved in their 
research, not only intellectually, but emotionally, describing this process as being“in 
the work” (p10).  When absent from work due to illness, I noted that I was required 
to state the medical reasons for this. This form was kept in a communal folder and 
open to the scrutiny of others.  Furthermore, the question of disclosure again 
emerged in my professional life when seeking to gain access to the nurse specialist 
diabetic clinics I was required to complete a medical form citing previous and 
current medical conditions and was informed that dependent upon my responses, I 
may be contacted by an occupational health advisor.  This led me to consider that 
disclosure of sensitive health topics might be problematic.  When I began a course of 
psychoanalytic counselling, once more, the question and implications of disclosing 
to others arose again, such as to whom I should disclose and why, and how would 
others react?  Thus the unexpected aspects of grounded theory emerged for me in as 
much as I had commenced the project with limited knowledge of disclosure and by 
the end of the project, had learned directly through my own unanticipated personal 
experiences.  Other studies have emerged from academics‟ personal experiences and 
interest in the area.  It is worth noting that Glaser and Strauss‟s (1967) original 
grounded theory study on death and dying in hospital emerged from their personal 
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experiences of the subject and this demonstrates that our professional and personal 
lives are frequently intertwined as Charmaz (2006) has argued: “your journey 
through grounded theory may transform you” (p185).   
The researcher‟s role in the study raises the question of ethical issues and these are 
now discussed.   
6.43 Ethical Issues Raised in the Study 
The ethical implications of the study not only for the participant, but also the 
researcher are increasingly considered in terms of the emotional impact of 
conducting research on potentially sensitive topics (Commissioned Enquiry Risk to 
Well-being of Researchers in Qualitative Research, 2007, Lalor et al 2006, Craig et 
al, 2000, Lees, 1993).   
6.44 Ethical Issues for the Participants 
Some participants were distressed during the interviews and that raised the question 
as to my role as a researcher in managing this.  In particular, many of the epilepsy 
clinical nurse specialist attendees were unaware that they could access local groups 
for support and so appeared to be somewhat isolated.  In one of the interviews the 
participant was tearful during the interview, but assured me when asked, that she 
wanted to continue with the interview. I deemed that she appeared quite isolated and 
provided her with a contact number for a local support group co-ordinator whilst 
underlining that it was entirely her choice to do so.   
6.45 Ethical Issues for the Researcher  
In this study I was frequently surprised at the sensitive nature of some of the content 
of the interviews and on occasions during my fieldwork this left me feeling fatigued 
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and drained emotionally.  As noted earlier Charmaz (1991) does state that the 
unexpected may emerge during the process of interviews and so I was prepared for 
this to a certain extent.  I debriefed interviews with my supervisor which I had found 
difficult or emotionally draining and found this to be a valuable process that enabled 
me to maintain a professional approach as suggested by Bowling, (1997).  Other 
studies have identified the emotional impact of conducting qualitative interviews on 
researchers (Lalor et al, 2006).  I reflected that I was not trained as a counsellor but 
rather my role was to listen and to enable participants to tell their story (Charmaz, 
2006, Bowling, 1997).   
For those participants newly diagnosed, participating in the research interview may 
have been a cathartic experience.  Three of the younger participants asked me 
specifically what others had said in the interviews.  I reflected that the purpose of 
this was to gauge whether or not they shared similar experiences to those of their 
own age. To minimise undue concern and without going into specific details I told 
them that their accounts were comparable to others.  Others noted it was liberating to 
have someone to talk to and described it as “too good an opportunity to miss.”  
Some of the issues for participants which emerged in the course of the interviews 
included, feeling unfairly judged for having developed a condition, perceived to be a 
result of their own behaviour, some described how the reactions of others to their 
condition led them to feelings of depression and notions that life was not worth 
living. Others voiced extreme difficulties around coming to terms with the condition 
and its subsequent management.  Where appropriate I did offer additional 
information on local patient support groups but emphasised that making contact was 
entirely a personal choice. 
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I now go on to reflect on the process of coding the data in this study. 
6.46 The Process of Coding 
Upon reflection a number of negative aspects of disclosing to others emerged in the 
interviews alongside positive responses.  Using the grounded theory qualitative 
approach facilitated an understanding of such views changing over time, a process 
which would not have been easily captured on a questionnaire.  For example, it 
captured a number of changes over time and both retrospective and prospective 
views on disclosure such as reflecting back on previous experiences and for younger 
newly diagnosed participants‟ anticipatory reflections on potential difficulties around 
disclosure.  Constructivist grounded theory is particularly well suited to the 
exploration of long-term conditions because it is a flexible approach allowing one to 
follow up key issues which emerge in the data such as capturing participants views 
of changes over time (Charmaz, 1990, 2000, 2006).  
More specifically adopting constructivist grounded theory was particularly beneficial 
in the current study because it offers greater flexibility in coding procedures 
compared to other grounded theory approaches (Glaser and Strauss, 1967, Glaser, 
Strauss and Corbin 1990).  A key approach which Charmaz (2007) recommends 
is“learning to tolerate ambiguity” (p28) to facilitate emergence.  Using this 
approach I was able to examine the data in terms of “action” to facilitate insight into 
the social process of disclosure in addition to exploring the data for thematic issues, 
this led to the identification of the process of “learning about disclosure”.  I found 
this fresh approach helpful because I was seeking insight into the area of disclosure 
which lacked definition.  
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6.47 An Emergent Approach 
Upon reflection, a narrative approach was a possible alternative to grounded theory 
to have researched and analysed the data collected (Clandinin and Connelly, 2000).   
The narrative approach encourages participants to recount stories about their lives. 
Conducting unstructured interviews within a narrative approach may have also 
identified emergent themes that could have focused on learning to live with a long 
term condition and how telling people about chronic illness is part of this.  This 
approach would have been particularly well suited to exploring the temporal, 
chronological findings which emerged in the data with regard to aspects of 
disclosure, in particular “learning to disclose” as well as the temporal aspects of 
living with a long term condition which emerged in the interviews.  The narrative 
approach also encourages a collaborative narrative by combining the participants 
perspective and the researcher‟s.  As Clandinin and Connelly (2000) note: 
"Research… is a collaborative document, a mutually constructed story out of the 
lives of both researcher and participant"(p12). Thus the researchers life stories are 
taken into account as well as the participants.  This would have also been a 
particularly helpful approach to take given my personal experiences of disclosure.  
In considering: “what is truth?” it is argued within the constructivist paradigm that 
truth is “antifoundational” (Lincoln and Guba, 2000).  They describe 
antifoundational as follows: “the term used to denote a refusal to adopt any 
permanent, unvarying (or “foundational”) standards by which truth can be 
universally known” (p177).  In my personal correspondence with Charmaz (2007) it 
was confirmed that there is no single end product which is “arbitrarily preordained.”  
In other words what emerges from the study is itself a “construction” developed by 
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the researcher.  I felt it was particularly important to adopt a strategy which did not 
force me to adopt a preconceived endpoint to ensure that the findings reflected the 
participants‟ perspective and thus a flexible approach was for me pertinent.  Many of 
the studies conducted on disclosure were specifically based in the workplace.  This 
study provides perspective and broader insight into the decision making process 
around disclosure or non-disclosure in the lives of those living with type 1 diabetes 
or epilepsy. 
In particular the methodology highlighted the key role which others play in making 
sense of one‟s health condition: it is through interaction with others that one makes 
sense of things (Blumer, 1969).  For example participants felt stigmatised or 
conversely felt supported directly through others‟ reactions.  The negative reactions 
of others led many to avoid disclosure altogether.  Disclosure fundamentally 
involves others and thus adopting a constructivist approach which considers the role 
of others was essential.  I now go on to reflect on the role of theoretical sampling in 
this study. 
6.48 Theoretical Sampling 
Charmaz (2006) defines the role of theoretical sampling as follows: “to elaborate 
and refine the categories constituting your theory” (p96).  The sample includes a 
range of participants in terms of how long they have been living with the condition.  
This has resulted in a sample with older participants mainly reflecting back upon 
their experiences of disclosure and younger participants reflecting on their current 
experiences of disclosure and prospective views on disclosure.  This adds range and 
rich depth to the study as it includes a range of perspectives.  It also taps into how 
views of the conditions and attitudes towards disclosure of the condition changed 
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over time.  I now go on to discuss the literature review conducted in this study, 
taking the debates surround its timing into account. 
6.49 The Timing of the Literature Review 
There is considerable debate in the field of grounded theory methodology regarding 
the timing and the role of the literature review in grounded theory (Glaser and 
Strauss 1967, Glaser 1978, Charmaz, 2006).  It has been argued that in order to avoid 
what has been termed “received theory” (Glaser and Strauss 1967, Glaser 1978), the 
literature review should be delayed until data analysis has been completed so that the 
researcher remains open to fresh insights and is not swayed by existing literature. In 
the development of this study a literature review was required to set out a clear 
rationale for conducting the study.  Conducting the literature review after the data 
has been analysed can serve a key role in terms of clarifying and building upon the 
data analysis (Charmaz, 2006).  This process facilitates the process of critiquing 
existing work in relation to the grounded theory which emerges.  In this study I 
initially completed the literature review to set out the broad parameters of the study 
and then sought new literature for example, in the area of concordance and young 
people, to compare the data against existing work.  This played a key role in 
clarifying the study‟s contribution to the field of disclosure.   
I now go on to discuss some limitations of the methodology.  
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6.50 The Limitations of Constructivist Grounded Theory  
Charmaz‟s ( 2000) extensive critique of Glaser‟s (1978) grounded theory approach 
as “positivist” appears contradictory since she recommends adopting his criteria for 
what constitutes a good grounded theory as: “useful for thinking about how your 
constructed theory renders the data”(p182).  As stated earlier, Charmaz (2006) 
presents constructivist grounded theory to be a flexible approach whose methods can 
be adopted relatively easily in contrast to the rigid approach grounded in positivism.  
Indeed, Charmaz (2006) argues that one can use the procedures set out by Glaser and 
Strauss (1967) and later modified by Glaser (1978) and then Strauss and Corbin 
(1990) because these are themselves “neutral”:  “Techniques themselves are neutral 
– the researchers role is key: We may think our codes capture the empirical reality. 
Yet it is our view: we choose the words that constitute our codes” (p9). However, 
Charmaz‟s argument (2006) that the researcher plays an integral role in the study in 
terms of the data analysis raises the question of pre-existing knowledge the 
researcher has.  This does however suggest that differences in terms of the data 
analysis are likely to occur among experienced researchers rather than those who 
may be new to the field.  For example, Charmaz herself has conducted research on 
long-term conditions for many years which are arguably difficult to exclude (see 
Charmaz, 1983,1990,1991,2000,2002).   
Charmaz (2006) argues that constructivist grounded theory is an innovative approach 
which promises new things for the future: “…we look back into the history of 
grounded theory in the twentieth century and look forward into its yet unrealised 
potential for the twenty-first century” (p1).  However there is little detail in her book 
as to how to achieve this and it seems to be largely based upon the rhetoric rather 
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than the process of how to achieve such: “unrealised potential.”  She sees grounded 
theory methods as: “a set of principles and practices, not as prescriptions or 
packages” (p9).   
It might be argued that her argument of flexibility in the approach of grounded 
theory is not consistent with her approach to the assessment of the emergent 
grounded theory which is more prescriptive as I go on to discuss.   
This study has provided additional insights into the methodology in the following 
way.  Charmaz (2006) states: “analytic directions arise from how researchers 
interact with and interpret their comparisons and emerging analyses rather than 
from prescription” (p178).  This study found however that “external prescriptions” 
do exist and do play a role in terms of “analytic directions” in the following ways:   
 External prescriptions exist in the form of limitations in terms of accessing 
“ideal” sources of theoretical sampling: pragmatic issues of both access to 
the study sites and the timeframe of data collection in the field 
 the process of gaining access to specific sites through clinicians form 
additional “external prescriptions” as they can play a key role in the 
recruitment and sampling process 
 the role and timing of adopting the literature review links into the discussion 
of “external prescriptions”   
Issues around the role of the literature review do however further illustrate the 
limitations of a constructivist approach.  Whilst it is true that it is the researcher who 
codes the data, and therefore influences the“analytic directions”.  Charmaz (2006) 
also encourages the researcher to consider the literature to define the parameters of 
 
267 
the study. Therefore the researcher does not live in a knowledge vacuum and 
inevitably must draw upon “external prescriptions” in the development and 
construction of the grounded theory.   
In the next section I go on to discuss the implications of the study findings which are 
relevant to a number of audiences. 
6.51 The Implications of the Study Findings 
6.52 Introduction 
This section presents the implications across three areas: 
 Health Care Practice  
 Policy and Education  
 Future Research  
6.53 Health care Practice  
6.54 Clinical Nurse Specialists 
An increased awareness of the issues around disclosure and how these can affect 
individuals‟ self-care regimes has implications for health care practice and in 
particular clinical nurse specialists.  As key providers of care for those living with 
long-term conditions, nurses are arguably well placed to offer support to clinic 
attendees regarding issues around disclosure.   
The implications for practice are that specialist nurses might provide an information 
leaflet to patients identifying how disclosure can be an issues and how it can be 
related to the medical management of their condition.  Specific support and 
education for newly diagnosed patients and their families on methods of negotiating 
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disclosure including its role in their medication regimes.  In addition, incorporating a 
discussion on disclosure when providing education on how to manage their 
condition.   
I go on to present the implications of the study for policy and education.   
6.55 Policy 
The study findings build upon the policy work which sets out to support those living 
with long-term conditions to self-care and the development of patient-centred 
services by illustrating that learning about disclosure is a key element of living with 
and managing a long-term condition.  There have been a prolific number of policy 
documents concerning long-term conditions however the role of disclosure is 
currently absent and should be included in future policy documents on long-term 
conditions.  There is an additional need for policy documents to be tailored to 
specific long-term conditions rather than generically as is currently the case.  Policy 
documents should take into account the dynamic nature of living with a long-term 
condition as ways of managing disclosure may change over time in relation to 
mediating issues such as the heterogeneity of the symptoms, severity and ability to 
cope with living with the condition into account particularly in relation to supporting 
individuals self-care strategies.  Policy might support health care professionals in the 
delivery of education programmes which might include the topic of disclosure, 
delivering a programme of education in schools and the workplace on the 
implications of living with long-term conditions including epilepsy or type 1 
diabetes in particular with emphasis on the heterogeneity of the conditions.  The 
current study raised the difficulties which those living with epilepsy faced in terms 
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of gaining support and information for their condition and there is a need for 
epilepsy to have a higher policy profile than present.  
The development of health education leaflets for the patient living with the condition 
on disclosure strategies and those around them such as friends, family and 
employers.  
It is argued that ongoing education on long-term conditions might play a key role in 
terms of educating the general public and thus making the process and responses to 
disclosure less burdensome.  I now go on to present the implications of the study 
findings for patient support groups.  
6.56 Patient Support Groups 
The study findings raised a number of important implications for patient support 
groups are as follows:  
 innovative ways of supporting those who are younger by targeting their 
specific needs 
 raised awareness of patient support groups by offering contact details 
through primary and secondary clinics  
 Advice and guidance on disclosure  
The implications of the study for the workplace are set out in the following section.  
6.57 Employers 
Decisions around disclosure in the workplace were particularly challenging for 
participants.  Many experienced discrimination and were fearful of the consequences 
of disclosing their condition to employers and co-workers.   
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The study findings have important implications for employers.  Disclosure of health 
was deemed to be a highly personal matter for employees and so advice on 
employers‟ responsibilities in supporting employees living with long-term conditions 
in the workplace would be beneficial drawing on these study findings which suggest 
a need for:  
 Raised awareness of the heterogeneous symptoms and experiences of living 
with such conditions and their impact on the individual‟s role in the 
workplace 
 Raised awareness of continuing discrimination in the workplace (despite 
legislation) 
 Raised awareness of the psychosocial impact of discrimination and stigma 
 Raised awareness, advice and support in terms of the practical implications 
of managing long-term conditions within the workplace: workplace 
adjustments linked to self-care.  
6.58 Employees 
 Advice on disclosure to employers and work colleagues 
 Guidance on how the condition may impact on their role in the workplace 
This appears to be particularly relevant as the number of people living with long-
term conditions who wish to continue in employment may rise in line with the 
increased percentage of the population living with such conditions.  I now set out the 
implications of the study findings for future research. 
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6.59 Future Research 
The implications for future research are as follows:  
 Taking the role of disclosure in the management of long-term conditions 
into account in health care research 
 Views of partners, carers and family on disclosure should be taken into 
account to facilitate greater insight into the role of disclosure.   
 An exploration of ethnic communities perspectives on the role of disclosure  
 An exploration of gender differences on disclosure 
 Using a longitudinal research design to further explore perceptions of the 
nature and role of disclosure over time  
 Constructivist grounded theory is a methodology which can successfully 
explore long-term conditions and disclosure 
 Exploratory work on disclosure in the workplace taking employers views 
into account 
I now turn to the summary and conclusions of this thesis.  
6.60 Summary and Conclusions 
In conclusion, this study has provided clarification as to what constitutes disclosure 
and consequently broadened understanding of the role of disclosure in the lives of 
those living with either epilepsy or type 1 diabetes.  The rationale for this study 
stemmed from the paucity of research in the area of the role of disclosure of long-
term conditions in health care research.  This study adds to the field of research in 
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several different ways: providing insight into the nature of disclosure, process, and 
role in the lives of those living with type 1 diabetes or epilepsy. 
The conceptual framework and findings in this study extend current definitions of 
disclosure (as set out on p50) in the following ways.  Firstly, the findings support 
Charmaz‟s (1991) definition which suggests disclosure is an ongoing process 
throughout the lives of those living with a long term condition.  Furthermore this 
study also identified the process of “protective disclosure” which Charmaz (1991) 
notes sets out to manage to whom disclosure occurs and when. Schneider and 
Conrad‟s (1980) “preventive disclosure” which seeks to disclose to others to 
minimise potential distress of having an acute episode was also identified in this 
study.  
However in contrast to this previous work this study extends and develops 
conceptually understandings in the area of disclosure by strongly identifying the 
temporal aspects of disclosure.  Participants described how many changed their 
strategies of disclosure from concealing their condition towards disclosing to others 
in advance.  This study identified the process of “learning about disclosure” to be a 
dynamic process subject to change over time.  In contrast previous definitions of 
disclosure have suggested “fixed” strategies of disclosure (Charmaz, 1991, 
Schneider and Conrad, 1980, Beatty, 2004, Joachim and Acorn, 2003, Munir et al 
2005). 
The conceptual framework (figure four) and findings extend and develop 
conceptually understandings in this area in three key ways.  Firstly, by illustrating 
that disclosure may occur in a diverse number of ways not only verbally but 
indirectly such as through visual aspects.  This study extends understandings in this 
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area by illustrating that disclosure is not a straightforward process and may occur in 
broader ways than current definitions suggest (Dyck and Jongbloed, 2000, Williams 
and Healy, 2001, Munir et al, 2005).  Furthermore this study has raised the point that 
individuals living with a long term condition did consider “who needs to know?” 
about their condition across contexts such as the workplace, family and friends.   In 
contrast previous work has focussed on disclosure primarily in the context of the 
workplace (Beatty 2004, Munir et al, 2005, Dyck and Jongbloed, 2000).  Secondly, 
the framework identified that there are a number of key mediators taken into account 
when deciding to tell or not to tell.  These are not included in current definitions of 
disclosure (Charmaz, 1991, Beatty, 2004, Troster, 1997, Dyck and Jongbloed, 2000, 
Joachim and Acorn, 2003).  Finally this study identified a key role of disclosure to 
gain: “access to self-care and social support”: enabling participants to manage their 
condition medically in terms of self-care and gaining social support.  Therefore this 
study has identified that disclosure plays a key role in the lives of those living with a 
long term condition, aside from the management of stigma thus building upon other 
work in this area (Schneider and Conrad, 1980, Charmaz, 1991, Troster, 1997). 
The study identified that disclosure of a long-term condition was itself deemed to be 
a highly personal process and therefore only to be divulged for a reason within 
appropriate settings and context.  This study has provided additional insight into the 
process of disclosure illustrating that it may occur in a number of different ways.  
For example, opportunities for disclosure emerged indirectly through the process of 
self-care of the condition through questions posed to participants such as, “do you 
drive?” for those living with epilepsy and: “why do you have a fridge in your room?” 
for those with diabetes.  Disclosure also emerged through self-care: the process of 
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medically managing their condition.  Thus the potential opportunities for disclosure 
are broader than previously assumed.   
Outwith the context of friends and family disclosure was deemed to be more “risky” 
particularly when linked to the fear of being stigmatised by others.  In this context 
the role of disclosure was to gain access to social support and medical support where 
required.  Disclosure therefore presented participants with the challenge of managing 
their condition medically whilst seeking to maintain control over the personal and 
private nature of their condition.  The question of disclosure was therefore identified 
as an additional challenge to be managed in the lives of those living with long-term 
conditions as it had both profound social and medical implications.   
This study identified that decisions around disclosure were not straightforward and a 
number of mediating issues around disclosure were identified.  These included the 
enduring nature of the condition; issues of the visibility of the condition as linked to 
perceptions of medical “controllability” of the condition, and coping with the 
potential unpredictability of the condition.  Across both groups and conditions, 
participants appeared to be “learning about disclosure” over time.  Issues of 
temporality emerged in the data suggesting that strategies around disclosure or non-
disclosure may change over time.  For example participants recruited from the 
patient support group setting who tended to be older and to have lived with the 
condition for a longer period of time described a process of changing from seeking to 
avoid disclosure altogether where possible, described in the literature as “passing” 
(Goffman, 1963) to disclosing to others in advance as a means of redressing potential 
myths about the condition: “preventive disclosure” (Schneider and Conrad, 1980).  
This study extends the concept of “preventive disclosure” by illustrating that it is 
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subject to change over time.  
In contrast those recruited from the nurse specialist clinics identified their ongoing 
frustrations with reactions to disclosure leading many to choose to avoid disclosure 
where possible.  Such negative reactions were perceived to be a consequence of a 
lack of understanding concerning the heterogeneity of the conditions and potential 
limitations on their daily lives.  In this group disclosure was identified to be an 
additional burden to be avoided.  
Differences in information sources emerged across the settings and provided insight 
as to why younger participants tended not to seek out patient support groups.  
Overall this study has identified that the role of disclosure is not only linked to the 
need for others to: “know what to do” in the event of a potential acute episode as 
Schneider and Conrad (1980) have argued.  Disclosure plays a broader role in the 
lives of those living with either epilepsy or diabetes in terms of the medical 
management of their condition and the social management of their condition. The 
study identified three different and diverse roles of disclosure:   
 Firstly, disclosure is a key process which enables participants to manage 
their condition medically in terms of self-care and gaining social support.   
 Secondly, the role of disclosure appears to be applied in redressing myths 
about the condition in advance.  
 Thirdly, non-disclosure also plays a role as others choose not to disclose at 
all, in order to protect one‟s identity from stigma.  
A number of common issues were identified across both conditions.  The nature of 
disclosure was deemed to be highly personal as a consequence it must have a 
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“functional” role which is influenced by context and the passage of time. This study 
also  identified that disclosure may occur in a broad range of ways: verbally, visibly 
as a result of an acute episode, visibly when linked to the self-care of the condition.  
Triggers for disclosure illustrated that it is not always possible to control the timing 
of disclosure. 
This thesis has identified that disclosure is a key yet often overlooked concept in 
health care research and deserves further empirical attention.  Learning about 
disclosure is an integral part of living with a long-term condition.  In the context of 
the rise in the proportion of those living with a long-term condition and the 
implications for health services, the government has focussed upon supporting self-
care as a means of addressing this.  The link between disclosure as it impacts on self-
care has been strongly identified in this study.  Therefore, the role of disclosure in 
managing a long-term condition must be taken into account in future policy work as 
well as future research to explore this further. Living with a long-term condition is 
an increasingly important part of many people‟s lives. Part of this includes learning 
about disclosure and this study highlights that this is an area which those living with 
long-term conditions require additional support with managing which in turn will 
improve individuals‟ experiences of living with such conditions. 
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Literature Review Search Strategy 
Search Strategy (1982-2008) 
The following electronic databases were searched: SOCIOLOGICAL 
ABSTRACTS, MEDLINE, EMBASE, CINAHL, PsycINFO, BRITISH 
NURSING INDEX, AMED, INDEX TO THESES and DISSERTATION 
ABSTRACTS 
The following search terms were used: Self-disclosure, Truth-Disclosure, disclos$, 
prejudice, decision-Making, work-place, chronic-disease, Chronic illnessS or long-
term illness$, long-term condition, coping, self adj care, self-care# work or 
workplace, employment, managing, coping, interpersonal-communication, invisible, 
visible, stigma, views of illness, carers, patients, sick role, social support, complex 
condition, patient experiences, Epilepsy, type 1 diabetes 
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REQUEST FORM TO TAKE PART IN RESEARCH INTERVIEW 
Please tick the appropriate response and post in the pre-paid 
envelope. Thank you. 
□ I am willing to take part in an interview about my 
experiences of telling others that I have a long term 
health condition 
Please contact me to arrange an interview 
NAME ..............................................................  
TELEPHONE NUMBER ................................. 
BEST TIME TO CALL ....................................  
□ I am not willing to participate in an interview 
THANK YOU FOR YOUR TIME 
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Personal Data Collection Sheet 
 
Oxfordshire Research Ethics Committee "A" (O6/Q1604/79) 
Please can you give us the following information to help us to plan the 
study 
1. Please can you tell us your age? 
 
2. Are you female/ male? Please circle one. 
 
3. Can you tell us your occupation or job? 
 
4. Please tell us about your marital status? Please tick one option. 
 
Single  
Married  
Divorced  
Cohabiting  
Other (please tell us)  
Please return this slip in the prepaid envelope. Thank you. 
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RCN Institute 
Whichford House 
Building 1400, Parkway Court, 
Oxford Business Park, 
Cowley 
Oxford OX4 2JY 
Lorna Henderson Postgraduate 
Research student 
Telephone (01865) 787105/787113 
P.mail:loma. hendcrson@rcn.org.uk 
Invitation Letter (Patient Support Group) 
Study title: Patients' experiences of telling others that they have a long term health 
condition 
Dear Patient, 
I am a postgraduate research student registered at the Royal College of Nursing Institute, 
Oxford. I am contacting you because you have attended your patient support group. I am 
undertaking a study of patients' views and experiences of telling others that they have a long 
term condition e.g. friends, family, employers or other people. 
Whilst many people are living with a long term condition it is currently unclear how and why 
patients choose to tell others about their condition and how others react to the news. I am 
keen to hear your views. The findings of the research will be used to help understanding of 
what it's like to tell others about a long term illness. 
An information sheet is enclosed which explains the study in further detail. If you would like 
to participate please return the slip in the pre-paid envelope and 1 will contact you to arrange 
an interview at a time and place that suits you. It would be very helpful for the study if you 
could return the slip within the next two weeks. If you require any additional information 
please do not hesitate to contact me. This study has been approved by the Oxford Research 
Ethics Committee "A" reference number (06/Q1604/79). 
Yours sincerely,  
Lorna Henderson 
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RCN Institute 
Whichford House 
Building 1400, Parkway Court, 
Oxford Business Park, 
Cowley 
Oxford OX4 2JY 
Lorna Henderson Postgraduate 
Research student 
Telephone (01865) 787105/787113 
Email:lorna. henderson@rcn.org.uk 
Invitation Letter (nurse specialist clinic) 
Study title: Patients' experiences of telling others that they have a long term 
health condition 
Dear Patient, 
I am a postgraduate research student registered at the Royal College of Nursing 
Institute, Oxford. I am contacting you because you are due to attend a nurse specialist 
clinic at the (Hospital name). I am undertaking a study of patients' views and 
experiences of telling others that they have a long term condition e.g. friends, family, 
employers or other people. 
Whilst many people are living with a long term condition it is currently unclear how 
and why patients choose to tell others about their condition and how others react to the 
news. I am keen to hear your views. The findings of the research will be used to help 
understanding of what it's like to tell others about a long term illness. 
An information sheet is enclosed which explains the study in further detail. If you 
would like to participate please return the slip in the pre-paid envelope and I will 
contact you to arrange an interview at a time and place that suits you. To recompense 
you for your time in taking part in the interview we would like to offer 
participants a £15 voucher for the record shop HMV. It would be very helpful for 
the study if you could return the slip within the next two weeks. If you require any 
additional information please do not hesitate to contact me. This study has been 
approved by the Oxford Research Ethics Committee "A" reference number 
(06/Q1604/79). Yours sincerely, Lorna Henderson 
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Patient Information Sheet (Patient Support Group) 
Study Title: Patients' experiences of telling others that they have a 
long term health condition 
Oxfordshire Research Ethics Committee "A" (O6/Q1604/79) 
You are being invited to take part in a research study. Before you 
decide whether you would like to participate, we would like to explain 
why the research is being done and what it will involve. Please take time 
to read the following information carefully and discuss it with others if 
you wish. The information sheet tells you the purpose of this study and 
what will happen to you if you take part. Please contact me if anything is 
unclear or if you would like more information. Take your time in 
deciding whether or not you wish to take part. The research is being 
conducted by the Royal College of Nursing Institute, Oxford. 
(1) What is the purpose of the study? 
1 am a postgraduate research student registered at the Royal College of 
Nursing Institute, Oxford. The aim of this research is to find out more 
about patients' experiences of telling others that they have a long term 
health condition. The purpose of this research is also to understand 
more about patients' views and experiences of telling others that they 
have a long term health condition and to find out more about how others 
have responded to the news. We hope this will help health professionals 
understand more about what it is like to have a long term health condition. 
(2) Why have I been chosen? 
You have been sent this information pack because you recently attended 
your patient support group. 
(3) Do I have to take part? 
No, it is up to you to decide whether or not to take part. If you do, you 
will be given this information sheet to keep, and you will be asked to 
sign a consent form. You are still free to withdraw at any time and 
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without giving a reason. It is possible that some people may find talking 
about their disclosing their condition to others distressing.  A decision 
to withdraw at any time, or a decision not to take part, will not affect the 
standard of care you receive now or in the future. An example of a 
consent form is included in this pack for you to read. This is just for 
your information at the moment; please do not complete it yet. 
(4) What would happen in the interview? 
I would like to interview you at a time and place that suits you in order to 
find out more about your experiences of telling others that you have a 
long term health condition. In the interview I will ask you about how you 
made the decision to tell (or not tell) others about your illness, how you 
thought others might react to the news, how others did in fact respond to 
the news of your condition and how you felt about that. The interview 
will last approximately one hour. We would like to tape record the 
interview if you are happy for us to do so. After the interview a typist will 
type it out in full and you will have the opportunity to receive a copy of 
the transcript and invited to remove or add anything should you wish to 
do so. Your comments will remain confidential and no information will 
be passed onto NHS staff. Any information about you will have your 
name and address removed so that you cannot be recognised from it. A 
summary of the results of the study will be available and I would be 
pleased to send you a copy if you would like them. If you have a concern 
about any aspect of this study please contact the research Lorna Henderson 
who will do her best to answer any questions. If you remain unhappy and 
wish to complain formally you can do this through the NHS complaints 
procedure. Details can be obtained from your local Patient and Advice 
Liason Service on (01865) 221473, Email: PALSIRgi'orh .nhs.uk. This 
study was given a favourable ethical opinion for conduct in the NHS by 
the Oxford Research Ethics Committee "A" reference number 
(06/Q1604/79). 
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Contact details 
If you have any questions or concerns about the research, please contact 
Lorna Henderson on (01865) 787105/787113 between 9.30am and 5pm 
Monday to Friday. Thank you for taking the time to read this. 
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Patient Information Sheet (nurse specialist clinic) 
Study Title: Patients' experiences of telling others that they have a long term 
health condition 
Oxfordshire Research Ethics Committee "A" (O6/Q1604/79) 
You are being invited to take part in a research study. Before you decide whether 
you would like to participate, we would like to explain why the research is being 
done and what it will involve. Please lake time to read the following information 
carefully and discuss it with others if you wish. The information sheet tells you the 
purpose of this study and what will happen to you if you take part. Please contact me 
if anything is unclear or if you would like more information. Take your time in 
deciding whether or not you wish to take part. The research is being conducted by 
the Royal College of Nursing Institute, Oxford. 
(1) What is the purpose of the study? 
I am a postgraduate research student registered at the Royal College of Nursing 
Institute, Oxford. The aim of this research is to find out more about patients' 
experiences of telling others that they have a long term health condition. The 
purpose of this research is also to understand more about patients' views and 
experiences of telling others that they have a long term health condition and to find 
out more about how others have responded to the news. We hope this will help 
health professionals understand more about what it is like to have a long term health 
condition. 
(2) Why have I been chosen? 
You have been sent this information pack because you are due to attend a nurse 
specialist clinic at the (Hospital name). 
(3) Do I have to take part? 
No, it is up to you to decide whether or not to take part, if you do, you will be given 
this information sheet to keep, and you will be asked to sign a consent form. You 
are still free to withdraw at any time and without giving a reason. It is possible that 
some people may find talking about their disclosing their condition to others 
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distressing. A decision to withdraw at any time, or a decision not to take part, will 
not affect the standard of care you receive now or in the future. An example of a 
consent form is included in this pack for you to read. This is just for your 
information at the moment; please do not complete it yet. To recompense you for 
your time in taking part in the interview we would like to offer participants a 
£15 voucher for the record shop HMV. 
(4) What would happen in the interview? 
I would like to interview you at a time and place that suits you in order to find out 
more about your experiences of telling others that you have a long term health 
condition. In the interview I will ask you about how you made the decision to tell (or 
not tell) others about your illness, how you thought others might react to the news, 
how others did in fact respond to the news of your condition and how you felt about 
that. The interview will last approximately one hour. We would like to tape record 
the interview if you are happy for us lo do so. After the interview a typist will type it 
out in full and you will have the opportunity to receive a copy of the transcript and 
invited to remove or add anything should you wish lo do so. Your comments will 
remain confidential and no information will be passed onto NHS staff. Any 
information about you will have your name and address removed so that you cannot 
be recognised from it. A summary of the results of the study will be available and I 
would be pleased to send you a copy if you would like them. If you have a concern 
about any aspect of this study please contact the research Lorna Henderson who will 
do her best to answer any questions. If you remain unhappy and wish to complain 
formally you can do this through the NI1S complaints procedure. Details can be 
obtained from your local Patient and Advice Liason Service on (01865) 221473, 
Email: PA LSJKtiftorh.nhs.uk. This study was given a favourable ethical opinion for 
conduct in the NHS by the Oxford Research Ethics Committee "A" reference 
number (06/Q1604/79). 
Contact details: If you have any questions or concerns about the research, please 
contact Lorna Henderson on (01865) 787105/787113 between 9.30am and 5pm 
Monday to Friday. Thank you for taking the time to read this. 
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Interview Topic Guide 
Interviews with patients will be broadly guided by the following topics - 
however we want to ensure the latitude for patients to raise issues that arc 
relevant to them, therefore interviews will also be conducted with this aim 
in mind. The study is exploratory and so the questions are open-ended. 
Key questions/topics to be explored - 
• Experiences of disclosing illness to others in different contexts 
• What is the outcome of telling others about the condition? 
• What are the barriers to disclosing illness to others? 
• Patients perceptions of the role of disclosure of illness 
EXPERIENCES OF TELLING OTHERS ABOUT THEIR 
ILLNESS 
• Please could you tell me about your experiences of telling 
others about 
your illness? 
(Aim of question to explore patients views and experiences of 
telling others that they have a condition) 
• Please can you tell me about who you have told about your 
illness? 
(Aim of question to explore contexts for telling others about their 
illness e.g. work, friends, family). 
CONTEXT OF DISCLOSURE 
• Please can you tell me about how others have responded to you 
when you 
told them about your illness? 
(Aim of question to explore others responses to disclosure of 
illness) 
• Please can you tell me about times when you have not told 
others about 
your illness? 
(Exploring patients reasons for not disclosing illness to others) 
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PROCESS OF DECISION MAKING 
• Please can you tell me about how you made the decision to tell 
others 
about your illness? 
(Aim of question to ascertain whether strategic decisions are 
made). 
• Is there anything else you would like to say that we have not yet 
covered? 
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Prompts 
Could you describe 
further? Tell me about? 
How does that differ 
from? Can you give me 
an example of? 
Ending question 
Is there anything else you would like to add? 
End of interview 
Thank participant for their time and infonnation. Inform they can receive 
summary of the projects findings. 
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Consent Form 
Project title: Patients' experiences of telling others that they 
have a long term health condition 
Oxfordshire Research Ethics Committee "A" (O6/Q1604/79) 
Name of Researchers: Lorna Henderson, Postgraduate research 
student, Royal College of Nursing Institute, Whichford House, 
Building 1400, Parkway Court, Oxford Business Park, Cowley, Oxford 
0X4 2JY Telephone: (01865) 787105/787113 
Please initial box 
1. I confirm that I have read and understand the information sheet for the 
above study and have had the opportunity to ask questions. 
2. I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving any reason, without my medical 
care or legal rights being affected. 
3.  I understand that no sections of any of my medical notes will be 
looked at by the research team. 
4.  I agree to take part in the above study. 
 
| 
Please turn page to 
next sheet. 
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Consent form continued 
 
Use of tape recorders for recording the interviews 
 
So that the interviewer can concentrate on talking to you during the interview, and not 
on writing down everything you say, we ask if you mind if the interviewer brings a 
tape recorder to record the conversation.  Your name would not be recorded on the 
tape, and no-one except the researchers and the person typing out the interviews 
would hear the tape.  If you decide you would rather not have the tape recorder used, 
we are happy to take full notes instead. 
 
It may be possible to use some quotes from the recordings in our final report and 
publications.  These quotes would be used anonymously. 
 
Please initial box 
 
5. I am happy for the interview to be tape-recorded [  ] 
6. I am not happy for the interview to be tape-recorded. [  ] 
 I agree that words I say during the interview can be used 
anonymously as quotes in the reporting of the study. [  ] 
7. I give permission for my personal data to be stored and securely 
processed. [  ] 
 
 
 
   
 Name of study participant Date Signatures 
 
 
   
 Researcher Date Signature 
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Examples of Visual Diagrams 
Diagram exploring: "the rationale for disclosure and its intention or 
purpose". 
 
 
Seeking to 
manage: "who 
knows?" 
Drawing on prior 
experiences of 
disclosure 
Safety/ "never 
fully in control 
of your own 
body". 
Rationale 
for 
disclosure 
So others know 
"what to do". 
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Diagram exploring: “barriers to disclosure”. 
 
 
 
 
 
 
 
 
 
 
 
 
Barriers to 
disclosing 
long-term 
conditions  
Don’t want 
to be seen as 
“different” 
Embarrassed 
“They don’t 
understand”/ 
Disappointment 
in others 
reactions
Illness is 
personal  
They always ask 
me: “the same 
questions!” 
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LIST OF LOCAL AND NATIONAL PATIENT 
ORGANISATIONS 
LOCAL ORGANISATION: 
PATIENT ADVTCE AND LIAISON SERVICE OXFORD: (01865) 221473 Email: 
PALSJR@orh.nhs.uk 
Long-term Medical Conditions Alliance 202 Hatton 
Square 16 Baldwins Gardens London EC IN 7RJ 
Tel: 020 7813 3637 Fax: 020 7813 3640 
Email: infoiajlmca.org.uk Website: 
www.lmca.ore.uk 
LIST OF NATIONAL ORGANISATIONS FOR EPILEPSY 
The National Society for Epilepsy 
Chesham Lane 
Chalfont St Peter 
Bucks SL9 ORJ 
UK 
Tel: 01494 601300 
Helpline: 01494 601400 
Website: http://www.cpilepsynse.org.uk/ 
LIST OF CONTACT ORGANISATIONS FOR DIABETES 
Diabetes UK Careline 
10 Parkway, London, NW1 7AA 
Tel: 0845-120 2960 
Email: carelineC^dia be tes.org.uk 
Website: http://diabetes.org.uk 
 
